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Abstract
Since the serendipitous discovery of the first antibiotic, the "wonder drug" penicillin by
Alexander Fleming, bacteria over time have slowly developed resistance to most antibiotics
through three well coordinated processes. Firstly, bacteria can evolve their genetic makeup to
become resistant against antibiotics; Secondly, bacteria can relay the modified antibiotic resistant
genes to other bacteria and other species through a process called conjugation. Thirdly, bacteria
quickly give up their individuality to become a part of a team to form surface attached
multicellular communities known as biofilms. Bacteria residing within biofilms are protected by
a layer of slime which renders the bacteria one thousand fold more resistant to the action of
antibiotics. Nearly eighty percent of bacterial infections are associated with biofilms and
therefore understandably, biofilms are considered as one of the seven most important health
issues facing mankind in the 21st century.
The focus of research work presented here is to discover small molecules that can control
multiple microbial multicellular behaviors. The fundamental approach was to deploy small
molecules that do not kill the bacteria (nonmicrobicidal), but are able to modulate bacterial
multicellular behaviors, like biofilm formation and swarming motility, which are not essential for
bacterial survival but are critical for infections. Consequently, the use of such nonmicrobicidal
agents is less likely to induce evolution of bacterial genes. The use of two different kinds of
nonmicrobicidal agents, maltose derivatives and brominated furanones, as modulators of
different bacterial multicellular behaviors has been demonstrated.
Rhamnolipids secreted by Pseudomonas aeruginosa are biosurfactants that are known to
be essential for at least three multicellular behaviors of P. aeruginosa, biofilm formation, biofilm
dispersion and swarming motility. Maltose derivatives, which are structurally related to

rhamnolipids were synthesized and found to be nonmicrobicidal to the growth of P. aeruginosa,
Escherichia coli and Staphylococcus aureus. Maltose derivatives were effective at inhibiting the
initial adhesion, biofilm formation and at dispersing pre-formed biofilm of P. aeruginosa.
Maltose derivatives were capable of both modulating the swarming motility of wild type P.
aeruginosa (PAO1) and activating swarming of a nonswarming P. aeruginosa mutant, rhlA.
Although, the maltose derivatives were able to inhibit the biofilm formation, these agents were
not effective at either inhibiting the initial adhesion or dispersing the preformed biofilms of both
E. coli and S. aureus.
Brominated furanones are known to disrupt bacterial chemical communication process
known as quorum sensing (QS). Here the mechanism of action of brominated furanones on both
E. coli and P. aeruginosa was explored. The presence of a methyl substituent either on the
furanone ring or on the exocylic vinyl bond was identified as an important structural element for
maintaining nonmicrobicidal action. The protein SdiA of E. coli was found to be critical for
antibiofilm activities of brominated furanones against E. coli. The lasI protein on P. aeruginosa
is a known homologue of the E. coli SdiA protein. It was found that the brominated furanones
were antagonistic to the las QS system but were agonistic to the rhl QS system of P. aeruginosa.
The nonmicrobicidal agents presented here, maltose derivative and brominated furanones
offer new approaches for controlling biofilm and bacteria-related problems.
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Chapter 1
Introduction

1.1. Bacterial multicellular behaviors
1.1.1

Bacteria: “Can’t live with them can’t live without them”
Bacteria are usually regarded as microbes that invade human body causing detrimental

effects making existence difficult. Contrary to this belief, human survival is indebted to the
existence of bacteria as some of these bacteria play key role in various life processes. Bacteria,
within the human body are responsible for carrying out metabolic activities like food digestion
and vitamin synthesis. Even outside host bodies, bacteria carry out multiple functions that are
essential for maintaining the global energy cycle. These functions include decomposing dead
matter, breaking down garbage, bioremediation, nitrogen fixation etc.
Traditionally, bacteria have been viewed as unicellular organisms that can exist in many
habitats including air, soil, oceans, rocks and snow. Bacteria are also known to coexist on or
within other organisms such as plants and animals. Coexistence of bacteria within humans is
usually (99%) symbiotic, while sometimes (1%) certain opportunistic or pathogenic bacteria may
invade the host immune system, causing diseases and infections.
1.1.2

Bacteria are unicellular social beings
Observance of “teamwork” in bacteria dates back to the 20th century. Notably, Sergei

Winogradsky identified that bacteria play a crucial role in the global carbon cycle by
decomposing cellulose.1 Interestingly he also reported that majority of the bacteria resided as
groups on soil particles rather than existing as isolated cells. 2,3 Sergei Winogradsky’s
1

observation of group behavior in bacteria was later confirmed by Kempner and Hanson in 1968
by the discovery of quorum sensing in marine Photobacterium fischeri (Vibrio fischeri). Why do
bacteria switch from unicellular organisms to social beings? While the answer to such a question
may be complex, the general belief is that the switch is triggered to ensure the survival of the
microbes in the environment or in-vivo to maintain its virulence. It is argued that, triggering a
switch to group mode of living would require a coordinated merger of many chemical and
physical cues in the bacteria.4 In combination, such physio-chemical changes are capable of
inducing morphological changes that are necessary for social living.
1.1.3

Quorum sensing as an intelligence system of bacterial social behavior
Quorum sensing is a sophisticated communication system within the bacteria which helps

them receive and send chemical messages to and from other bacteria.4 Quorum sensing is
responsible for coordinately controlling the gene expression of the entire community of bacteria
and hence concerting a unicellular organism into a multicellular community.5 Quorum sensing
controls many multicellular bacterial behaviors including symbiosis, virulence, antibiotic
production, biofilm formation and swarming.5 The process of quorum sensing was first observed
in the marine bacterium Vibrio fischeri by Kempner and Hanson in 1968. These marine
bioluminescent bacteria were only able to produce light at a specific density of bacteria in the
liquid culture but not at low density. To explain their observation, Kempner and Hanson
proposed that there exist inhibitors of luminescence in culture medium and hence when culture
becomes overpopulated with bacteria, bacteria overpower these inhibitors in the culture.6 But
later it was shown that the phenomenon of density dependent bioluminescence was not due to
inhibitors in the medium but was dependent on the concentration of small molecules secreted by
bacteria, and these small molecules are called autoinducers. The process in which bacteria

secrete autoinducers and respond to their accumulation in the environment is called quorum
sensing and it was first discovered for the V. fischeri (photobacterium) (Figure 1.1).7-9
Eberhard and co-workers in 1981 first isolated and identified N-(3-oxohexanoyl)-3aminodihydro-2(3H)-furanone (AHL) from V. fischeri as a bacterial signaling molecule
(autoinducer). They further showed that autoinducers stimulated light production in V. fischeri in
a concentration dependent manner.10
The circuit of quorum sensing in V. fischeri was first mapped out in 1983 by Engebrecht
and Silverman.11-13 In V. fischeri, a two component system is involved in quorum sensing
wherein, luxI gene controls the expression of LuxI type protein (signal synthase) which is
responsible for production of autoinducer (AI). Initially the concentration of the AI’s is low
inside and outside the cell wall but as the cell density increases the local concentration of these
AI’s increases to nanomolar levels. Upon reaching a threshold concentration AI’s strongly bind
LuxR protein (signal receptor) (controlled by luxR gene) giving maximum activation of LuxR
(Figure 1.1).14-16 Binding of autoinducer to LuxR protein activates the expression of luxI and
downstream genes which controls the multicellular bacterial behaviors such as bioluminescence
in V. fischeri.12, 13 Hence V. fischeri exhibits cell density dependent bioluminescence.
Another quorum sensing circuit which co-exists in V. fischeri is LuxPQ/LuxS.17 In this
system LuxS is an autoinducer synthase which produce AI-2. LuxP is a periplasmic protein
which binds to AI-2. LuxQ is an inner membrane sensor kinase which detects the binding
between LuxP and AI-2.18 Activation of LuxQ further regulates the downstream genes. In case of
V. fischeri AI-2 is furanosyl borate.19
The initial confinement of quorum sensing to marine bacterium was later modified as it
was observed in other gram negative as well as gram positive bacteria.20, 21 Variety of

structurally different autoinducers exist in nature whose structure is specific for that bacterial
species. Gram negative bacteria use derivatives of AHLs and gram positive bacteria use oligo
peptides.22, 23 For example, different gram negative bacteria are able to distinguish their own
chemical signal from that of others by recognizing the difference in the length of acyl side chain
of acyl-homoserine lactone (AHL) autinducers.
Similar to the quorum sensing circuit in V. fischeri other gram negative bacteria are
known to possess a two component system having homologous LuxI and LuxR-type proteins
that secrete and bind specific autoinducers (Table 1.1). Later it is also shown that bacteria are not
only capable of intraspecies but are also capable of interspecies communication. This intra and
interspecies communication is important in ensuring bacterial survival and propagation in the
natural environment where hundreds of bacterial species coexist (e.g, human oral cavity).24
As quorum sensing is the communication between the bacteria through the chemical
signals which gives them the decision making ability to control their growth, movement and
biochemical activities, it is an attractive therapeutic target in medicinal field for controlling
microbes.

Figure 1.1 Quorum sensing circuit of Vibrio fischeri 25 [Reprinted with permission from
Citation: David R. Spring, (2011) Quorum sensing in gram-negative bacteria: small molecule

modulation of AHL and AI-2 quorum sensing pathways. Chem. Rev. (111), 28-67; Copyright :
2011, American Chemical Society.]

Table 1.1 Autoinducers secreted by Gram-negative and Gram-positive bacteria. (Adapted and
modified from review by Spring and co-workers and also by Bassler and co-workers.)5, 25

Gram-negative bacteria
(LuxI / LuxR homologs)

Acyl-homoserine lactone
(AHL) autoinducer

Gram-positive bacteria
Bacillus subtilis / ComX

Agrobacterium tumeaciens
(TraI/R)

O

O
N
H
O

Burkholderia cenocepacia
(CepI/R)

N
H

O

Chromobacterium violaceum
(CviI/R)
Erwinia carotovara
(ExpI/R); (CarI/R)
Pseudomonas aeruiginosa
(LasI/R; QscR)

N
H
O

O
O

O
O

O
N
H

O

O
O

O
O

O
N
H

O

Bacillus Subtilis / CSF
Staphylococcus aureus /
subgroup 1
Staphylococcus aureus /
subgroup 2
Staphylococcus aureus /
subgroup 3
Staphylococcus aureus /
subgroup 4

Oligopeptide
autoinducers
ADPITRQWGD
ERGMT
Y S T C D F IM
S
O
G V N A C S S LF
S
O
Y IN C D F L L
S
O
Y S T C Y F IM
S

O

O

O

(RhlI/R)

N
H
O

Pseudomonas putida

O
N
H

(PpuI/R)
Serratia marcescens AS-1

O

O
N
H
O

(SpnI/R)

N
H

O

Vibrio fischeri

O
O

O
N
H

(LuxI/R)

O
O

O
O
O
O

O
O

O

(AinS/R)
Vibrio harvey
(Genertaed by LuxM, detected by LuxN)

•

N
H

OH O
N
H

O
O

O
O

The on the B. subtilis ComX oligopeptide autoinducer represents a modification of unknown
structure.

1.1.4

From human perspective social microbes are more harmful than unicellular beings
Multicellularity is an adaptive lifestyle that microbes exhibit and as such is an integrated

activity of different cells. The coordinated behavior in microbes foresees cellular proliferation,
manipulates availability of resources and nutrients, shields individual cell against anti-microbials
and generates cell populations with assigned work and enhanced survivability. From a human
standpoint, the culmination of such differentiation and added resistance exhibited by
multicellular bacteria makes combating such microbes even more difficult task.

1.2. Quorum sensing controlled multicellular behaviors
1.2.1. Biofilm formation and its development
Among quorum sensing controlled processes, the one which is most vital for microbial
survival and also a significant contributor to the pathogenesis is formation of biofilm. Biofilms
are surface associated three dimensional hydrated bacterial communities formed by secreted
networks of extra polymeric substances.26, 27 This communal living gives bacteria an added
advantage over unicellular existence. Inside the biofilm, bacteria becomes 1000 fold more
resistant to the action of antibiotics than the planktonic microbes.28 About 80 % of bacterial
infections in humans are associated with biofilms.29 Biofilms are serious threats not only in the
medical sector but also in industrial and agricultural sectors. Common medical conditions
associated with bacterial biofilms include cystic fibrosis,30-38 catheter infections, tooth decay,
endocarditis, otitis media, chronic urinary tract disease and whooping cough. In terms of impact
to the medical and healthcare sectors, increasing rates of antibiotic resistance strains is one of the
most important consequences of biofilms.

Bacteria residing inside the biofilms are phenotypically different than the bacteria in the
culture of the same species.39 Biofilm formation is a developmental process and each step is gene
regulated. First step of biofilm formation is the reversible attachment of bacteria on the biotic or
abiotic surfaces.40 This initial attachment is governed by Van der Waals forces and at this stage
bacteria can be easily removed from the surface. In the second step, bacteria use its adhesins
such as pilli, flagella to adhere irreversibly onto the surface.41 It is also suggested that some
bacteria also precondition the surface with polymeric substances or proteins they are constantly
secreting in their milieu and further receptors on the bacterial surface recognize these epitopes.42
In the third step bacteria start communicating with each other through quorum sensing. When a
quorum is achieved, bacteria start secreting polysaccharides to create a three dimensional matrix.
The fourth step in the process is formation of mature biofilms. Mature biofilm is usually a
mushroom shaped structure consisting of different phenotypes as we move from cap to root of
the mushroom. Last step of biofilm formation is dispersion of mature biofilm. Dispersion is
important stage of the biofilm cycle as it allows bacteria to spread and colonize new surfaces.

Figure 1.2 Biofilm formation is a developmental process; 1) reversible attachment of cells on the
surface; 2) irreversible attachment of cells to the surface; 3) start of secretion of polymeric
substances to form biofilm, controlled by quorum sensing; 4) mature biofilm formation; 5)
dispersion of bacterial cells from the mature biofilm to colonize new surface.43 [Citation:
Monroe D (2007) Looking for Chinks in the Armor of Bacterial Biofilms. PloS Biol 5 (11):e308.
Doi: 10.1371/journal.pbio.0050307; Image Credit: D. Davies; Copyright: © 2007 Don Monroe.
This is an open-access article distributed under the terms of the Creative Commons Attribution
License, which permits unrestricted use, distribution and reproduction in any medium, provided
the original author and source are credited.
1.2.2 Different ways of controlling biofilm formation
Progression of biofilm formation is associated with many developing stages (Figure 1.3)
and therefore, most biofilm treatment strategies target at least one or more developing stages.44
These strategies include;

(1) Arresting switch from unicellular to multicellular lifestyle. Cyclic diguanylate (c-diGMP) is a secondary messenger in bacteria and suggested to be crucial for taking environmental
and physiological signaling inputs.45 Increase in the production of surface adhesive organelles
while going from planktonic to sessile mode is directly correlated with high levels of production
of c-di-GMP. Hence this switch from planktonic to biofilm lifestyle can be regulated by
controlling the production of c-di-GMP in bacteria.46, 47 One example is sulfthiazole compounds
which are active against the biofilm of Escherichia coli (E. coli ) by interfering with the
biosynthesis of c-di-GMP.46

(2) Molecular intervention of bacterial adhesion to surfaces. Many biological recognition
events such as cell-to-cell interactions, bacterial, fungal and viral infections of human host cells
are mediated through carbohydrate-protein interactions.48, 49 Bacteria in particular use proteins
known as adhesins to bind carbohydrate epitopes present on host cells.50, 51 Additionally,
adhesion is also the first step in the colonization of abiotic surfaces by bacteria to form biofilm.52,
53

Molecular intervention of bacterial adhesion to prevent infection is therefore the cornerstone

of a therapeutic approach known as anti-adhesive strategy.54
(3) Blocking bacterial communication through chemical mimics. Another approach to
prevent biofilm formation is through interference with the quorum sensing pathways of the
bacteria by limiting communication using small molecules that mimic natural autoinducers (AIs).
These mimics can bind the receptor protein of the natural AI’s and block the active site for
natural AI. Many anti-biofilm agents have been discovered based on this strategy. As every
bacterial species have their own set of autoinducers, a variety of mimicking molecules have been
discovered and tested for biofilm inhibition. Brominated furanones and indoles are best known

for interfering with the quorum sensing system of the E. coli and inhibiting formation of
biofilm.55-58 2-Aminobenzimidazole derivatives have been shown to inhibit biofilm formed by
Pseudomonas aeruginosa (P. aeruginosa).59, 60 Derivatives of naturally occurring acyl
homoserine lactones have been synthesized and shown to effectively inhibit formation of biofilm
by binding to the receptor protein more efficiently than the natural autoinducers.61-63
(4) Increasing the antibiotic efficiency by reactivating the metabolic activity.
The bacteria residing within the biofilm formed by P. aeruginosa in the cystic fibrotic lungs are
many fold more tolerant to the action of antibiotics. Hence, completely eradicating the pathogen
from the lungs of the cystic fibrosis patients is difficult. It has been shown that limiting iron
levels could be a potential strategy to disintegrate biofilm of P. aeruginosa.64 Further researchers
used FDA approved iron chelators along with antibiotics to inhibit such antibiotic resistant
biofilms of P. aeruginosa. Synergistic effect of antibiotic and iron chelators was able to disperse
almost 90% of the biofilm.65
(5) Creating surfaces that resist biofouling. Initial attachment of bacteria on the surface can be
avoided by making the surface bioinert. If bacterial adhesins do not recognize the surface it will
not be possible for bacteria to attach on to the surface. Luk and coworkers have reported bioinert surfaces that resist adhesion of microbes. They reported that polyol terminated alkanethiol
self-assembled monolayers (SAMs) on gold surfaces resisted the attachment of E. coli for almost
21 days.66 Progress has been made in creating bioinert medical devices like catheters by coating
them with antiseptics to avoid adherence of antibiotic resistant bacteria like Staphylococcus
aureus (S. aureus) or P. aeruginosa in critically ill patients.67
(6) Strategies to disperse preformed biofilms. Strategies that disperse preformed biofilms are
more clinically relevant than strategies that prevent biofilm formation. Many small molecules

that mimic autoinducers not only inhibit the biofilm formation but have also been shown to
disperse preformed biofilms.68 Compounds like nitric oxide (NO) have been reported to disperse
P. aeruginosa biofilm.69 Collins and coworkers have reported the use of bacteriophages that
expresses biofilm degrading enzymes to disintegrate the biofilm of E. coli.70, 71

Figure 1.3. Five developmental stages of biofilm formation and different strategies to disrupt
each step of biofilm formation.44 [Citation: Bordi and de Bentzmann (2011) Hacking into
bacterial biofilms: a new therapeutic challenge. Annals of intensive care, 2011, 1: 19.
doi:10.1186/2110-5820-1-19; Image Credit: de Bentzmann; Copyright: © 2011 Bordi and de
Bentzmann; licensee Springer. This is an open-access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use, distribution and
reproduction in any medium, provided the original author and source are cited.
1.2.3 Swarming
When bacteria come in contact with the surfaces, apart from aggregating into sessile
colonies of biofilms, sometimes they rapidly move on the surface through a multicellular process
known as swarming. Both biofilm formation and swarming are surface associated multicellular

bacterial behaviors that are inversely regulated.72, 73 The reasons as to why bacteria choose one
multicellular behavior over another are probably central to its survival. Swarming is a flagella
driven coordinated rapid movement of bacteria on semisolid surface.74, 75 In laboratory set up this
phenomenon is observed on agar plates containing nutrient medium. Some bacterial species like
Vibrio parahaemolyticus and Proteus mirabilis can swarm on 1.5 to 3% of agar gel (hard agar)
but some bacteria like (E. coli, P. aeruginosa and Bacillus subtilis) swarm on medium agar gels
(0.5 to 0.8 % agar).76 Below 0.5 % of agar, bacteria swim inside the agar through the water
channels and this motility is a unicellular behavior. Swarming is just not a locomotive type of
motion but it is lifestyle adaptation in response to the environmental cues and nutrient conditions
and hence it is highly influenced by quorum sensing.74 Bacteria swarming on medium agar gels
usually synthesize biosurfactants to propagate their motility on the surface,77 but there are
exceptions like E. coli and salmonella which do not produce biosurfactants.78

1.3 Need of new therapeutic approaches and non-microbicidal agents to control
multicellular behaviors of bacteria
All the bacterial multicellular behaviors induce high degree of antibiotic resistance in the
microbes.29, 76 Since the first introduction of antibiotics, bacteria over time have evolved
sophisticated resistant strains against almost all the available antibiotics.79-81 Microbicidal agents
like antibiotics cause selection pressure on the bacteria to evolve their genetic makeup and
develop resistance against such agents. Bacterial strains that are resistant to most of the
antibiotics are called multi-drug resistant (MDR) strains or colloquially as “superbugs”.82
Shutting down multicellular behaviors (swarming and biofilm formation), with the use of only
antibiotics, of such superbugs is a very difficult task and nearly impossible. Hence scientific
community continuously seeks new strategies to overpower these resistant superbugs without

killing them.82, 83 As a consequence, scientifically there is an urgency to find alternative nonmicrobicidal strategies that can control bacterial group behaviors. The central theme of this
thesis is therefore presenting alternative nonmicrobicidal strategies to control multicellular
behaviors of both gram negative (P. aeruginosa and E. Coli) and gram positive (S. aureus)
bacteria.

1.4 A brief introduction of the following chapters
Chapter 2. Inhibition of Pseudomonas aeruginosa adhesion, biofilm formation and dispersion
of preformed biofilm by maltose derivatives
Chapter 3. Swarming activation and phenotypic bifurcation of nonswarming P. aeruginosa
mutant by maltose derivatives
Chapter 4. Maltose derivatives inhibit the biofilm formation of Escherichia coli and
Staphylococcus aureus
Chapter 5. Biofilm inhibition activities and mechanism of action of brominated furanones
against Escherichia coli and Pseudomonas aeruginosa

Chapter 2
Inhibition of Pseudomonas aeruginosa Adhesion, Biofilm Formation
And Dispersion of Preformed Biofilm by Maltose Derivatives

Overview
Microbial biofilm formation is associated with many medical conditions and causes huge
expenses to industrial setups. Treating biofilms formed by bacteria poses many key challenges
including the problem of inducing drug resistance in microbes due to the use of microbicidal
agents that kill the planktonic bacteria. Contrary to this, nonmicrobicidal agents are less likely to
invoke drug resistance in microbes. Here we demonstrate the use of twelve nonmicrobicidal
maltose derivatives to efficiently inhibit and disperse the biofilms formed by an opportunistic
pathogen, Pseudomonas aeruginosa. Maltose derivatives possessing bulky hydrocarbon groups
had higher potency than derivatives with n-alkyl aliphatic chains, with the most potent agents
exhibiting a half-maximal inhibitory concentration for biofilm inhibition (IC50) and dispersion
(DC50) of 23 µM and 31µM, respectively. These maltose derivatives also reduced the initial
adherence of Pseudomonas aeruginosa on polystyrene surfaces. Unlike many other anti-biofilm
agents reported by others, these maltose derivatives do not interfere with the quorum sensing
pathways of Pseudomonas aeruginosa. Many bacterial biological recognition events are known
to be mediated by protein-carbohydrate interactions and we believe that, the action of these
maltose derivatives could be a consequence of such a recognition process, wherein a putative
receptor protein exists for a natural ligand that structurally resembles such maltose derivatives.

2.1 Background and Significance
2.1.1 Detrimental effects of Pseudomonas aeruginosa and its biofilm
Pseudomonas aeruginosa is a gram negative, rod shaped opportunistic pathogen
associated with many medical conditions.84 Infections by P. aeruginosa can be complicated, lifethreatening and have become an epidemic problem in healthcare settings. Hence, P. aeruginosa
is a model system for studying many bacterial related problems.85 Very common victims of P.
aeruginosa infections are the patients with weakened immune systems and patients with wounds
from surgery or burn.86 But P. aeruginosa is most studied in context of lung infections associated
with Cystic fibrosis patients. Cystic fibrosis (CF) is a hereditary condition which disrupts the
normal function of epithelial cells.87 Cystic fibrosis is a genetic disorder and the rate of its
inheritance among Caucasians is 1 in every 2,000 live births.88 In CF patients, P. aeruginosa
colonizes the lung and over time mutates to an alginate overproducing mucoid phenotype.89 It
has been reported that the biofilm formed by mucoid P. aeruginosa is more resistant to the
antibiotics than wild type P. aeruginosa.35, 90 The overproduction of alginate by mucoid P.
aeruginosa is ultimately responsible for poor prognosis and high mortality rates among CF
patients.36
Overall P. aeruginosa biofilms are difficult to eradicate as compared to other bacterial
biofilms due to low permeability of antibiotics through outer membranes of P. aeruginosa and
therefore, it is intrinsically resistant to most antibiotics.91, 92 Outer membrane permeability of P.
aeruginosa is 12 -100 times lower than that of Escherichia coli (E. coli).93 Low antibiotic
membrane permeability along with mutation to mucoid phenotype enables secondary adaptive
resistance mechanisms of P. aeruginosa to work more effectively.41 Therefore, the increase in
the emergence of the antibiotic-resistant bacteria calls for fundamentally new approaches to treat

wide range of infectious diseases.29, 37, 94 The relevance of quorum sensing in bacterial biofilm
formation,7, 13, 95, 96 and the detrimental effect of the biofilms thus formed has made the
exploration of nonmicrobicidal anti-quorum sensing or anti-biofilm approaches an important area
of research.26, 61, 62
2.1.2 Clinically relevant Mucoid strain of P. aeruginosa
Over time P. aeruginosa residing in the lungs of Cystic fibrosis (CF) patients mutates
into a mucoid strain.89 The microenvironments within the lungs of the CF patients support
conversion of wt. P. aeruginosa into mucoid strain.97, 98 Mucoid strain of P. aeruginosa is known
to overproduce a biopolymer known as alginate and the biofilm formed as a consequence does
not easily dehydrate and has added impermeability for antibiotics.99, 100 For example, Parsek and
co-workers showed that the biofilm formed by mucoid strain was a thousand-fold more resistant
than the non-mucoid strain to the action of antibiotic Tobramycin.101 Hengzhuang and
coworkers demonstrated that the treatment of biofilms formed by mucoid strains required higher
doses and longer treatment times with two antibiotics, Colistin and Imipenem, as compared to
the biofilms of nonmucoid strain.102 While many nonmicrobicidal small molecule based
treatments of P. aeruginosa biofilms have been reported, most of these studies were done using
the nonmucoid strain, therefore, potency of these small molecules on the clinically relevant
mucoid strain remains essentially unknown.103 However, Singh and coworkers did explore the
use of Esomeprazole molecules to control the biofilms formed by mucoid strain.104
2.1.3 Different virulence factors secreted by P. aeruginosa
Virulence factors are the gene products or the properties that help bacteria to establish
themselves on or into the host systems to cause an onset of infectious diseases.41 The prominent

virulence factors that ensure bacterial survival and maintain its pathogenicity include secretion of
toxins, expression of surface proteins to mediate bacterial attachment, secretion of
polysaccharides and the secretion of hydrolytic enzymes.Virulence factors for P. aeruginosa are
adhesins (flagella and pili),105 alginate,106 biosurfactant-rhamnolipids,107 iron uptake system,108
pyocyanin,109 protease,110 elastase,111 quorum sensing112 and type III secretion system.113
Therefore, a good strategy for controlling bacterial infections can be developed by targeting
these virulence factors. While, individual virulence factors are easier to control, controlling
multiple virulence factors at the same time is a more challenging task. The overall goal of this
chapter is to inhibit the biofilms of P. aeruginosa with the help of a class of synthetic molecules
that are predicted to mimic a prominent virulence factor of P. aeruginosa, rhamnolipids.
2.1.4 Quorum sensing circuit of Pseudomonas aeruginosa
As biofilm formation is highly influenced by the quorum sensing (QS) pathways of the
bacteria, extensive work has been done toward inhibiting the quorum sensing of bacteria to
reduce the bacterial biofilm formation.61, 114, 115 Quorum sensing system in P. aeruginosa is
controlled by two regulatory systems which are homologous to lux QS systems of V. fischeri.
These two regulatory systems in P. aeruginosa are las and rhl QS circuits.116 Each of these
systems is controlled by a set of two proteins, of which one is the autoinducer synthase and other
is the autoinducer receptor. In las system, LasI protein (homologous to luxI of V. fischeri)
catalyzes the synthesis of autoinducer, N-3-oxododecanoyl-homoserine lactone (PAI-1) which
binds to the receptor protein, LasR (homologous to luxR of V. fischeri). The LasR-PAI-1
complex further controls the activation of the rhl QS system. In rhl QS system, RhlI protein
(homologous to luxS of V. fischeri) synthesizes N-butyryl-homoserine lactone (PAI-2) which
binds to RhlR protein (homologous to luxP of V. fischeri).117, 118 Complexes LasR-PAI-1 and

RhlR-PAI-2 together control almost 600 genes of P. aeruginosa and many of these genes are
responsible for secretion of different virulence factors.119 Therefore, designing mimics of PAI-1
and PAI-2 (Figure 2.1) that can interfere with bacterial quorum sensing and modulate biofilm
formation is an important anti-biofilm strategy.62, 120
O

O H

O
N
H
O
N-(3-oxododecanoyl)homoserine lactone (PAI-1)
O H
O
N
H
O
N-butyrylhomoserine lactone (PAI-2)

Figure 2.1. PAI-1 secreted by las system and PAI-2 secreted by rhl system of P. aeruginosa

2.1.5 Role of naturally occurring disaccharide hydrocarbons in biofilm formation and adhesion
of P. aeruginosa
2.1.5.1 Biosurfactant production in P. aeruginosa and its significance in biofilm formation
P. aeruginosa produces biosurfactants rhamnolipids, which is one of the many virulence
factors it secretes. The production of rhamnolipids by P. aeruginosa was first reported by Jarvis
et al in 1949 and the structure of the rhamnolipids was first discovered in 1965 by Hayashi J.
A.121, 122 Apart from P. aeruginosa, such glycolipid biosurfactants are also produced by other
bacterial species.123
The rhlAB operon is responsible for rhamnolipids synthesis and this operon is under rhl
QS system.124 Study by Greenberg and coworkers showed that rhlAB operon is over expressed in
the stalks of the mushroom-like biofilm structures.124 P. aeruginosa secretes three types of

surface active molecules, di-rhamnolipids, mono-rhamnolipids, and 3-(3 hydroxyalkanoyloxy)
alkanoic acids (HAAs) (Figure 2.2).125 Di-rhamnolipids are synthesized via a three step
enzymatically catalyzed process. Firstly, HAA acids are synthesized and this step is catalyzed by
the RhlA protein.126 In the next step, membrane bound rhamnosyl transferase enzyme RhlB,
transfers and attaches one sugar moiety (dTDP-L-rhamnose) to the precursor HAA to yield
mono-rhamnolipids.127 In the third step, RhlC protein adds the second sugar moiety to the monorhamnolipid product of step two to give di-rhamnolipids.128 In general, a mixture of HAA, monorhmanolipids and di-rhamnolipids produced in-situ by P. aeruginosa is referred to as
rhamnolipids. Since the production of rhamnolipids is controlled by quorum sensing, extensive
research has been done to understand the role of rhamnolipids in multicellular behaviors of P.
aeruginosa. In 2002, O’Toole and co-workers showed that rhamnolipids are required for
maintaining water channels and pores in the biofilm of P. aeruginosa .129 A mutant incapable of
producing rhamnolipids was unable to form three-dimensional biofilms and rather formed
collapsed layers (pancake-like) of biofilm over each other.130 Rhamnolipids inhibit the adhesion
of P. aeruginosa and E. coli, suggesting that biosurfactants have the ability to disrupt cell-to-cell
and cell-to-surface interactions.129 Another role of rhamnolipids is to protect intrusion of other
bacterial species into the biofilms formed by P. aeruginosa.129 Over production of rhamnolipids
by P. aeruginosa helps in the dispersion of bacteria from mature biofilms.129 Rhamnolipids have
also been reported to disperse biofilms formed by other bacteria.131

Figure 2.2 Biosynthesis of rhamnolipids by P. aeruginosa. [Adapted and modified with
permission from Citation: E C Pesci, (1997), “Regulation of las and rhl quorum sensing in
Pseudomonas aeruginosa” Journal of Bacteriology (179), 3127-3132; Copyright: 1997,
American Society for Microbiology.]
2.1.5.2 Role of carbohydrates in controlling bacterial adhesion
Adhesion of bacteria on host surface is the first and a critical step in the establishment of
bacterial infectious diseases.132 In general, carbohydrate-protein interactions are known to
mediate many biological events but, in bacteria specifically, such interactions mediate most of
the adhesion processes with host surfaces.133 Therefore, preventing adhesion by creating
molecular interventions that block bacterial adhesins like pilus, lectins and flagellin is an
important therapeutic approach to control infections.134, 135 P. aeruginosa adhesin, pili, has been
shown to be responsible for mediating initial adherence to both biotic and abiotic surfaces.50, 136
The mediation of adherence by pili protein is through the carbohydrate-protein type of
interaction. Further studies have shown that a domain in the C-terminal region of pili protein is

the minimum binding sequence that recognizes βGalNAc(1-4)βGal disaccharide moieties offered
by asialo-GM1 and asialo-GM2 present on human buccal epithelial cells (HBECs).137-139 This
minimum binding sequences was later identified as a seventeen aminoacid residue looped
sequence that is semi-conserved in many P. aeruginosa strains.140, 141 Structurally identical
synthetic peptides having similar sequence to naturally occurring C-terminal pili protein were
shown to inhibit adhesion of bacteria on HBECs.50 Randall and co-workers have reported the use
of βGalNAc(1-4)βGal based hydrocarbons to interfere with adhesion of P. aeruginosa.140, 142, 143
Although, the effects of structural variation of βGalNAc(1-4)βGal based hydrocarbons on P.
aeruginosa adhesion were reported by Randall and co-workers, the potency of other sugar
stereochemistries on adhesion and the use of such agents for biofilm inhibition still remains
unexplored.
2.1.6 Use of surfactants to inhibit biofilm formation
Surfactants are amphiphilic molecules that can be easily immobilized onto a surface and
therefore are commonly used to lower the surface tension of a material. Detergency and
dispersant properties of surfactants make them useful in washing and cleaning purposes in day to
day life. The hypothesis that surfactants can be used to wash away bacterial biofilms has been
pursued but it still remains a relatively unsuccessful anti-biofilm strategy as compared to quorum
sensing inhibitor techniques. The use of cationic surfactants which are toxic to microorganisms,
anionic surfactants, and nonmicrobicidal non-ionic surfactants to inhibit biofilm formation has
been reported.144, 145 Surfactin is an example of a biosurfactant that has been used for inhibition
and dispersion of Bacillus subtilis biofilm.146 Zegans and coworkers demonstrated the use of a
non-ionic surfactant, polysorbate 80 for P. aeruginosa biofilm inhibition.147 Rhamnolipids which
are self-secreted by P. aeruginosa have been shown to be effective in dispersion of biofilm

formed by PA17 strain of P. aeruginosa.148 Additionally, biosurfactants rhamnolipid and
surfactin have been shown to inhibit the adhesion and biofilm formation of several food borne
pathogens.149
2.1.7 Aim of the project
The abilities of three types of generic surfactants; non-ionic, anionic and cationic, to inhibit
the biofilm formation of P. aeruginosa were investigated. The preliminary investigation brought
forward the non-ionic surfactant, dodecyl-β-maltoside as a potent biofilm inhibitor. Additionally,
the diverse bioactivities of the biosurfactant rhamnolipids, which include, their role in
maintaining three-dimensional structures of P. aeruginosa biofilms and their ability to disperse
bacteria from mature biofilms, along with the fact that many saccharide-hydrocarbons are
involved in bacterial surface recognition events, further prompted us to explore the effect of
different maltose derivatives on bacterial adhesion and biofilm formation.

2.2 Results
2.2.1. Non-ionic surfactant dodecyl-β-maltoside inhibits biofilm formation where as other
generic surfactants do not
Four generic surfactants were tested for anti-biofilm activities against P. aeruginosa. For
this, an anionic surfactant, sodium dodecyl sulfate (SDS); a cationic surfactant, dodecyl trimethyl
ammonium chloride (DTAC); and two nonionic surfactants, tetra (ethylene glycol) monododecyl
ether (C12EG4OH) and dodecyl-β-maltoside (DβM) were used (Figure 2.3A). The toxicity of
these surfactants at 170 µM was tested on the growth of planktonic bacteria. While all four tested
surfactants were non toxic to microbial growth, DTAC seemed to retard the growth of
planktonic P. aeruginosa (Figure 2.3B). The biofilm was grown for 24 h in media within the
wells of 96-well microtiter plate. The amount of surface attached biofilm formed in presence or

in absence of such agents on the surface of the wells was quantified using crystal violet dyestain. The percent biofilm inhibition was calculated by comparing the biofilm content in wells
treated with various surfactants against biofilm formed in wells without any agent. Surprisingly,
only the surfactant with a sugar head group and a long aliphatic chain, dodecyl-β-maltoside
(DβM) was active against the biofilm formation of P. aeruginosa. Among the tested surfactants,
DβM exhibited 64 % biofilm inhibition, whereas other types of surfactants showed no inhibition
(Figure 2.3C). The biofilm growing in wells treated with 170 µM of DβM appeared to be loosely
bound to the surface with chunks floating in the culture (Figure 2.3D). These initial results
suggested that the maltose derived hydrocarbon DβM was effective at inhibiting the biofilm
formation of P. aeruginosa although the mechanism of such an inhibition seemed unclear. The
biofilm inhibition by DβM could either be due to the physical washing away of the biofilm or it
could be a biological effect wherein, DβM targets a particular biological pathway of P.
aeruginosa. A preliminary observation that, another non-ionic surfactant, C12EG4OH which has
better surface activity than DβM (Table 1) was incapable of inhibiting biofilm formation
suggests that, surface activity alone cannot explain the biofilm inhibition ability of DβM.

Figure 2.3 (A) Structures of generic surfactants, DβM, C12EG4OH, SDS and DTAC. (B)
Growth curve of P. aeruginosa in presence of 170 μM of generic surfactants. (C) Inhibition of P.
aeruginosa biofilm by 170 µM of generic surfactants measured by crystal violet dye staining;
Error bar is standard error of the mean from 6 replicates. (D) Image of P. aeruginosa (PAO1)
biofilm in presence or in absence of 170 µM DβM taken after 24 h of inoculation.

Table 2.1 Surface activity of generic surfactants
Generic Surfactant
Tetraethylene glycol dodecyl
ether (C12EG4OH)
Dodecyl-β-maltoside (DβM)

Critical micelle
concentration (CMC)
50 µM

Surface tension
(γ) at CMC
27.6 mN/m

170 µM

35.3 mN/m

2.2.2. Design and synthesis of maltose derivatives
In order to understand the importance of structural details for biofilm inhibition activity,
variants with the same disaccharide stereochemistry as of DβM (Glcα(1 4)Glcβ) were included
in the structure activity study (Figure 2.4). The structures synthesized include maltose derivative
having a 10 (decyl β-matoside; DeβM), 11 (undecyl β-maltoside; UβM) and 12 (dodecyl βmaltoside; DeβM) carbons aliphatic chain. Maltose derivatives with the hydrocarbon tails having
terminally bulky aromatic groups such as, benzyl decyl-β-maltoside (BDeβM); benzyl dodecylβ-maltoside (BDβM); 4-tertiary butyl benzyl decyl-β-maltoside (4-tBuBDeβM); 4-tertiary butyl
benzyl dodecyl-β-maltoside (4-tBuBDβM); 3,5-dimethyl benzyl dodecyl-β-maltoside (3,5DMBDβM); 4-methyl benzyl dodecyl-β-maltoside (4-MBDβM) and benzophenonyl decyl-βmaltoside (BPDeβM) were synthesized. Maltose derivative with hydrocarbon tail bearing
terminal non-aromatic bulky group, adamantane dodecyl-β-maltoside (ADβM) was also
synthesized. Additionally, the effect of having a polar group attached at the end of the
hydrocarbon chain was also investigated by synthesizing 12-hydroxyl decyl-β-maltoside (12HODeβM).
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Figure 2.4 Library of maltose derivatives

Synthesis of all the maltose derivatives was done using a literature reported procedure with a
few modifications.150 Here the synthesis of one maltose derivative, BDβM (5) is described
(Scheme 1) and the synthesis of others was done similarly (see materials and methods). Briefly,
maltose was per-O-acetylated with AcBr/AcOH mixture with simultaneous bromination at the
anomeric position. This was followed by glycosidation with 12-(benzyloxy) dodecan-1-ol in
presence of FeCl3. Separation of α and β anomer was done by column chromatography. The
deprotection of acetyl groups with sodium methoxide followed by neutralization to pH ~ 6.5
with amberlite H+ resins (Zemplen deacetylation) yielded molecule BDβM (5).

HO(CH2)12OH
Benzyl bromide NaH, DMF
AcBr
AcOH

F e C l3
M eC N

CH3ONa
CH3OH

H+ (pH ~6.5)

(5)
Scheme 2.1 Synthesis of maltose derivative BDβM (5)

2.2.3. Maltose derivatives did not inhibit the growth of P. aeruginosa
All the maltose derivatives were first examined for their effect on the growth of
planktonic P. aeruginosa. None of the tested maltose derivatives inhibited the growth of P.
aeruginosa strain at 170 μM (Figure 2.5). In fact at 170 μM, some of the maltose derivatives
promoted the growth of P. aeruginosa. The concentration (170 μM) tested is higher than the
effective concentration of these molecules at which all the following biological assays (biofilm
inhibition, bacterial adhesion, biofilm dispersion and gene reporter assays) were done. The nontoxicity of these agents against P. aeruginosa indicates that the associated biological activities of
such agents are not consequences of growth inhibition. Such a non-microbicidal mode of action
is important as these agents are less likely to invoke drug resistance over time.26
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Figure 2.5 P. aeruginosa growth response curve in absence and in presence of various maltose
derivatives at 170 µM. Error bar is the standard error of the mean from 6 replicates.

2.2.4. Nonmicrobicidal anti-biofilm and anti-adhesion activities of maltose derivatives
The amount of biofilm inhibited by maltose derivatives was quantified using crystal violet
(CV) dye based assays. Two generic surfactants, SDS and C12EG4OH and one quorum sensing
inhibitor, brominated furanone (BF8)151 was used as a control to contrast the anti-biofilm
activities of the twelve maltose derivatives against P. aeruginosa biofilms. The results indicate
that biofilm inhibition activity of maltose derivatives was sensitive to their structural details
(Figure 2.6). Introduction of an aromatic bulky group on the aliphatic chain increased the
potency of three maltose derivatives, BPDeβM, BDβM and 4-tBuBDeβM as compared to the
maltose derivative with n-alkyl aliphatic chain, DβM. Five maltose derivatives, BPDeβM,
BDβM, 4-tBuBDeβM, DβM, and 4-MBDβM inhibited more than 80 % of P. aeruginosa
biofim. Inhibition in the range of 40 to 60 % was obtained by six maltose derivatives, ADβM,
3,5-DMBDβM, 4-tBuBDβM, BDeβM, UβM and DeβM. Maltose derivative, 12-HODeβM
having a hydrophilic terminal group (hydroxyl) on the aliphatic chain was structurally different
than other maltose derivatives in not having an amphiphilic structure. This non-amphiphilic

molecule showed very low anti-biofilm activity (only ~ 30% inhibition). Increasing the aliphatic
chain length of maltose derivatives from ten carbons (DeβM) which had a biofilm inhibition of ~
40% at 110 µM to twelve carbons (DβM) increased the inhibition to ~ 64 % at similar
concentration. This suggests that the length of the aliphatic chain plays an important role in
conferring anti-biofilm property to the agents.
Usually the adhesion of planktonic cells onto the surfaces is the first step of bacterial
infections and biofilm formation. While many studies have been done on designing carbohydrate
ligands that behave as molecular interventions against microbial adhesion,143, 152, 153 not many
studies have focused on using these ligands for inhibition of bacterial biofilm formation.
Important examples are the GalNacβ(1→4)Galβ based carbohydrate ligands reported by Randall
and co-workers, which can bind P. aeruginosa adhesin protein, pili. 140 The anti-biofilm
activities of such GalNacβ(1→4)Galβ based molecules remains unknown. Hence all the maltose
derivatives were further tested for anti-adhesion activities against P. aeruginosa. A P.
aeruginosa strain (PAO1-EGFP) that constitutively expresses green fluorescent protein (GFP)
was allowed to adhere on a polystyrene surface for two hours with (85 µM) and without maltose
derivatives (no agent). After two hours, the bacterial culture was discarded and replaced with
fresh media. The amount of bacteria attached on the polystyrene surface was determined by
measuring the fluorescence of the GFP expressed by the adhered bacteria. The amount of
fluorescence from wells treated with maltose derivatives was compared to the fluorescence from
the control wells and percent inhibition of adhesion was calculated (Figure 2.6). Most of the
effective anti-biofilm agents were also potent anti-adhesion agents and in general there was a
direct correlation between anti-biofilm and anti-adhesion activities Two maltose derivatives, 4tBuBDeβM and BDβM inhibited almost 80% of the P. aeruginosa adhesion on polystyrene

surface. Five maltose derivatives; BPDeβM, DβM, 4-MBDβM, ADβM and 3, 5-DMBDβM
inhibited more than 50 % of P. aeruginosa adhesion, while the remaining four maltose
derivatives; 4-tBuBDβM, BDeβM, UβM and DeβM inhibited the adhesion by 20 to 50%.
Maltose derivative; 12-HODeβM did not show any anti-adhesion activity.

Although the known biofilm inhibitor, brominated furanone (BF8) inhibited the biofilm
formation of P. aeruginosa by 40 %, it did not inhibit the bacterial adhesion. While the biofilm
inhibition activity by BF8 can be attributed to the disruption of quorum sensing, the interference
of quorum sensing does not lead to inhibition of adhesion.68 Even though the biofilm inhibition
by two generic surfactants; SDS and C12EG4OH was very poor (Figure 2.6); these agents were
able to inhibit the adhesion of P. aeruginosa by ~40 % (Figure 2.6). This set of two contrasting
results suggests the following. Firstly, inhibition of quorum sensing may not imply inhibition of
adhesion and that such maltose derivatives may not have a traditional mode of action, i.e through
disruption of quorum sensing. Secondly, while surface activity or washing property seemed
important to prevent bacterial adhesion, this physical property alone cannot explain why at 85
µM, DβM, having lower surface activity than C12EG4OH (Table 2.1), was able to prevent more
bacterial adhesion.
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Figure 2.6 Inhibition of biofilm and adhesion by maltose derivatives, generic surfactants (SDS,
C12EG4OH) at 110 µM (anti-biofilm) and 85 µM (anti-adhesion) and known anti-biofilm agent
BF8 at110 µM (anti-biofilm) and 100 μM (anti-adhesion) measured using CV dye-based and
fluorescence assays, respectively. Error bar is standard error of the mean from 6 replicates.

2.2.5. Dose-dependent anti-biofilm activity of maltose derivatives
Five of the most potent anti-biofilm inhibitors; BPDeβM, BDβM, 4-tBuBDeβM, 4MBDβM and DβM were further tested in a dose-dependent manner (between ~20 to 140 μM) to
determine their half maximal inhibitory concentrations (IC50)s for inhibition. For this, the percent
biofilm inhibition at each selected concentration was plotted against the concentration (Figure
2.7). Accordingly, the IC50s were calculated by solving for equation y = mln(x), where y = 50%.
Maltose derivatives, BPDeβM and 4-tBuBDeβM showed the lowest IC50 of 23 μM (Figure 7).
For the rest of the three maltose derivatives; BDβM, 4-MBDβM, and DβM, IC50s for biofilm
inhibition were in the range of 23 to 48 μM (Figure 2.7). The IC50s values of the DSHs reported

here are comparable to and in some cases even better than the IC50s of some of the known potent
biofilm inhibitors reported in literature previously.55, 60, 154, 155
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Figure 2.7 Dose response curve for biofilm inhibition and IC50 values for compounds (A)
BPDeβM (11) and BDβM (5) (B) 4-MBDβM (9), 4-tBuBDeβM (6) and DβM (3). Biofilm was
quantified by staining with CV dye. Error bar is standard error of the mean from 6 replicates.

2.2.6 Demonstrating anit-biofilm activities of maltose derivatives by fluorescence microscopy

Anti-biofilm activity of three active maltose derivatives; BPDeβM, BDβM and DβM
was also verified by fluorescence based static biofilm assay. P. aeruginosa strain, PAO1-EGFP
that constitutively expresses green fluorescent protein (GFP) was allowed to grow on sterile steel
coupons for 24 h. The biofilms formed on the steel coupons grown in presence (85 µM) and in
absence of maltose derivatives were viewed under confocal laser scanning microscope (CLSM).
The fluorescence observed indirectly indicates the amount of biofilm formed on the steel
coupons. The CLSM micrographs shows that the fluorescence signal and hence the biofilm
formed on steel coupons in presence of BPDeβM, BDβM and DβM was significantly lower than

the steel coupons without agents (Figure 2.8). Additionally, the biofilm thickness on steel
coupons treated with maltose derivatives was significantly lower than the thickness of biofilm on
steel coupons grown in absence of such agents. Results obtained by fluorescence based static
biofilm assay were consistent with the results obtained from crystal violet assays.

Figure 2.8 Representative confocal laser scanning microscopy (CLSM) micrographs of biofilm
formed by PAO1-EGFP on steel coupons; (A) in the absence of agents, and in the presence of 85
μM (B) BPDeβM (11); (C) BDβM (5); (D) DβM (3). Scale bar = 76 µm.

2.2.7 Minimal media (M9+) is the optimum medium for higher biofilm inhibition activities by
maltose derivatives.
The type of nutrients and the carbon sources present in the culturing media impact both the
amount of biofilm formed and its structure.156, 157 Hence, maltose derivatives anti-biofilm
activities were tested in three different culture medias, Luria-Bertani (LB), Luria-Bertani no salt
(LBNS) and minimum media M9+ (95 % M9 and 5 % LB). Luria-Bertani (LB) medium is very
rich in nutrients and contains sodium chloride, tryptone and yeast extracts and LB media without
sodium chloride is known as LBNS medium. Minimal media M9+ contains inorganic salts,

carbon source like glucose and casamino acids as nitrogen source. Detailed composition of each
of these media is discussed in Materials and Methods. The amount of biofilm formed was
maximum in LB broth followed by M9+ medium and then LBNS medium. Blackwell and coworkers have reported that despite the higher biofilm formation in LB media, the biofilm
adhered to the bottom of the well surfaces, known as “surface attached” biofilm, is maximum in
M9+ medium and not in LB media.114 The anti-biofilm activities of the maltose derivatives
appeared to be lower in LB media than in M9+ media, and no significant biofilm inhibition was
observed in a medium without sodium chloride, LBNS (Figure 2.9). This suggests that the
quantitatively lesser biofilm formed in LBNS medium was more robust and maltose derivatives
are incapable of inhibiting this biofilm.
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Figure 2.9 Inhibition of P. aeruginosa (PAO1) biofilm with selective maltose derivatives in M9+
(95 % M9 and 5 % LB), LB and LBNS medium

2.2.8 Maltose derivatives disperse one-day old P. aeruginosa biofilm
Dispersing preformed biofilms is not only a more challenging task, but also more relevant
for applications related to medical devices and industries. Once biofilms mature, they become
more robust and more immune to treatment techniques than biofilms that are still in the early
stages of development. To test the versatility of these maltose derivatives as both biofilm

inhibitors and dispersers, we screened the ability of all the maltose derivatives at 110 μM to
disperse 24 h old biofilm of P. aeruginosa (Figure 2.10). P. aeruginosa was first grown in M9+
media within wells of 96-well microtiter plates for 24-h and the one day old biofilm thus formed
was further treated for additional 24-h with the various maltose derivatives. The biofilms
remaining in the wells after the treatment with agents for 24-h was quantified by staining with
crystal violet (CV) dye stain. The percent biofilm dispersed was calculated by comparing the
biofilm remaining in wells treated with maltose derivative to wells that contained no agents. The
trend in the ability of maltose derivatives to disperse the preformed biofilm was similar to the
trend for biofilm inhibition activity (Figure 2.10). Two maltose derivatives, BPDeβM and
BDβM were the most potent biofilm dispersers. Five maltose derivatives BPDeβM, BDβM, 4tBuBDβM, DβM and 4-MBDβM exhibited > 50 % biofilm dispersion.

A dose-dependence study was also done using the biofilm dispersers that exhibited
maximum dispersion activity at 110 μM, BPDeβM, BDβM, 4-tBuBDβM, DβM and 4MBDβM. Dose dependence study for dispersion of 24 h old biofilm gave half-maximal
dispersion (DC50) values to be 31 μM, 32 μM, 43 µM, 66 µM and 77 µM for BPDeβM, BDβM,
4-tBuBDβM, DβM and 4-MBDβM, respectively (Figure 2.11). The DC50 values of DSHs
reported here are comparable to dispersion potencies of some of the best biofilm dispersers
reported so far.114, 115 However, unlike previously reported biofilm dispersers, we believe that the
mechanism of the anti-biofilm activities of these maltose derivatives is likely not due to direct
disruption of bacterial quorum sensing.
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Figure 2.10 Dispersion of PAO1 biofilm by adding 110 µM of maltose derivatives to the 24-h
old biofilms followed by quantifying the biofilm remaining with CV-dye staining. Error bar is
standard error of the mean from 6 replicates.

Figure 2.11 Dose response curve and values of half-maximal inhibitory concentrations for
biofilm dispersion (DC50) for compounds BPDeβM (11), BDβM (5), 4-MBDβM (9), 4tBuBDeβM (6) and DβM (3). The biofilm remaining after treatment with various maltose

derivatives were quantified by staining with crystal violet dye. Error bar is standard error of the
mean from 6 replicates.

2.2.9 Maltose derivatives are effective at inhibiting the biofilm formation of mucoid P.
aeruginosa
As discussed previously, inhibition of mucoid biofilm is more difficult than the inhibition
of wild type P. aeruginosa biofilms. However, the inhibition of the biofilm formed by mucoid P.
aeruginosa is important because this strain is associated with multiple medical conditions
including Cystic Fibrosis. Therefore, three maltose derivatives, BDβM, DβM and ADβM were
tested against the biofilm formation of mucoid P. aeruginosa. At 160 µM, all the three maltose
derivatives were effective at inhibiting the biofilm formation of mucoid P. aeruginosa and the
trend in biofilm inhibition activities was similar to the trend for wild type P. aeruginosa (Figure
2.12 A). Maltose derivative BDβM inhibited almost ~78% of the mucoid P. aeruginosa biofilm.
Interestingly, maltose derivatives were capable of reducing the secretion of extra polymeric
substances by mucoid P. aeruginosa as seen from the pictures of the falcone tube in which
mucoid P. aeruginosa was allowed to grow (stationary) for 24 h with and without 160 µM of
DβM (Figure 2.12 B).

Figure 2.12 (A) Inhibition of mucoid P. aeruginosa biofilm by maltose derivatives at 160 µM.
The biofilm contents after inhibition were measured by staining with CV dye-stain. Error bar is
standard error of the mean from 6 replicates. (B) Inhibition of production of extra polymeric
substances by maltose derivatives. Mucoid P. aeruginosa incubated in 15 mL falcone tube with
(160 µM) and without DβM at 37 °C for 24 h.

2.2.10 Maltose derivatives do not interfere with the quorum sensing of P. aeruginosa
A very common and well studied strategy for biofilm inhibition is the disruption of
bacterial quorum sensing. Autoinducer mimics introduced into the bacterial cultures interfere
with the natural quorum sensing process and hence these mimics are able to inhibit multicellular
phenomena like biofilm formation. Even though the structure of maltose derivatives had no
resemblance to the structures of natural autoinducers, they did possess some structural
similarities with another molecule secreted by P. aeruginosa, biosurfactant rhamnolipids. The
production of rhamnolipids by P. aeruginosa is controlled by the quorum sensing circuits of the
bacteria. Hence a gene reporter assay was used to investigate if maltose derivatives interfered
with the quorum sensing circuits of P. aeruginosa. The quorum sensing process in P. aeruginosa

is controlled by las and rhl gene systems. In antagonist gene reporter assay externally added
agents compete with natural autoinducers for the two receptor proteins of las and rhl systems,
lasR or rhlR, respectively. Depending upon whether external agents are lasR or rhlR protein
agonists or antagonists, they either activate or repress the expression of lasI or rhlI, synthases
proteins. Expression of lasI and rhlI proteins is quantified by measuring the expression of green
fluorescent protein (GFP) fused to lasI and rhlI genes in a plasmid. We tested the effect of
maltose derivatives on the las or rhl quorum sensing system by quantifying the GFP expressed
by two reporter strains (PAO1/plasI_LVAgfp or PAO1/prhlI_LVAgfp). For both las and rhl
quorum sensing systems addition of maltose derivatives had no significant change in the
fluorescence of the two reporter strains (Figure 2.13), which implies that maltose derivatives do
not compete with natural autoinducers of P. aeruginosa and their biological activity is not by
interfering with the major quorum sensing circuitry.
For investigating the agonistic activities of the maltose derivatives, we used the double
knockout strains of PAO1, PAO-JP2 (plasI-LVAgfp) and PAO-JP2 (prhlI-LVAgfP) that lack the
synthesis of both the natural autoinducers AI-1 and AI-2.61 For the double knock out strains, the
activation of las and rhl systems, by agonists is reflected by the expression of green fluorescent
protein (GFP) expressed by the plasmids plasI-LVAgfp and prhlI-LVAgfP respectively.62 The
addition of maltose derivatives did not increase in the fluorescent signals of the two double
knock out reporter strains (Figure 2.14), indicating that these agents do not agonize the quorum
sensing of P. aeruginosa.
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Figure 2.13 Fluorescence (GFP) signal by PAO1 having plasmid (a) plasI_LVAgfp, and (b)
prhlI_LVAgfp in the absence and in the presence of selective maltose derivatives (85 µM).
Fluorescence signals were corrected for cell density by dividing by OD600 of cell culture. Error
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Figure 2.14 Agonist gene reporter assay with two reporter stains PAO-JP2(plasI-LVAgfp) (for
las system) and PAO-JP2(plasI-LVAgfp) (for rhl system). Fluorescence signal by two reporter
strains in the presence of natural autoinducers was used as a control. Concentration of all the
maltose derivatives used was 85 µM. Fluorescence signals were corrected for cell density by
dividing by OD600 of the cell culture. Error bar is standard error of the mean from 4 replicates.

2.3 Discussion
The structure activity studies with maltose derivatives revealed that the effects of such
agents on biofilm formation and adhesion were highly sensitive to the structural details. For
example, the only difference between the structures of the two maltose derivatives, 4tBuBDeβM and 4-tBuBDβM is that the aliphatic chain is longer in 4-tBuBDβM by two
methylene units, but the anti-biofilm and anti-adhesion activities of 4-tBuBDeβM were
significantly better than 4-tBuBDβM (Figure 2.6). A contrasting comparison was obtained for
two other maltose derivatives, BDeβM and BDβM, where the agent with the longer aliphatic
chain, BDβM was a better anti-biofilm and anti-adhesive agent than the agent possessing the two
methylene shorter aliphatic chain, BDeβM. These results suggest that there exists a requirement
for appropriate size of the agent, where agents with extra bulky terminal groups (4-tertiary butyl
benzyl) exhibit higher potencies when attached to a shorter aliphatic chain (ten carbons) and
agents with relatively smaller terminal groups (benzyl) had better activities when attached to
longer aliphatic chains (twelve carbons). Because of this structural sensitivity for various
bioactivities, we believe that these results support the notion that such maltose derivatives bring
about different levels of allosteric activations of the putative receptor leading to different
agonistic or antagonistic effects.
Another hypothesis is that the physical washing-away effect of such maltose-based
amphiphilic molecules can explain the anti-adhesion and the anti-biofilm activities of such
agents. However, at least two observations here could not be explained by the physical
explanation alone. Firstly, the half-maximal inhibitory constants for inhibition and dispersion
(IC50 and DC50 respectively), for most of these agents were much lower that the critical micelle
concentration (CMC) of a typical maltoside (DβM ~170 μM). Secondly, in general other generic

surfactants like SDS and C12EG4OH did not exhibit any observable anti-biofilm activities. Also,
the non-ionic surfactant, C12EG4OH has a higher surface activity than DβM, but C12EG4OH
was comparably a much poorer anti-biofilm and anti-adhesive agent than DβM.
Therefore, we believe that, there exists a receptor or multiple receptors for such maltose
derivatives on the surface of the bacteria. It is widely understood that many protein receptors do
exist on the bacterial surface that can recognise different saccharide stereochemistries.140, 143, 158

For P. aeruginosa, there exist at least two receptors systems that are known to be
involved in adhesion or the biofilm formation processes, pilus protein and putative rhamnolipids
receptor. Pilus protein is known to be essential for mediating bacterial adhesion onto surfaces.
The pilus protein has been found to specifically recognize the disaccharide-derivatives
possessing GalNAcβ(1 4)Galβ stereochemistry. The maltose derivative presented in this study
possesses Glcα(1 4)Glcβ stereochemistry and it remains to be found if such a stereochemistry
is also recognized by the pili of P. aeruginosa. Another possible target of such maltose
derivatives could be the putative receptor system of rhamnolipids ligands. Rhamnolipids are
disaccharide based lipids that are known to control biofilm architecture and biofilm dispersion.
While the receptor for rhamnolipids remains unclear, rhamnolipids have been suspected to be
strongly associated with protein SadB (surface attachment-defective gene product).159

While maltose derivatives could be targeting either of the two mentioned receptor
systems, they could also possess promiscuous binding abilities to bind both pili and putative
rhamnolipids receptor, or they could also have entirely different receptor system.

2.4. Conclusion and perspectives
In this study, we presented a class of maltose derivatives that are effective towards three
bioactivities of P. aeruginosa: reducing adhesion, preventing biofilm formation and inducing
dispersion of the formed biofilms. Structure-activity study brought forward some potent agents
and revealed that potency is closely related to structural details. The washing effect due to
surface activity of maltose derivatives could not be used to explain the anti-biofilm activities of
these agents as a surfactant molecule with better surface activity than a maltose derivative
showed insignificant effect on biofilm of P. aeruginosa. It is possible that, the maltose
derivatives interfere with the putative receptor site of rhamnolipids or they are recognized by
pilus protein of P. aeruginosa. Formation of biofilm is a multicellular behaviour that is
consistent across most microbes and if such microbes have homologous disaccharide receptors,
then a nonmicrobicidal anti-biofilm strategy based on the use of maltose derivatives could be
developed for an array of microbes or for biofilms formed by two or more microbes together.123

2.5 Materials and Methods
Bacterial strains and growth media
Wild type P. aeruginosa, PAO1 and mucoid P. aeruginosa strains were obtained from Dr.
Guirong Wang (Upstate Medical University). Strains PAO-JP2 (plasI-LVAgfp) and PAO-JP2
(prhlI-LVAgfp) were obtained from Dr. Helen E. Blackwell (Univ. of Wisconsin-Madison).
Plasmids plasI-LVAgfp and prhlI-LVAgfp were gifted by Dr. Hiroaki Suga (The University of
Tokyo). All the bacterial strains were grown in Luria-Bertani (LB) medium containing 10 g/L
tryptone, 5 g/L yeast extract, and 10 g/L NaCl at 37 °C. For biofilm inhibition and dispersion
assays 95 % M9+ medium with 5% of LB broth was used unless otherwise stated. M9+ medium

contained 18.7 mM NH4Cl, 21.7 mM KH2PO4, 47.7 mM Na2HPO4, 8.6 mM NaCl, 0.1 mM
CaCl2, 1 mM MgSO4, 0.2% anhydrous α-D(+)-glucose, 0.4% L-Arg, 0.2% citric acid
monohydrate, 0.5% Casamino Acids (CAA), 0.2% sodium succinate dibasic hexahydrate and
0.2% L-glutamic acid monopotassium salt monohydrate.114

Stock solutions of generic surfactants and synthesized maltose derivatives
Stock solutions of all the agents (11.5 mM) were prepared in autoclaved water, sterilized by
filtering through 0.2 µm syringe filter, and stored at -20 °C in sealed vials. Appropriate amount
of sterile water was added to controls in all assays to eliminate the solvent effect.
Crystal violet dye-based biofilm inhibition assay
Inhibitory effect of all the maltose hydrocarbons on P. aeruginosa biofilm formation was
determined by crystal violet dye based biofilm inhibition assays (Figure 2.S1). Overnight culture
of wild type P. aeruginosa (PAO1) was sub cultured to an OD600 of 0.01 into the 95:5 M9+/LB
medium or LB medium. Aliquots (200 µL) of the sub culture were introduced into the wells of
96-well polystyrene microtiter plate when it reached the OD600 of 0.1. Predetermined
concentrations of the test compounds were then added to the respective wells containing sub
culture. Sample plates were wrapped in GLAD Press n’ Seal® followed by incubation under
stationary conditions for 24 h at 37 °C. After incubation the media was discarded and the plates
were washed with water and dried for 1 h at 37 °C. The sample plates were stained with 200 μL
of 0.1% aqueous solution of crystal violet (CV) and followed by incubation at ambient
temperature for 20 min. The CV stain was then discarded and the plates were washed with water.
The remaining biofilm adhered stain was re-solubilized with 200 μL of 30 % acetic acid. After
the stain was dissolved (15 minutes), 100 μL of the solubilized CV was transferred from each

well into the corresponding wells of a new polystyrene microtiter dish. Biofilm inhibition was
quantified by measuring the OD600 of each well in which a negative control lane wherein no
biofilm was formed served as a background and was subtracted out. The percent inhibition was
calculated by the comparison of the OD600 for biofilm grown in the absence of compound
(control) versus biofilm grown in the presence of compound under identical conditions. Biofilm
inhibition assay with all the maltose derivatives was repeated four times and each data point in
the graph is the average of values from 6 wells.
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Figure 2.S1 Schematic representation of crystal violet (CV) dye based biofilm inhibition assay

Anti-adhesion assay

Overnight culture of PAO1-GFP was subcultured to an OD600 of

0.01 into the 95/5 M9+/LB medium. Subculture was allowed to reach the OD600 of 0.1 in a rotary
shaker at 250 rpm and 37 °C. 200 µL of the subculture was then transferred to the wells of black
microtiter plate with and without (control) maltose derivatives. This black 96-well plate was then
incubated in a shaker at 37 °C for 2 h. After 2 h, bacterial culture from the plate was discarded
and each well was washed once with saline water (0.85 w/v% aqueous NaCl solution). Fresh

95/5 M9+/ LB medium was added to the black 96 well plate and fluorescence of the surface
adhered bacteria was measured by Synergy 2 multi-mode microplate reader with Gen5 data
analysis software at an excitation wavelength of 500 nm and an emission wavelength of 540 nm.
Background signal from 95/5 M9+/LB medium was eliminated from all the samples.
Dispersion assay for preformed biofilm

Plate for biofilm dispersion assay was set up similar

to crystal-violet based- biofilm inhibition assay but without adding any maltose derivative at the
time of inoculation of bacteria in the 96 well plate (Figure 2.S2). PAO1 was allowed to grow for
24 h at 37 °C. After 24 h, bacterial culture was pipetted out and replaced with 200 µL of 110 µM
maltose hydrocarbons in fresh medium. After 24 h treatment with maltose hydrocarbons, biofilm
was fixed and quantified using crystal violet dye as described above. The amount of dispersed
biofilm was determined by comparing (normalizing) the amount of biofilm at 48 h with and
without maltose hydrocarbons.
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Figure 2.S2 Schematic representation of crystal violet (CV) dye based biofilm dispersion assay

Dose dependence assays for biofilm inhibition and dispersion

Five maltose derivatives with

highest activity for biofilm inhibition and dispersion were selected for plotting dose response
curve. Predetermined amounts of maltose derivatives stock solution were added to the 200 µL
bacterial culture in 96 well plate so that the final concentration of the agent reaches the desired
values of 1, 5, 10, 20, 40, 85, 113, 140 µM.
Effect of maltose derivatives on the growth of P. aeruginosa

Optical density was measured

using Biotek ELx800 TM absorbance microplate reader (BioTek Instruments, Inc., Winooski,
VT) using Gen5TM data analysis software. The OD600 values were taken in sterile conditions at
0, 2, 4, 6, 8, 10, 12, and 24 h after bacterial culture inoculation in 96-well polystyrene plate with
and without agents in LB broth.
Gene reporter assays for las and rhl quorum sensing systems of P. aeruginosa 5,6 Plasmids plasILVAgfp and prhlI-LVAgfp were provided by Dr. Hiroaki Suga (The University of Tokyo).
Strains PAO-JP2 (plasI-LVAgfp) and PAO-JP2 (prhlI-LVAgfp) were obtained from Dr. Helen
Blackwell. For an antagonist assay, overnight culture of P.aeruginosa PAO1/plasI-LVAgfp (las
system ) or PAO1/prhlI-LVAgfp (rhl system) in LB broth (supplemented with 300 µg/mL
carbenicillin) was grown from a single colony on a LB agar plate supplemented with 300 µg/mL
carbenicillin. The overnight culture was diluted and grown to OD600 of 0.1 in LB broth
containing 300 µg/mL of carbenicillin. Bacterial culture (200 µL) was added to each well of a
polystyrene 96-well microtiter plate containing an appropriate amount of maltose derivatives or
sterile water as a control. The plate was incubated at 37 °C for 24 h in a rotary shaking incubator
(250 rpm). The culture from each well was then transferred to a flat-bottom, 96-well plate with
black wall (µClear, Greiner-One 655096). The fluorescence and OD absorbance in each well was
measured by Synergy 2 multi-mode microplate reader with Gen5 data analysis software.

Background signals from LB broth were eliminated from all samples. Fluorescence was
measured at an excitation wavelength of 500 nm and an emission wavelength of 540 nm. Agonist
assay was also done in a similar manner except PAO-JP2 (plasI-LVAgfp) and PAO-JP2 (prhlILVAgfP), double knockout strains (do not produce natural autoinducers) were used instead of wt
PAO1. Agonist activities of the maltose derivatives were compared to the activities exhibited by
externally added natural autoinducers.
Electroporation of plasmids to prepare gene reporter strains Plasmids plasI-LVAgfp and prhlILVAgfp were transferred to wild type P. aeruginosa (PAO1) by electroporation method. Briefly,
overnight culture of PAO1 was subcultured in 25 mL LB broth and was grown to reach the
OD600 of 0.5 to 0.8 by shaking the culture at 37 °C. Flask containing subculture was cooled on
ice for 30 min. Cell pellet was obtained by centrifugation at 4500 rpm for 5 min. Supernatant
was removed and cell pellet was resuspended in 20 mL ice-cold 300 mM sucrose solution. Cells
were centrifuged at 4500 rpm for 5 min. Supernatant was discarded and cell pellet was
resuspended in 1 mL ice-cold 300 mM sucrose solution. Cell suspension was transferred to a
new 1.5 mL ice-cold microcentrifuge tube and spun down at 13,000 rpm for 30 sec. Supernatant
was discarded and cell pellet was resuspended in 500 µL ice-cold 300 mM sucrose solution. For
the last time cells were spun down at 13,000 rpm for 30 sec. After removal of the supernatant,
cell pellet was resuspended in 100 µL ice-cold 300 mM sucrose solution. 50 µL of the competent
cell suspension along with 5 µL of plasmid DNA in TE buffer was transferred to the cold 0.1 cm
electroporation cuvette. Electroporator was set to Ec1 and pulse was passed through the cells. LB
medium (1 mL) was immediately added to the electroporator cuvette and cell suspension was
transferred to a sterile microcentrifuge tube and incubated for 1 h at 37 °C with shaking at 180
rpm. Cells were then spread on the LB agar (1.5 %) plates supplemented with 300 µg/ mL

carbenicillin (antibiotic) and incubated over night at 37 °C to get the microcolonies of PAO1
(plasI-LVAgfp) or PAO1 (prhlI-LVAgfp).

Materials and methods for organic synthesis
All reagents were bought from commercial sources (Sigma-aldrich, TCI-America,
Acros). Solvents were obtained from Fisher and Sigma and used without any further purification.
HRMS was obtained through positive ESI on Bruker 12 Tesla APEX-QE FTICR-MS with an
Apollo II ion source at Cosmic instrumentation center, Virginia. TLC visualization was done
under UV light (254 nm) or with ceric ammonium molybdate (CAM) staining. Solvents were
removed in vacuo using Bűchi rotary evaporator below 40oC. EMD silica gel 60 F254 pre-coated
plates (0.25-mm thickness) were used for TLC. Column chromatography was performed using
Silicycle, silia-P flash silica gel with 40-63 μ mesh size. 1H and 13C NMR spectra were recorded
on 300 MHz or 400 MHz and 75 MHz or100MHz Bruker instruments respectively. 1H chemical
shifts are reported in ppm relative to CDCl3 δ 7.27 or CD3OD δ 3.31. 13C chemical shifts are
reported in ppm relative to CDCl3 δ 77.0 or CD3OD δ 49.0.
Organic Synthesis
Synthesis of monobenzyl alkyl ether
R1

Br
HO

R2
R3

n

OH

NaH (0.8 eq), DMF
rt, 12h

R1

O

n

OH

R2
R3

4a - 10a, 11a

1,12-dodecanediol or 1,10-decanediol (5.0 mmol) was dissolved in 20 mL DMF and to
this was added a heterogeneous dispersion of NaH (60% by weight) in mineral oil (0.22 g, 4

mmol). Reaction mixture was stirred at room temperature (rt) for one hour and benzyl bromidederivative (5.0 mmol) was added slowly to this heterogeneous solution. Reaction was allowed to
stir at room temperature for 12 h. The reaction mixture was added into 100 mL water and
extracted with diethyl ether (30 X 3 mL). The organic layer was washed with brine (100 mL),
dried over Na2SO4, and concentrated in vacuo. The crude product was purified by column
chromatography (15% EtOAc/hexanes) to afford the monobenzyl alkyl ether. 160

O

8

OH

4a

(4a: R1= R2= R3 = H, n = 8) A white solid (0.6 g, 40%) Rf – 0.62 (Hexane : EtOAc, 3:2). 1H
NMR (300 MHz, CDCl3): δ 7.38-7.26 (m, 5H), 4.51 (s, 2H), 3.64 (t, J = 6.6 Hz, 2H), 3.47 (t, J =
6.6 Hz, 2H), 2.05 (br s, 1H), 1.64-1.52 (m, 4H), 1.37-1.27 (m, 12H).

O

10

OH

5a

(5a: R1= R2= R3 = H, n = 10) A white solid (1.3 g, 43%) Rf – 0.70 (Hexane : EtOAc, 3:2). 1H
NMR (300 MHz,CDCl3): δ 7.45-7.21 (m, 5H), 4.50 (s, 2H), 3.63 (t, J = 6.8 Hz, 2H), 3.47 (t, J =
6.8 Hz, 2H), 2.10 (br s, 1H), 1.66-1.52 (m, 4H), 1.31-1.27 (m, 16H); 13C NMR (100.6 MHz,
CDCl3): δ 138.6, 128.3, 127.6, 127.4, 126.9, 72.8, 70.5, 63.0, 32.7, 29.7, 29.5, 29.4 (br), 29.3
26.1, 25.7.161

O

8

OH

6a

(6a: R1= R3 = H, R2= t-Butyl, n = 8) Colorless liquid (0.83g, 40%) Rf – 0.72 (Hexane: EtOAc,
1:1). 1H NMR (300 MHz,CDCl3): δ 7.38 (dt, J = 8.4Hz, J = 1.7Hz, 2H), 7.29 (m, 2H), 4.48 (s,
2H), 3.65 (dd, J = 9.7Hz, J = 6Hz, 2H), 3.46 (t, J = 6.6Hz, 2H), 1.55-1.64 (m, 4H), 1.27-1.33 (br
s, 12H), 1.32 (s, 9H). 13C NMR (75 MHz, CDCl3): δ 150.7, 150.4, 138.0, 135.7, 127.5, 126.9,
125.5, 125.3, 77.4, 77.2, 77.0, 76.7, 72.7, 70.5, 65.2, 63.1, 34.6, 34.5, 32.8, 31.4, 29.8, 29.6, 29.5,
29.4, 26.2, 25.7. HRMS (ESI) m/z: Calcd. (C21H36O2)Na+: 343.2607; Found: 343.2608.

O

10

OH

7a

(7a: R1= R3 = H, R2= t-Butyl, n = 10) White solid (1.23g, 36%), Rf – 0.74 (Hexane: EtOAc, 1:1).
1

H NMR (400 MHz,CDCl3): δ 7.41 (dt, J = 8.6Hz, J = 2.2Hz, 2H), 7.29-7.34 (m, 2H), 4.51 (s,

2H), 3.67 (t, J = 6.6Hz, 2H), 3.50 (t, J = 6.6Hz, 2H), 1.55-1.67 (m, 4H), 1.35 (s, 9H), 1.27-1.45
(br s, 16H). 13C NMR (75 MHz, CDCl3): δ 150.7, 150.4, 138.0, 135.7, 127.5, 126.9, 125.5,
125.3, 77.4, 77.2, 77.0, 76.7, 72.7, 70.5, 65.2, 63.1, 34.6, 34.5, 32.8, 31.4, 29.8, 29.6, 29.5, 29.4,
26.2, 25.7. HRMS (ESI) m/z: Calcd. (C23H40O2)Na+: 371.2920; Found: 371.2921.

O

10

OH

8a

(8a: R1 = R3 = -CH3, R2 = H, n= 10) White solid, yield (0.57 g, 36 %) Rf – 0.60(Hexane: EtOAc,
3:2). 1H NMR (300 MHz, CDCl3): δ 6.99-6.91 (m, 3H), 4.42 (s, 2H), 3.68 -3.61 (m, 2H), 3.45 (t,
J = 6.6 Hz, 2H), 2.61-2.27 (m, 6H), 1.66 -1.52 (m, 4H), 1.44 -1.27 (m, 16H).

O

10

OH

9a

(9a: R1= R3 = H, R2= -CH3, n = 10) White solid, yield (0.45 g, 41%) Rf – 0.60 (Hexane : EtOAc,
3:2). 1H NMR (300 MHz, CDCl3): δ 7.28-7.14 (m, 4H), 4.64 (s, 2H), 3.64 (t, J = 6.6 Hz, 2H),
3.55 (t, J = 6.6 Hz, 2H), 2.55 (s, 3H), 2.05 (br s, 1H), 1.68-1.52 (m, 4H), 1.37-1.27 (m, 16H).
O
O

8

OH

11a

(11a: R1= -(C=O)Ph, R2= R3 = H, n = 8) White solid, yield (0.30 g, 22 %) Rf – 0.50 (Hexane :
EtOAc, 3:2). 1H NMR (300 MHz, CDCl3): δ 7.81-7.78 (m, 4H), 7.62-7.55 (m, 1H), 7.48-7.41
(m, 4H), 4.59 (s, 2H), 3.68 -3.61(m, 2H), 3.50 (t, J = 6.6 Hz, 2H), 2.61-2.27(m, 6H), 1.69-1.58
(m, 2H), 1.44 -1.29 (m, 14H)

Synthesis of adamantyl dodecyl ether
Br

O
HO

10

TEA

OH

110 °C, 12 h

10

OH

10a

Mixture of 1-bromoadamantane (2 g, 4.648 mmol), triethylamine (1.6 mL, 28.2 mmol) and 1,12dodecanediol (20 g, 46.48 mmol) was heated at 110 °C for 12 h. After 12 h, reaction mixture was
cooled down to rt and diluted with 50 mL of CH2Cl2. The solution was washed with 1 M HCl (3
× 10 mL) and water (2 × 10 mL). The organic layer was dried over Na2SO4 and concentrated in
vacuo. The crude product was purified by column chromatography (15% EtOAc/hexanes) to
afford 10a as a colorless solid (0.438 g, 14 %), Rf – 0.65 (Hexanes: EtOAC, 3:2).162 1H NMR
(300 MHz, CDCl3): δ 3.64 (t, J = 6.6 Hz, 2H), 3.38 (t, J = 6.9 Hz, 2H), 2.13 (s br, 3H), 1.74 (d, J
= 3 Hz, 5H), 6.78 - 1.45 (m, 10 H), 1.27 (s, 17 H).
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OH
HO
HO

O
i. AcBr, AcOH, rt, 50 min

HO
OH
O

O
HO

AcO
AcO

OH ii. 4a-11a, or 1,10-decanediol
(12a), MeCN (for β anomer ),
OH
FeCl3, rt. 1 h
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AcO
OAc
O
AcO

O

O

OAc

O
n

R

4b - 12b

The synthesis of aceto-bromo maltose was done under anhydrous conditions. D-(+)Maltose monohydrate (1.0 g, 2.8 mmol), AcBr (~7.2 mL, 88.8 mmol), and AcOH (19 mL) were
mixed in oven dried round bottom flask and stirred at rt for ~ 50 min. Reaction mixture was
concentrated in vacuo at 35 ⁰C followed with co-evaporation three times with PhMe (2×10 mL,
anhydrous). The flask was further heated in vacuo at 50 ⁰C for 15 min to obtain a crude acetobromo maltose as foamy solid.

The crude aceto-bromo maltose was dissolved in MeCN (10mL) and various alcohols (2
equivalents as compared to maltose monohydrate) were added. Under vigorous stirring, FeCl3 (2
equivalents as compared to maltose monohydrate) was added to this mixture and the reaction
mixture was allowed to stir at rt for 1 h. To the reaction mixture was added aq KBr (10%, 25
mL) and PhMe (60 mL) under stirring. The organic phase was washed twice with aq KBr (10%,
2×25 mL), once with aq NaHCO3 (5%, 25 mL) and twice with H2O (2×25 mL). Using a gradient
elution (100 % hexane to 35 % ethyl acetate in hexane) the crude product was then purified
through a silica column. 150
OAc
AcO
AcO

O
AcO
OAc
O
AcO

O

O

OAc

O
8
4b

Foamy solid, Yield: (0.25 g, 9 %, 2 steps), Rf – 0.47 (Hexane : EtOAc, 1:1). 1H-NMR (300 MHz,
CD3OD): δ 7.35-7.26 (m, 5H), 5.42 – 5.25 (m, 2H), 5.23 (t, J = 7.2 Hz, 1H), 5.03 (t, J = 11.4 Hz,
1H), 4.94 – 4.67 (m, 2H), 4.50 – 4.43 (m, 4H), 4.27 (m, 2H), 4.18 – 3.92 (m, 4H), 3.82 (m, 1H),
3.68 – 3.60 (m, 1H), 3.43 (t, J = 6.6 Hz, 3H), 2.17 – 1.98 (s, 7 × 3 H), 1.61 -1.45 (m, 4H), 1.23 (s,
12 H). 13C NMR (75 MHz, CDCl3): δ 170.2, 170.1, 170.0, 169.8, 169.5, 169.1, 169.0, 138.2,
127.9, 127.1, 127.0, 99.8, 95.0, 75.0, 72.4, 72.3, 71.8, 71.6, 71.5, 70.1, 69.8, 69.5, 68.9, 68.0,
67.6, 67.4, 62.4, 62.3, 61.0, 29.3, 29.1, 29.0, 29.0, 28.9, 28.8, 28.7, 25.7, 25.5, 25.3, 20.5, 20.5,
20.4, 20.2, 20.2, 20.2,20.1. HRMS (ESI) m/z: Calcd. (C43H62O19)Na+: 905.3777; Found:
905.3781.
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White solid, Yield: (0.45 g, 17 %, 2 steps), Rf – 0.47 (Hexane : EtOAc, 1:1). 1H-NMR (300
MHz, CD3OD): δ 7.33-7.21 (m, 4H), 5.42 – 5.30 (m, 2H), 5.23 (t, J = 7.2 Hz, 1H), 5.03 (t, J =
11.4 Hz, 1H), 4.94 – 4.67 (m, 2H), 4.50 – 4.43 (m, 4H), 4.27 (m, 2H), 4.18 – 3.92 (m, 4H), 3.82
(q, J1-3 = 16.8 Hz, J1-2 = 7.2 Hz, 1H), 3.68 – 3.60 (m, 1H), 3.43 (t, J = 6.3 Hz, 3H), 2.16 – 1.98 (s,
7 × 3 H), 1.65 -1.45 (m, 4H), 1.23 (s, 16 H). 13C NMR (75 MHz, CDCl3): δ 170.1, 170.1, 169.9,
169.9, 169.6, 169.2, 169.0, 138.3, 127.9, 127.2, 127.0, 99.9, 95.1, 95.1, 75.1, 72.4, 72.3, 71.8,
71.6, 71.1, 70.1, 69.8, 69.6, 68.9, 68.4, 68.0, 67.6, 67.0, 62.5, 62.4, 61.1, 61.0, 60.0, 29.4, 29.2,
29.1, 29.0, 28.9, 28.8, 25.8, 25.6, 25.4, 20.7, 20.6, 20.5, 20.5, 20.3, 20.2. HRMS (ESI)
m/z: Calcd. (C45H66O19)Na+: 933.4090; Found: 933.4080.
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White solid, Yield: (0.275g, 17%, 2 steps), Rf – 0.53 (Hexane: EtOAc, 1:1). 1H-NMR (300 MHz
CDCl3): δ 7.35-7.39 (m, 2H), 7.26-7.29 (m, 2H), 5.42 (d, J = 4.1Hz, 1H), 5.37 (t, J = 11.8Hz,
1H), 5.26 (t, J = 9.3Hz, 1H), 5.06 (t, J = 10Hz, 1H), 4.79-4.89 (m, 2H), 4.52 (d, J = 8Hz, 1H),
4.45-4.49 (m, 3H), 4.25 (h, J = 12.4Hz, J = 6.8Hz, J = 4.2Hz, 2H), 3.95-4.07 (m, 3H), 3.85 (dt, J
= 9.6Hz, J = 6.1Hz, 1H),3.65-3.70 (m, 1H), 3.45-3.50 (m, 3H), 2.01-2.18 (s, 7*3H), 1.55-1.60
(m, 4H), 1.32 (s, 9H), 1.25-1.40 (br s, 12H). 13C NMR (400 MHz, CD3OD): δ 20.6, 20.7, 20.8,

20.9, 25.8, 26.0, 26.2, 29.3, 29.4, 29.5, 29.8, 31.4, 32.8, 34.5, 61.5, 62.9, 67.5, 68.0, 68.5, 68.8,
69.4, 70.0, 70.2, 70.5, 71.5, 72.0, 72.2, 72.7, 72.8, 75.5, 76.7, 77.1, 77.3, 77.4, 95.5, 100.3, 125.2,
127.5, 135.7, 150.4, 169.4, 169.6, 169.8, 169.9, 170.3, 170.5, 170.7. HRMS (ESI) m/z: Calcd.
(C47H70O19)Na+: 961.4403; Found: 961.4386.
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Colorless solid, Yield: (0.261g, 11.3%, 2 steps), Rf – 0.55 (Hexane: EtOAc, 1:1). 1H-NMR (400
MHz CDCl3): δ 7.37 (dt, J = 8.4Hz, J = 2Hz, 2H), 7.27 (m, 2H, overlapping with CDCl3), 5.42
(d, J = 4Hz, 1H), 5.36 (t, J = 10.3Hz, 1H), 5.25 (t, J = 9.3Hz, 1H), 5.06 (t, J = 10Hz, 1H), 4.794.88 (m, 2H), 4.51 (d, J = 7.9Hz, 1H), 4.47 (m, 3H), 4.25 (h, J = 12.4Hz, J = 7.9Hz, J = 4Hz,
2H), 3.94-4.06 (m, 3H), 3.84 (dt, J = 9.6Hz, J = 6.3Hz, 1H), 3.67 (ddd, J = 9.6Hz, J = 4Hz, J =
2.8Hz, 1H), 3.44-3.49 (m, 3H), 2.00-2.14 (s, 7*3H), 1.57-1.62 (m, 4H), 1.32 (s, 9H), 1.25-1.40
(br s, 16H). 13C NMR (400 MHz, CD3OD): δ 20.6, 20.7, 20.8, 20.9, 22.7, 25.8, 26.0, 26.1, 26.2,
28.6, 29.2, 29.3, 29.4, 29.5, 29.6, 29.7, 29.8, 31.4, 32.8, 34.5, 60.9, 61.5, 62.9, 64.7, 67.2, 68.0,
68.5, 69.4, 70.0, 70.2, 70.5, 70.6, 72.1, 72.1, 72.2, 72.7, 72.8, 75.5, 76.7, 77.0, 77.2, 77.4, 86.6,
95.5, 100.3, 125.2, 126.4, 127.1, 127.5, 128.3, 130.0, 130.3, 130.4, 132.4, 135.7, 150.4, 169.4,
169.5, 169.6, 169, 170.0, 170.3, 170.5. HRMS (ESI) m/z: Calcd. (C49H74O19)Na+: 989.4716;
Found: 989.4699.
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White solid.Yield: (0.18 g, 11%, 2 steps), Rf – 0.43 (Hexane : EtOAc, 1:1). 1H-NMR (300 MHz,
CD3OD): δ 6.93-6.84 (m, 3H), 5.41 – 5.30 (m, 2H), 5.24 (t, J = 9.0Hz, 1H), 5.03 (t, J = 9.9 Hz,
1H), 4.87 – 4.77 (m, 2H), 4.51 – 4.39 (m, 4H), 4.26-4.21 (m, 2H), 4.05 – 3.85 (m, 4H), 3.81-3.74
(m, 1H), 3.68 – 3.60 (m, 1H), 3.43 (t, J = 6.6Hz ,3H), 2.29 (s, 6H), 2.21 – 1.99 (s, 7 × 3 H), 1.71
-1.45 (m, 4H), 1.23 (s, 16 H). 13C NMR (75 MHz, CDCl3): δ 170.1, 170.0, 169.8, 169.5, 169.1,
169.0, 138.1, 137.4, 128.6, 125.1, 99.8, 95.0, 75.0, 72.5, 72.3, 71.8, 71.6, 70.1, 69.8, 69.5, 68.9,
68.0, 67.5, 67.0, 62.4, 61.0, 29.3, 29.1, 29.0, 28.9, 28.8, 25.7, 25.4, 20.8, 20.5, 20.4, 20.2, 20.2,
20.2, 20.1 HRMS (ESI) m/z: Calcd. (C47H70O19)Na+: 961.4403; Found: 961.4391.
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Colorless liquid, Yield: (0.21 g, 11 %, 2 steps), Rf – 0.43 (Hexane : EtOAc, 1:1). 1H-NMR (300
MHz, CD3OD): δ 7.26-7.12 (m, 4H), 5.41 – 5.32 (m, 2H), 5.24 (t, J = 9.0Hz, 1H), 5.03(t, J = 9.9
Hz, 1H), 4.87 – 4.75 (m, 2H), 4.51 – 4.34 (m, 5H), 4.26-4.21 (m, 2H), 4.05 – 4.00 (m, 3H), 3.853.81 (m, 1H), 3.68 – 3.60 (m, 1H), 3.46 - 3.40 (m, 3H), 2.32(s, 3H), 2.13 – 1.98 (s, 7 × 3 H), 1.71
-1.45 (m, 4H), 1.23 (s, 16 H). HRMS (ESI) m/z: Calcd. (C46H68O19)Na+: 947.4247; Found:
947.4233.
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Colorless liquid, yield: (0.05 g, 13 %, 2 steps), Rf – 0.51 (Hexane : EtOAc, 1:1). 1H-NMR (300
MHz CDCl3): δ 5.38-5.29 (m, 1H), 5.21 (t, J = 8.7 Hz, 1H), 5.00 (t, J = 9.9 Hz, 1H), 4.84-4.74
(m, 2H), 4.49-4.40 (m, 2H), 4.24-4.17 (m, 2H), 4.03-3.89 (m, 3H), 3.84-3.76 (m, 1H), 3.67-3.60
(m, 1H), 3.47-3.38 (m, 1H), 3.37 (t, J = 6.6 Hz, 2H), 2.25-1.96 (s, 7 ×3H), 1.70 (d, J = 3.04 Hz,
5H), 1.64-1.40 (m, 10 H), 1.21 (br s, 18 H). 13C NMR (75 MHz, CDCl3): δ 170.1, 170.1, 169.9,
169.7, 169.6, 169.2, 169.0, 99.9, 95.1, 75.1, 72.4, 71.8, 71.6, 71.2, 69.8, 69.6, 69.0, 68.1, 67.6,
62.5, 61.1, 59.4, 41.2, 36.2, 30.4, 30.1, 29.2, 29.2, 29.1, 29.0, 28.9, 25.9, 25.4, 20.5, 20.5, 20.3,
20.2, 20.2. HRMS (ESI) m/z: Calcd. (C48H74O19)Na+: 977.4716; Found: 977.4705.
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White solid.Yield: (0.11 g, 7 %, 2 steps), Rf – 0.46 (Hexane : EtOAc, 1:1). 1H-NMR (300 MHz,
CD3OD): δ 7.85-7.77 (m, 4H), 7.65-7.41(m, 5H), 5.55 – 5.48 (m, 1H), 5.46-5.30 (m,2H), 5.06 (t,
J = 9.9Hz, 1H), 4.95-4.94 (m, 1H), 4.89 – 4.84 (m, 1H), 4.74 – 4.70 (m, 1H), 4.58 (s, 2H), 4.484.40 (m, 1H), 4.30 – 4.14 (m, 2H), 4.09-3.90 (m, 4H), 3.71 – 3.60 (m, 1H), 3.51-3.40 (m, 3H),
2.17 – 1.99 (s, 7 × 3 H), 1.71 -1.55 (m, 4H), 1.25 (s, 12 H). 13C NMR (75 MHz, CDCl3): δ
197.0,170.2, 170.1, 169.9, 169.5, 169.4, 169.0, 143.2, 137.2, 136.2, 131.9, 129.8, 129.6, 127.8,
126.6, 95.1, 95.0, 72.3, 72.2, 71.8, 71.0, 70.5, 69.8, 69.5, 68.9, 68.4, 68.0, 67.5, 67.0, 29.3, 29.1,

29.1, 29.0, 28.9, 28.8, 25.7, 25.5, 20.5, 20.4, 20.2, 20.2, 20.2, 20.1. HRMS (ESI)
m/z: Calcd. (C50H66O20)Na+: 1009.4039; Found: 1009.4043.
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White solid.Yield: (0.24 g, 15 %, 2 steps), Rf – 0.40 (Hexane : EtOAc, 1:1). 1H-NMR (300 MHz,
CD3OD): δ 5.43-5.33 (m, 2H), 5.29-5.26 (m, 1H), 5.09-5.02(m, 1H), 4.89-4.79 (m, 2H), 4.52 –
4.45 (m, 2H), 4.29 – 4.21 (m, 2H), 4.06-3.93 (m, 3H), 3.88 – 3.78 (m, 1H), 3.70-3.61 (m, 3H),
3.51 – 3.43 (m, 1H), 2.15 – 2.01 (s, 7 × 3 H), 1.51 -1.46 (m, 4H), 1.41-1.26 (br s, 12 H). 13C
NMR (75 MHz, CDCl3): δ 170.2, 170.1, 170.0, 169.8, 169.5, 169.1, 169.0, 99.8, 95.0, 77.0, 76.6,
76.2, 75.0, 72.3, 71.8, 71.6, 69.8, 69.5, 68.9, 68.0, 67.5, 62.5, 29.0, 29.0, 28.9, 28.9, 28.8, 25.3,
25.2, 20.5, 20.4, 20.2, 20.2, 20.2, 20.1, 20.1.
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Zemplen deacetylation was used to deprotect the acetylated glycosides.150 Briefly,
acetylated glycosides were treated with methanolic solution of MeONa (10 mM) followed by
neutralization (pH ~ 7) over H+ amberlite resins. The product was filtered and dried under
vacuum overnight.
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White solid.Yield: (0.15 g, 80 %), 1H-NMR (300 MHz, CD3OD): δ 7.34-7.26 (m, 5H), 5.15 (t, J
= 4.2 Hz, 1H), 4.46 (br S, 2H), 4.23 (d, J = 7.5 Hz, 1H), 3.93-3.79 (m, 4H), 3.70-3.53 (m, 4H),
3.52-3.42 (m, 5H), 3.35-3.18 (m, 3H), 1.59 (m, 4H), 1.28 (br s, 12 H). 13C NMR (75 MHz,
MeOD): δ 137.9, 127.5, 127.0, 126.8, 102.5, 101.1, 79.5, 76.0, 74.7, 73.2, 72.9, 72.8, 72.2, 72.0,
70.4, 69.7, 69.6, 69.2, 60.8, 60.3, 29.0, 28.9, 28.8, 28.8, 28.7, 25.4, 25.2. HRMS (ESI)
m/z: Calcd. (C29H48O12)Na+: 611.3037; Found: 611.3041.
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Yield: (0.11 g, 85 %), 1H-NMR (300 MHz, CD3OD): δ 7.36-7.29 (m, 5H), 5.15 (t, J = 4.2 Hz,
1H), 4.48 (br S, 2H), 4.27 (d, J = 7.5 Hz, 1H), 3.93-3.79 (m, 4H), 3.70-3.57 (m, 4H), 3.54-3.42
(m, 5H), 3.35-3.21 (m, 4H), 1.60 (m, 4H), 1.29 (br s, 16 H). 13C NMR (75 MHz, CD3OD): δ
128.6, 127.6, 127.1, 126.9, 126.5, 125.9, 102.5, 101.1, 79.5, 76.0, 74.7, 73.9, 73.3, 73.0, 72.8,
72.4, 72.0, 69.7, 69.6, 69.2, 60.9, 60.4, 30.6, 29.0, 29.0, 28.9, 28.9, 28.7, 27.3, 27.1, 25.5, 25.3.
HRMS (ESI) m/z: Calcd. (C31H52O12)Na+: 639.3350; Found: 639.3345.
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Colorless solid, Yield: (0.163g, 85%), 1H-NMR (400 MHz, CD3OD): δ 7.37 (dt, J = 8.4Hz, J =
2Hz, 2H), 7.24 (dt, J = 8.4Hz, J = 2Hz, 2H), 5.14 (d, J = 4Hz, 1H), 4.44 (s, 2H), 4.25 (d, J = 8Hz,
1H), 3.84-3.90 (m, 2H), 3.77-3.82 (m, 2H), 3.57-3.69 (m, 4H), 3.52 (p, J = 9.6Hz, J = 4.8Hz,
2H), 3.45 (t, J = 6.4Hz, 2H), 3.43 (dd, J = 10Hz, J = 3.6Hz, 1H), 3.34 (ddd, J = 9.6Hz, J = 4.8Hz,
J = 2.4Hz, 1H), 3.23 (p, J = 17.6Hz, J = 9.2Hz, 2H, overlapping with CD3OD), 1.59 (m, 4H),
1.30 (s, 9H), 1.25-1.40 (br s, 12H). 13C NMR (100 MHz, CD3OD): δ 150.4, 135.3, 127.4, 127.1,
124.8, 124.5, 102.9, 101.5, 79.9, 76.5, 75.2, 73.7, 73.5, 73.4, 73.3, 72.8, 72.3, 70.1, 69.9, 69.6,
61.4, 60.8, 33.9, 30.4, 30.2, 29.4, 29.3, 29.2, 29.1, 25.8, 25.7, 25.5. HRMS (ESI) m/z :
Calcd. (C34H60O12)Na+: 611.3037; Found: 611.3041.
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Light brown solid, Yield: (0.056g, 29 %), 1H-NMR (400 MHz, CD3OD): δ 7.38 (dt, J = 8.6Hz, J
= 2.1Hz, 2H), 7.25 (d, J = 8.4Hz, 2H), 5.17 (d, J = 3.8Hz, 1H), 4.46 (s, 2H), 4.27 (d, J = 7.8Hz,
1H), 3.80-3.93 (m, 4H), 3.60-3.72 (m, 4H), 3.51-3.57 (m, 1H), 3.44-3.49 (m, 3H), 3.35-3.39 (m,
1H), 3.25 (p, J = 17.4Hz, J = 9.3Hz, 2H, overlapping with CD3OD), 1.61 (m, 4H), 1.32 (s, 9H),
1.25-1.45 (br s, 16H). 13C NMR (100 MHz, CD3OD): δ 150.3, 135.3, 127.4, 124.8, 102.9, 101.5,

79.9, 76.4, 75.2, 73.7, 73.4, 73.3, 72.8, 72.3, 70.1, 69.9, 69.6, 61.4, 60.8, 33.9, 30.4, 29.4, 29.3,
29.2, 29.1, 25.8, 25.7. HRMS (ESI) m/z: Calcd. (C34H60O12)Na+: 667.3663; Found: 667.3667.
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White solid.Yield: (0.10 g, 80 %), 1H-NMR ( 300 MHz, CD3OD): δ 6.89-6.85 (m, 3H), 5.12 (d, J
= 3.9 Hz, 1H), 4.37 (s, 2H), 4.24-4.21 (m, 1H), 3.87-3.70 (m, 4H), 3.70-3.35 (m, 6H), 3.35-3.19
(m, 6H), 2.30 (s, 6H),1.63-1.57 (m, 4H), 1.39-1.31 (m, 16 H). 13C NMR (75 MHz, CD3OD): δ
136.6, 134.9, 128.1, 127.2, 102.5, 101.1, 79.5, 76.0, 74.7, 73.2, 72.9, 72.8, 72.3, 71.9, 69.7, 69.4,
69.1, 60.9, 60.3, 29.0, 28.9, 28.9, 28.8, 28.7, 25.4, 25.3, 19.4. HRMS (ESI) m/z : Calcd.
(C33H56O12) Na+ : 667.3663; Found: 667.3660.
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White solid.Yield: (0.10 g, 89 %), 1H-NMR ( 400 MHz, CD3OD): δ 7.23-7.15 (m, 4H), 5.17 (d, J
= 4.4 Hz, 1H), 4.45 (s, 2H), 4.28 (d, J = 7.6 Hz, 1H), 3.91-3.84 (m, 4H), 3.70-3.45 (m, 6H), 3.363.33 (m, 3H), 3.33-3.24 (m, 3H), 2.34(s, 3H), 1.63-1.57 (m, 4H), 1.39-1.31 (m, 16 H). 13C NMR
(100 MHz, CD3OD): δ 137.9, 135.3,128.5, 128.2, 127.6, 102.9, 101.5, 98.6, 80.4, 79.9, 76.4,
75.1, 73.6, 73.5, 73.3, 73.2, 72.8, 72.7, 72.3, 71.8, 70.8, 70.0, 69.8, 69.5, 67.9, 62.9, 61.6, 61.3,

60.7, 60.6, 32.2, 29.4, 29.3, 29.3, 29.2, 29.1, 25.8, 25.7, 25.5, 22.8. HRMS (ESI) m/z: Calcd.
(C32H54O12)Na+: 653.3507; Found: 653.3504.
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White solid, Yield: (0.02 g, 88 %), 1H-NMR (300 MHz, CD3OD): δ 5.17 (d, J = 3.6 Hz, 1H),
4.28 (d, J = 7.8 Hz, 1H), 3.92-3.78 (m, 4 H), 3.72 – 3.51 (m, 6H), 3.47 – 3.34 (m, 4H,
overlapping with CD3OD), 3.29 – 3.19 (m, 2H), 2.13 (S, 3H), 1.77 – 1.73 (m, 13H), 1.46 (m,
2H), 1.32 (br s, 17 H). 13C NMR (75 MHz, CD3OD): δ 102.5, 101.1, 79.5, 76.0, 74.7, 73.2, 72.9,
72.8, 72.3, 71.6, 69.6, 69.1, 66.4, 61.1, 59.0, 40.8, 35.7, 30.1, 29.8, 29.0, 28.9, 28.8, 28.7, 25.4,
25.2. HRMS (ESI) m/z: Calcd. (C34H60O12)Na+: 683.3976; Found: 683.3971.
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White solid.Yield: (0.064 g, 83 %), 1H-NMR (300 MHz, CD3OD): δ 7.89-7.80 (m, 4H), 7.687.43 (m, 5H), 5.15 – 5.14 (m, 1H), 4.88-4.87 (m, 1H), 4.76 (s, 2H), 3.91 – 3.81 (m, 4H), 3.70 –
3.53 (m, 5H), 3.51 – 3.35 (m, 6H), 3.34-3.27 (m, 3H), 1.71 -1.55 (m, 4H), 1.25 (s, 12 H).
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C

NMR (75 MHz, CD3OD): δ 196.4, 143.6, 137.0, 136.0, 131.9, 129.3, 129.1, 127.7, 126.5, 101.1 ,
98.1, 79.9, 73.2, 73.0, 72.9, 72.4, 71.3, 71.2, 70.4, 70.0, 69.6, 67.4, 60.8, 60.2, 29.3, 28.9, 28.8,
28.8, 28.7, 28.7, 25.4. HRMS (ESI) m/z: Calcd. (C36H52O13)Na+: 715.3300; Found: 715.3304.
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72.2, 69.6, 69.1, 62.4, 61.1, 60.8, 60.3, 31.8, 28.9, 28.8, 28.8, 28.7, 25.2, 25.1. HRMS (ESI)
m/z: Calcd. (C22H42O12)Na+: 521.2568; Found: 521.2567.
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Chapter 3
Swarming Activation and Phenotypic Bifurcation of Nonswarming
P. aeruginosa Mutant by Maltose Derivatives
Overview:
Like biofilm formation, swarming is a multicellular behavior adopted by many bacterial
species for colonizing surfaces during infections. Rhamnolipids are biosurfactants secreted by
Pseudomonas aeruginosa and these amphiphilic molecules are known to be critical for at least
three bacterial bioactivities; making channels in the biofilm, dispersing bacteria from mature
biofilms and assisting in swarming motility. The maltose derivatives are amphiphilic molecules
with structural similarities to rhamnolipids and results in the previous chapter showed that such
agents are able to interfere with two bioactivities of P. aeruginosa that are associated with
presence of rhamnolipids; biofilm formation and dispersion. It was thus logical to test the effect
of these maltose derivatives on swarming motility of P. aeruginosa, the third activity controlled
by secretion of rhamnolipids. Results presented here show that maltose derivatives activated the
swarming of a P. aeruginosa mutant, rhlA that cannot produce rhamnolipids and is therefore
nonswarming in nature. The swarming activation of wild type P. aeruginosa and its
nonswarming mutant (rhlA) by maltose derivatives at lower concentration is peculiarly reversed
at relatively higher concentration, signifying an apparent “activity reversal” with increase in
concentration of maltose derivatives. Similar “activity reversal” phenomenon was also observed
during the early discovery of a bacterial cell signaling molecule. Several results presented here
indicate that maltose derivatives are mimicking the natural ligand in controlling swarming
motility of P. aeruginosa. In the argument of whether secreted rhamnolipids play a biological or

a physical role during swarming, the results are more inclined to the rhamnolipids having a
biological role. While maltose derivatives seem to mimic natural rhamnolipids, some maltose
derivatives dominate others at activating the swarming of rhlA mutant. These maltose derivatives
were also able to induce a concentration dependent phenotypic bifurcation of swarming PAO1
and rhlA cells. Maltose derivatives presented here are potential mimics of rhamnolipids, and
these agents posses the versatility of controlling three bioactivities of P. aeruginosa, biofilm
formation, dispersion and swarming motility. Results brought to the forefront the biofunctions of
rhamnolipids as new therapeutic target for controlling bacterial behaviors.

3.1 Background and significance
3.1.1 Swarming: A bacterial multicellular motility behavior
When bacteria comes in contact with a surface, they either decide to stay and form sessile
colonies known as biofilms or they decide to move rapidly (several µm s-1) on the surface with a
motility behavior known as swarming.72 Swarming is an important translocation movement that
is used by the bacteria to colonize surfaces in the natural environment and this kind of movement
is common to many flagellated bacteria.163 The decision to either form biofilm or swarm on the
surface is an important one for the bacteria and is made after receiving and evaluating the
information about nutrients availability, antagonistic conditions and other bacterial species
around in the environment.72 For many bacterial species the first step where bacteria sense the
surface is a very poorly understood phenomenon, but in the case of V. parahaemolyticus flagella
has been implicated as a sensor for surface contact.164

Swarming motility in bacteria was first discovered by Henrichsen and coworkers in 1972,
where hundreds of bacterial strains were tested for different types of translocation movements
and based on these results bacterial translocations were classified into six categories; swarming,
swimming, twitching, gliding, sliding and darting.165 Unlike the other five motilities, swarming
is a multicellular behavior and like biofilm formation swarming motility is also controlled by
quorum sensing.166, 167 Although, swarming has been observed in different gram negative and
gram positive flagellated bacteria, this kind of motility has been extensively studied only in a few
bacterial species like Escherichia coli (E. coli), Pseudomonas aeruginosa (P. aeruginosa),
Bacillus subtilis (B. subtilis) and salmonella.166
Since swarming motility is a multicellular phenomenon like biofilm formation, swarming
cells of P. aeruginosa isolated from Cystic fibrosis patients have also shown the ability to
produce high levels of virulence factors.168 Recently Butler and co-workers also showed that
swarming colonies are resistant to otherwise lethal doses of antibiotics.76 This resistance to
antibiotics during swarming was attributed to the high cell densities and high rate of mobility at
the swarm edge.76 It has been reported that during infections in Cystic fibrosis, a switch to either
sessile (biofilm) or motile (swarming) lifestyle by P. aeruginosa is usually accompanied by an
increase in resistance to a range of antibiotics.41
3.1.2 Two multicellular behaviors, biofilm formation and swarming motility are inversely
regulated
Switching between sessile and motile multicellular behavior is an important decision for the
bacteria to ensure its survival.72 Clinically it is critical to understand under exactly which
conditions bacteria prefer one social behavior over other. However, external environmental
stimuli that causes transition from sessile to motile mode still remains unclear.72, 167, 169 As both

swarming and biofilm formation are surface associated multicellular behaviors that are
controlled by bacterial quorum sensing, it is important to understand the relation between the two
behaviors. Recently, O’Toole and co-workers have proposed that sadB gene of P. aeruginosa is
responsible for inversely regulating the swarming and biofilm formation through the chemotaxis
cluster IV (Figure 3.1).73, 170 It has been observed that, during biofilm formation bacterial cells
differentiate and likewise in transitioning from one lifestyle to another, cells differentiate to
adapt to the new lifestyle.171 For example, during biofilm formation the cells of P. aeruginosa
usually synthesize single polar flagella to assist in surface adherence, but during swarming
motility, P. aeruginosa seems to develop two polar flagella.167, 172

Figure 3.1 Biofilm formation and swarming motility are inversely regulated. Both SadB gene
and type IV cluster together are responsible for deciding whether the bacteria will swarm or form
biofilm on the surface. The variation in the greyness of the surface indicated that the properties
of the surface like viscosity and wetness also play an important role in choosing between the two
multicellular behaviours. [Reprinted and modified with permission from Citation: Nicky C.
Caiazza, (2007), “Inverse Regulation of Biofilm Formation and Swarming Motility by
Pseudomonas aeruginosa PA14” J. Bacteriol. (189), 3603-3612; Copyright: 2007, American
Society for Microbiology.]

3.1.3 Swarming modulation by small molecules
Swarming motility is dependent on the quorum sensing process; a process which
proceeds through the recognition of small-molecule based chemical signals. Therefore, small
molecules like brominated furanones that interfere with bacterial quorum sensing are reported to
be effective swarming inhibitors for two different bacteria, B. subtilis and E. coli.56, 173 In another
report, a synthetic cationic peptide consisting of nine amino acids inhibited both the biofilm
formation and swarming motility of P. aeruginosa.174 Salicylic acids, which are known to
interfere with the flagella related motilities, inhibited the swarming motility of P. aeruginosa and
also inhibited the biofilm formation.175

3.1.4 Swarming motility of Pseudomonas aeruginosa
Swarming is a complex mode of translocation that is fundamentally different from other
bacterial motilities like swimming and twitching. While swarming is a surface associated
adaptive multicellular social behavior, swimming and twitching motilities are associated with the
planktonic mode of living that may be unrelated to surface propagation.166 It has been reported
that, P. aeruginosa requires all of the following features to successfully swarm on a semisolid
surface; quorum sensing , flagella, pili and production of biosurfactant rhamnolipids.167 In the
laboratory set up, swarming motility of bacteria is observed on the semisolid surface (0.5% agar)
and swimming motility can be studied on the soft surfaces (0.3%).159 What is unique and still a
poorly understood swarming phenomenon is the formation of complex patterns on the swarm
gels. While, some strains of P. aeruginosa when inoculated at the center of a semisolid surface,
grow outward from the point of inoculation to form complex branched tendrils,176 others simply

grow outward from the point of inoculation without forming any pattern. Deziel and coworkers
compared swarming motility of various strains of P. aeruginosa obtained from different sources
and studied their swarming motility under identical swarming conditions.176 Based on this study,
some strains were capable of forming tendrils but some were not under similar swarming
conditions (Figure 3.2).176 PAO1 strain used in this study does not form tendrils while swarming
and rather swarms like PAO1-Lory and PG201 strains from Figure 3.2.

Figure 3. 2 Swarm patterns of different P. aeruginosa strains on semisolid surface (0.5% agar).
[Reprinted with permission from Citation: Eric Déziel, (2008), “Improving the reproducibility of
Pseudomonas aeruginosa swarming motility assays” Journal of Basic Microbiology (48), 509515; Copyright: 2008, WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.]

3.1.5 Importance of flagella in swarming

Flagella have been demonstrated to be critical for carrying out swimming motility
associated with planktonic bacteria. Apart from their role in swimming motility, flagella also
play an important role in swarming process associated with bacterial swarm colonies.166

Generally, it is reported that, for swarming on a surface, bacteria modify their phenotype and go
from vegetative swimming cells having only one flagellum to hyper-flagellated swarmer cells
having a peritrichous arrangement of flagella along the surface.167 Swarming entails that a group
of cells move side-by-side to each other and such an association is called a raft. The existence of
raft formation has been demonstrated in Proteus mirabilis with the aid of scanning electron
microscopy and an integrity of rafts is attributed to the bundling of flagella.177
There are phenotypic differences between the swarming cells at the edge of the swarm
colony and the cells at the center of the swarm colony.167 Hyperflagellated swarming cells found
on the swarm edge are more elongated (3-4 µm) than the cells in the center of the swarm colony
(2 µm).167 Kohler and coworkers demonstrated that the deletion of the gene responsible for
flagellar biosynthesis in P. aeruginosa resulted in generation of a nonswarming mutant strain.167
P. aeruginosa is known to use a single polar flagellum to enable the swimming process. But
during swarming, P. aeruginosa produces a second polar flagellum and also synthesizes an
alternative motor system to rotate the flagellum and enable movement through viscous
environments.166, 172
3.1.6 Requirement of pili in swarming of P. aeruginosa
Pilus is one of the appendages present on the bacterial surface and are known to facilitate
initial adherence to the surfaces.142 Particularly, the type IV pili of P. aeruginosa recognize
carbohydrate epitopes present on human epithelial cells and enable adhesion.50, 140 Kohler and
coworkers reported that the existence of type IV pili in PAO1 strain is necessary for swarming
on semisolid surface.167 They reported that, while PAO1 could swarm on a semisolid surface its
pili mutant, pilA that lack type IV pili was unable to swarm. However, in two different studies,

O’Toole et al and Kornberg et al showed that the requirement of type IV pili for swarming in
another P. aeruginosa strain, PA14 was not important.172, 178 These contradictory reports that IV
pili may or may not be important could manifest from different experimental conditions or
different bacterial strains.
3.1.7 Quorum sensing controls swarming
Many studies have brought forward the role of bacterial quorum sensing (QS) in
swarming motility.179 These include the acyl homoserine lactone (AHL, AI-1) based expression
of genes that control the synthesis of biosurfactants that are required for swarming. For example,
the LuxI and LuxR system of genus Serratia control the production of biosurfactant
serrawettin.180 Another example is the secretion of biosurfactant rhmanolipids by P. aeruginosa
which is under the control of las and rhl quorum sensing systems of the bacteria.124 It has also
been demonstrated that, AHL mimics can modulate the swarming of S. liquefaciens, E. coli, B.
subtilis and Acinetobacterium baumanni.181 Relation between AI-2 mediated QS and swarming
was found in Proteus mirabilis and Vibrio parahaemolyticus. It is also known that QS regulates
the differentiation of swarmer cells that are required for the swarming process.
Study by Kohler et al. in 2000, showed that the swarming of P. aeruginosa is dependent
on quorum sensing circuits, las and rhl.167 In their study they used lasI, lasR, rhlI and rhlR
mutants of wild type P. aeruginosa. As per the hierarchy of P. aeruginosa QS circuits, the las
system controls the rhl system which further controls the rhlAB operon that eventually controls
the biosynthesis of rhamnolipids. Among the four mutants, swarming of lasI and lasR mutants
was reduced but the swarming of rhlI and rhlR mutants was completely abolished. The complete
inability of rhlI and rhlR mutants to swarm could either be attributed to lack of flagellar

functioning or to the lack of biosurfactant synthesis. However, Kohler and coworkers showed
that rhlI and rhlR mutants are capable of flagella dependent motility movement, swimming in
soft gels. Therefore, the inability of rhlI and rhlR mutants to swarm on semisolid surface could
be due to the lack of production of biosurfactant rhamnolipids.
3.1.8 Production of biosurfactants is critical for P. aeruginosa swarming
Many bacteria produce biosurfactants to reduce surface tension and facilitate their
movement through viscous environments.182 During swarming, B. subtilis and S. liquefaciens
secrete the lipopeptide surfactants surfactin and serrawettin, respectively, whereas P. aeruginosa
secretes di-rhamnolipids, mono-rhamnolipids and rhamnolipid precursor fatty acid βhydroxydecanoyl-β-hydroxydecanoate (HAA) (Figure 3.3).
Apart from reducing the surface tension to enable swarming, rhamnolipids have been
implicated to play a role in bacterial cell signaling.130 O’Toole et al showed that in P. aeruginosa
swarming process, rhamnolipids prevent colonization between two tendrils. O’Toole et al
showed that when rhamnolipids extracted from P. aeruginosa culture were externally added into
the semisolid gel (0.5 % agar), the swarming cells detected the presence of rhamnolipids and
changed courses to move away from the region that contained rhamnolipids. In another work,
O’Toole et al inoculated wild type P. aeruginosa or its SadB mutant along with P. aeruginosa
nonswarming mutant flgK. Although flgK mutant is nonswarming, it still retains the ability to
produce rhamnolipids. Results showed that, swarming tendrils of wild type P. aeruginosa moved
away from the region inoculated with the nonswarming mutant, flgK.159 Therefore, they conclude
that rhamnolipids act as repellants and that wild type P. aeruginosa was able to detect the
presence of such a repellant. Swarming tendrils of sadB mutant did not deviate from the region

where flgK mutant was inoculated and hence O’Toole et al strongly suggested that protein SadB
could be the receptor for rhamnolipids.
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Figure 3.3 Chemical structures of HAA, mono-rhamnolipids, di-rhamnolipids

3.1.9 Existence of different phenotypes during swarming
P. aeruginosa biofilms are known to contain many phenotypes that are responsible for
performing various functions in the biofilm.170, 171 Swarming is another bacterial multicellular
behavior and therefore the existence of multiple phenotypes within the swarming colonies is
highly anticipated. The swarming of P. aeruginosa is associated with three types of phenotypic
changes: lag phase, cell elongation and colony pattern formation.166
The first phenotypic change occurs after the inoculation of bacteria from a liquid medium
onto the semisolid surface (0.5 % agar). During this lag phase, the bacteria are characterized by a
non-motile behavior. While this non-motile phase is poorly understood, it is believed that during
this time the swimming bacteria undergo multiple phenotypic transformations to prepare for
swarming motilities. In B. subtilis, the lag-phase constitutes at least three important activities;
increase in cell-density, biosurfactant production and hyperflagellation.164, 183
The second phase of swarming is characterized by phenotypic changes that cause reduced
cell divisions and hence cell elongation.166 It has been shown that in the liquid cultures, Proteus
mirabilis grows as short rod-shaped cells, but during swarming it becomes multinucleated,

elongated and multiflagellated.183, 184 In the case of P. aeruginosa, it has been reported that the
cells at the edge of the swarm colony are elongated with two polar flagella.178
The third phenotypic change occurs during the formation of complex macroscopic
colonies by swarming bacteria on semisolid surfaces remains the most poorly understood
phenotypic change.
For example P. mirabilis forms bullseye shaped colonies that result from the periodic
synchronized movement and halting of the bacteria.185 P. aeruginosa (PA14) when inoculated on
a semisolid surface is known to form tendrils that grow outwards from the point of inoculation.
Another gram negative bacteria B. subtilis swarms with the formation of tendrils that arise when
the local rates of motility exceed the rate of bulk population growth.186, 187
3.1.10 Different theories to explain the tendril formation during swarming by P. aeruginosa

(A) Physical explanation- Marangoni effect
As many bacteria secrete surfactants to perform swarming motility, according to some
reports, the likelihood of gradients in surface tension driving flow and creating tendrils is highly
probable.188, 189 As bacteria continuously secrete biosurfactants at the interface of the swarm
colony and the semisolid surface, there is expected to be a gradient of surface tension caused by
either the change in composition of surfactant, change in viscosity; or change in temperature.190
This surface tension gradient gives rise to Marangoni forces that in turn generate flow forming
tendrils.191 190 There seems to be biomass accumulation at the tendril tips and this gives rise to
swarm patterns. Although, the involvement of signaling molecules, transport of oxygen or
transport of nutrients was taken into account while using Marangoni effect to explain tendril
formation; further understanding of the complex pattern forming process is desirable.192

(B) Chemotaxis
Bacteria sense and respond to their environment through a physicochemical process called as
chemotaxis. The response of the bacteria to chemicals that can either be attractants or repellants
has often been used to articulate complex pattern formation. Modeling studies have shown that
bacteria can change their swarming patterns depending upon the nutrient levels in the
surroundings.193 Based on these modeling studies, at high nutrient concentrations bacteria first
swarm in a circular pattern up to a certain distance and then start forming tendrils; when the
concentration of the nutrients is decreased, the simulation model predicted a swarm pattern with
branched tendrils; with very low nutrient concentrations the model predicted a spread out
colonial pattern (Figure 3.4).193 Using general modeling studies and experimental evidences,
Vicsek and coworkers showed that the pattern formation by bacteria changed with the
concentration of peptones in the agar.194 A concentration dependent study with peptone by
Vicsek and coworkers showed pattern formation similar to Figure 3.4.

Figure 3.4 Different patterns formed by bacteria depending on the level of concentration of food.
(A) tendrils formed at higher level of food; (B) pattern formed at intermediate food levels; (C)
colonial patterns formed at low food level. [Reprinted with permission from Citation: Ben‐Jacob,
E., (2009) Learning from bacteria about natural information processing. Annals of the New York
Academy of Sciences, 1178, (1), 78-90; Copyright: 2009, New York academy of sciences]

(c) Deziel’s coworker’s attractant/repellant theory
Deziel and co-workers extracted and purified the components of the rhamnolipids extract
to obtain three amphiphilic molecules, di-rhamnolipid, mono-rhamnolipid and HAA.195 In this
work, Deziel and coworkers showed that di-rhamnolipid acts as an attractant and promotes
tendril formation whereas mono-rhamnolipids only serve as wetting agents and third the
component HAA acids, act as repellants that inhibit tendril formation during swarming.195 They
also showed that in the semisolid gel the rate of diffusion of attractant is faster than that of the
repellant (Figure 3.5). Deziel and coworkers proposed that the ratio of attractant to repellant
propels the outward movement of swarmer cells from the point of inoculation to initiate the
formation of tendrils (Figure 3.5). Also, externally added di-rhamnolipids activated swarming of
a non-swarming P. aeruginosa mutant that lacks the production of rhmanolipids, rhlA.195

Figure 3.5 Deziel and coworkers attractant repellant model for explaining tendril formation. (A)
rate of diffusion from the point of inoculation of the attractant (di-rhamnolipids) on the semisolid
surface is faster than that of the repellent (HAA). (B) At the edge of the swarming colony, the
cells are attracted towards di-rhamnolipids and repelled by the mono-rhamnolipids and therefore
cells move outward up the attractant/repellent concentration gradient. [Reprinted with permission
from Citation: Eric Déziel, (2007) Self-produced extracellular stimuli modulate the

Pseudomonas aeruginosa swarming motility behavior, Environmental Microbiology, 9, 26222630; Copyright © 2007, John Wiley and Sons]

3.1.11. Concenpt of “Activity Reversal”

Eberhard and coworkers in their pioneering work reported that the production of light in
Photobacterium fischeri was increased by both synthetic and natural AHLs, between 0.3 and 3
µg /mL and then decreased upon further increase of the ligand concentration.10 LuxI enzyme of
V. fischeri synthesizes autoinducer which is AHL. Autoinducers can freely diffuse across the cell
and their concentration is dependent on the density of the bacterial culture. As cell density
increases concentration of AHL also increases and when concentration reaches threshold, AHL
molecules binds to the receptor protein LuxR regulated by gene luxI. Binding of AHL with LuxR
protein regulates different set of genes. Genes which come under positive feedback system are
upregulated, whereas genes which come under negative feedback system are downregulated.
Since autoinducer synthase gene luxI comes under positive feedback loop, synthesis of
autoinducer is accelerated which leads to an exponential increase in the light production by V.
fischeri. But at the same time autoinducer receptor gene luxR comes under negative feedback
loop. Therefore, binding of AI with luxR, reduces the expression of luxR protein, and hence the
intracellular concentration of receptor protein decreses. Hence this negative regulatory system is
responsible for the decrease in the light production of V. fischeri.

3.1.11 Aim of the chapter

In this chapter the correlation between reduction of surface tension and activation of
swarming was investigated and the importance of structural details of the surface active agent
was examined. Also the effect of various maltose derivatives on swarming motilities of P.
aeruginosa and its nonswarming mutant, rhlA were examined. Swarming experiments were
analyzed to understand the correlation between the anti-biofilm activities of the maltose
derivatives and the effect of such agents on swarming motilities.

3.2 Results and Discussion

3.2.1 Surface activity of molecules does not correlate with swarming activation ability
In order to reduce the surface tension between the bacterial cell and the surface on which
bacteria swarm, certain gram negative bacteria secrete biosurfactants.123, 166 Gram negative
bacteria, P. aeruginosa secrete a class of glycolipid based biosurfactant known as rhamnolipids.
If reduction in surface activity is the sole factor responsible to activate swarming in bacteria like
P. aeruginosa, then any generic surfactant should induce a similar effect on swarming. Here we
test the hypothesis that any surface tension reducing agent can modulate swarming of P.
aeruginosa. To test this hypothesis we investigated the ability of generic surfactants to reactivate
swarming of a non-swarming P. aeruginosa mutant, rhlA. Since rhlA mutant lacks the
production of natural biosurfactant rhamnolipids, introduction of generic surfactants into the
swarm agar plates constitutes an agonist type swarming assay.

Different types of generic surfactants used here to investigate the activation of rhlA
swarming include, anionic, sodium dodecyl sulfate (SDS, CMC ~ 8000 µM); cationic, dodecyl
trimethyl ammonium chloride (DTAC, CMC ~ 20300 µM); and two non-ionic, tetraethylene
glycol monododecyl ether (C12EG4OH, CMC ~ 69 µM) and dodecyl-β-maltoside (DβM, CMC
~ 170 µM). These generic surfactants were homogeneously mixed in the swarm agar (0.5%)
plates to a final concentration of 170 µM. Nonswarming mutant, rhlA was inoculated on such
swarm agar (0.5%) plates containing various generic surfactants and the swarming modulation
was compared to the rhlA inoculated on agar plates lacking any surfactant. Among all the tested
generic surfactants, only DβM activated the swarming in nonswarming mutant, rhlA while other
generic surfactants (SDS, DTAC, C12EG4OH) were incapable of restoring swarming (Figure
3.6). This result indicated that, while DβM; having amphiphilic structure similar to that of
biosurfactant rhamnolipids; restored swarming in nonswarming mutant rhlA; other generic
surfactants also having amphiphilic structures were incapable of inducing a similar effect.
Although surface tension (Table 3.1) of C12EG4OH (27.6 mN/m at CMC ~ 50 µM) at 170 µM
was lower than that of DβM (35.3 mN/m at CMC ~ 170 µM), only DβM was able to activate the
swarming of rhlA mutant. Therefore, results indicate that surface activity alone cannot explain
the activation of swarming in rhlA mutant by DβM and that a ligand-receptor approach would be
more applicable to explain this phenomenon. Results also show that, DβM induced tendril
formation in the swarm pattern of rhlA mutant (Figure 3.6). Deziel and coworkers have
previously shown that externally added rhamnolipids extracts not only restore the swarming in
nonswarming mutant, rhlA but also induce tendril formation in the swarm patterns.195
Additionally, the formation of tendrils in rhlA swarm patterns by presence of DβM was similar

to the swarm pattern of a wild type P. aeruginosa strain, PA14. Therefore, these results suggest
that DβM could be mimicking rhamnolipids.

Figure 3.6 Swarming activation of non-swarming mutant rhlA by dodecyl β-maltoside, dodecyl
(DβM), dodecyl trimethyl ammonium chloride (DTAC), sodium dodecyl sulfate (SDS), tetra
ethyleneglycol monododecyl ether (C12EG4OH). Concentration of all the surfactants in the
swarm agar (0.5%) plate was 170 µM.

Table 3.1. Surface activity of generic surfactants
Generic Surfactant

Critical micelle
concentration (CMC)
50 µM196

Surface tension
(γ) at CMC
27.6 mN/m196

170 µM197

35.3 mN/m197

Sodium dodecyl sulfate (SDS)

8000 µM197

39 mN/m197

Dodecyl trimethyl ammonium
chloride (DTAC)

20300 µM198

39.25 mN/m198

Tetraethylene glycol dodecyl
ether (C12EG4OH)
Dodecyl-β-maltoside (DβM)

3.2.2 Synthetic library of maltose derivatives used for swarming studies
In order to investigate the ligand-receptor approach for explaining the swarming
activation by maltose based derivatives we did a structure-activity study. The same library of
maltose derivatives which was previously tested (Chapter 2) for its effect on biofilm inhibition
was used to study the effect on swarming of both rhlA and PAO1 (Figure 3.7). The structures
used for the swarming assays include amphiphilic molecules; with varying number of carbon
atom in aliphatic chains, decyl-β-maltoside (DeβM), undecyl-β-maltoside (UβM), dodecyl-βmaltoside (DβM), with terminal bulky group, adamantane dodecyl-β-maltoside (ADβM), with
aromatic bulky groups, benzyl decyl-β-maltoside (BDeβM), benzyl dodecyl-β-maltoside,
(BDβM), 4-tertiary butyl benzyl decyl-β-maltoside (4-tBuBDeβM), 4-tertiary butyl benzyl
dodecyl-β-maltoside (4-tBuBDβM), 3,5-dimethyl benzyl dodecyl-β-maltoside (3,5-DMBDβM),
4-methyl benzyl dodecyl-β-maltoside (4-MBDβM), benzophenonyl decyl-β-maltoside
(BPDeβM) and a nonamphiphilic molecule having maltose on one side and hydroxyl group on
the other side of the ten carbon aliphatic chain, 1,2-hydroxy decyl-β-maltose (12-HODeβM).
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Figure 3.7 Library of maltose derived hydrocarbons

3.2.3 Three types of swarming behaviors by rhlA mutant in presence of maltose derivatives
suggest different level of agonism to the putative receptor

All the maltose derivatives (Figure 3.7) were tested for their ability to activate the
swarming of nonswarming mutant, rhlA at 85 µM concentration. Based on the swarming
activation abilities, the twelve maltose derivatives were classified into three groups. Group I,
four maltose derivatives (UβM, BDeβM, BDβM and BPDeβM) activated swarming of rhlA
mutant but did not induce tendril formation (Figure 3.8). Group II, four maltose derivatives
(DβM, 3,5-DMBDβM, 4-MBDβM and ADβM) activated the swarming of rhlA mutant with

tendril formation (Figure 3.8). Group III, four maltose derivatives (DeβM, 4-tBuBDeβM, 4tBuBDβM, HODeβM) did not activate the swarming of rhlA mutant (Figure 3.8).
It is evident from the images of group I swarm agar plates that the diameters of rhlA
mutant swarm with 85 µM of three maltose derivatives, UβM (83 %), BDβM (77 %) and
BPDeβM (87 %) were comparable to the swarm diameter of the wild type PAO1 (100 %)
without any added agents. However the fourth group I maltose derivative, BDeβM had a
significantly reduced swarm diameter (51 %) as compared to wild type PAO1 (100 %).
However, with the four group II maltose derivatives, the rhlA swarm diameter was comparable to
the diameter of wild type P. aeruginosa, the overall swarm area of rhlA mutant in presence of the
four maltose derivatives was less than the swarm area of wild type P. aeruginosa due to tendril
formation. Maltose derivative in group II, ADβM promoted tendrils that were thinner than the
tendrils formed in presence of other group II maltose derivatives. Also, tendrils formed in
presence of ADβM showed irregular turns and the pattern thus formed was more fractal-like.
The swarming diameter of rhlA mutant in presence of a four group III maltose derivatives,
(DeβM, 4-tBuBDeβM, 4-tBuBDβM, HODeβM) were approximately the same (1-2 cm), and
comparable to swarm diameter of rhlA mutant without any added agents (~1.2 cm) and about 95
% less than the swarming diameter of wild type PAO1. Generic non-ionic surfactant C12EG4OH
was also included in the swarming study at 85 µM and the results indicate that this molecule
behaved like maltose derivatives in Group III.
The swarming results of rhlA mutant show that the modulation of swarming by maltose
derivatives is dependent upon the structural details and with no direct correlation to both
aliphatic chain bulkiness or the biofilm inhibition ability of these agents (See Figure 2.6 for %

biofilm inhibition). If these agents are mimicking rhamnolipid, then the difference in swarming
activation abilities suggest different levels of agonism to the putative rhamnolipid receptor.

Figure 3.8 Nonswarming P. aeruginosa mutant rhlA inoculated on the M8 swarm agar (0.5 %
agar) plates with and without 85 µM of maltose hydrocarbons and generic surfactant
C12EG4OH. Pictures were taken 24 h after the inoculation of bacteria on the plates.

3.2.4 Maltose derivatives modulate swarming motility of wt. P. aeruginosa
We also tested the twelve maltose derivatives (Scheme 1) at 85 µM for their ability to
modulate PAO1 swarming. Although the presence of maltose derivatives did not alter the swarm
diameter of PAO1, the ability to induce tendril formation gives two classes of maltose
derivatives. Group I, six maltose derivatives did promote tendril formation (4-tBuBDeβM,
DβM, 4-MBDβM, 3,5-DMBDβM, ADβM and 4-tBuBDβM) and Group II, six maltose

derivatives did not promote tendril formation (BPDeβM, BDβM, UβM, BDeβM, DeβM and
HODeβM). There is no correlation between PAO1 biofilm inhibition ability (See Figure 2.6 for
% biofilm inhibition) of these agents and the ability to form tendrils in swarming of wild type
PAO1. For example, agent BDβM which inhibited ~ 89 % of PAO1 biofilm did not promote
tendril formation but 4-tBuBDeβM with ~ 88% promoted tendril formation (Figure 3.9).

Figure 3.9 Wild type P. aeruginosa inoculated on the M8 swarm agar (0.5 % agar) plates with
and without 85 µM of maltose hydrocarbons. Pictures were taken 24 h after the inoculation of
bacteria on the plates.

3.2.5 Concept of concentration dependent “activity reversal” during swarming motility,
activated by different maltose derivatives
(A) Increasing the concentration of DβM exhibits a transition from swarm activating at low
concentrations to swarm inhibiting at relatively higher concentrations for the rhlA mutant
Preliminary results suggested a role of ligand-receptor interaction and traditionally protein
carbohydrate binding is regarded as weak interactions that can be countered by either increasing

the valency of the ligand or by increasing the concentration of the ligand.133, 199 Therefore, we
were curious to know the effect of concentration of such carbohydrate ligands on swarming.
Therefore, we initially tested DβM in a concentration and time dependent manner for its ability
to modulate swarming of both wild type P. aeruginosa and its nonswarming mutant, rhlA.
Firstly, we tested the effect of DβM on swarming of rhlA mutant in the concentration range
between 10 to 250 µM (Figure 3.10). The time-elapse images of this swarming assays show that,
at 10 µM; DβM rhlA mutant did not swarm (~ 8.80 cm2 at 12 h), but as concentration was
increased to 20 µM the swarm area increased significantly (~ 36.6 cm2 at 12 h), when the
concentration was increased further to 85 µM, although there was an overall swarming activation
(~ 24.51 cm2 at 12 h) as compared to control (no added agents, 8.8 cm2 at 12 h), there was a
reduction (33%) in swarming area as compared to swarming at 20 µM. On further increasing the
concentration beyond 85 µM to 250 µM, there is an apparent increase in swarming area. This
“activity reversal” of swarming area (Figure 3.13) on increasing the concentration of DβM is
indicative of a phenomenon reported in the early discovery of the quorum sensing molecule N(3-oxohexanoyl)-3-aminodihydro-2(3H)- furanone by Eberhard and coworkers.10 Eberhard and
coworkers in their pioneering work reported that the production of light in Photobacterium
fischeri was increased by both synthetic and natural AHLs, between 0.3 and 3 µg /mL and then
decreased upon further increase of the ligand concentration.10 Intrigued by this we were further
curious to know the exact concentration at which this transition from swarming activating to
swarming inhibiting occurred for DβM. Therefore, we tested additional concentrations between
10 and 80 µM (Figure 3.11). With rhlA mutant, the “transition concentration” for DβM from
swarm activating to swarm inhibiting was ~ 45-50 µM. Figure 3.11 shows that at 45 µM of DβM
swarming of rhlA was more like wild type PAO1, i.e without tendril formation and a swarming

area of 45.8 cm2, but, as the concentration of DβM increased from 45 to 50 µM, rhlA mutant
swarmed with distinct tendril formation and reduced overall swarming area to 21.72 cm2, 47.4%
reduction as compared to swarm area at 45 µM (Figure 3.11).

Figure 3.10 Effect of DβM on swarming of rhlA

Figure 3.11 Effect of DβM on swarming of rhlA mutant

(B) Antagonistic swarming assay with PAO1 in presence of increasing concentration of DβM
traces an “activity reversal” for swarming area

Performing the swarming assay with rhlA mutant that lacked the production of
rhamnolipids served as a platform for testing the agonistic effect of DβM. On the contrary,
because wild type PAO1 produces the natural rhamnolipids, the swarming assay with this wild
type strain constitutes an antagonistic assay. Therefore, we tested DβM in a concentration
dependent manner for its ability to modulate PAO1 swarming. Similar to the swarming results of
rhlA mutant in presence of DβM, PAO1 also exhibited no observable tendril formation in the
concentration range between 20 and 40 µM, however at 85 µM there was distinct tendril
formation (Figure 3.12). After 12 h, swarm area of PAO1 on 40 µM DβM plate was 85.31 cm2
and at 85 µM was 41.75 cm2 (Figure 3.13), which indicated that DβM can induce concentration
dependant “activity reversal” of PAO1 too.

If surface activity was the only important factor for promotion of swarming then,
swarming areas would increase with increasing concentration of surface active agent. It is

predicted that, as the concentration of DβM is increased the surface tension would
simultaneously decrease.200 Results of swarming area for both PAO1 and rhlA mutant with
increasing concentration of DβM shows an “activity reversal.” For example maximum swarming
activation by DβM for PAO1 was observed at 20 µM beyond which the swarm area decreased
(Figure 3.13). These “activity reversal” results indicate that, surface activity of the agent is not
the most important factor for predicting the size of the swarm pattern. Maltose derivative, DβM
modulated PAO1 swarming at all tested concentrations, suggesting that DβM probably is a better
antagonist than natural rhamnolipids for the putative rhamnolipids receptor.

Figure 3.12 Time dependent (h) effect of increasing concentration of DβM on swarming of
PAO1. Concentrations (µM) are indicated above and times (h) are shown to the left of the
pictures. PAO1 was inoculated on the semisolid gel (0.5 % agar).
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Figure 3.13 Plot of swarming areas of either (A) rhlA mutant or (B) PAO1 versus the
concentrations of DβM. The bacteria were inoculated on semi-solid (0.5 % agar) for 24 h in
presence of various concentrations of DβM.

(C) Concentration-dependant swarming study with different maltose derivatives for both the rhlA
mutant and PAO1

Since DβM exhibited a concentration dependent “activity reversal” of swarm area for
both PAO1 and rhlA mutant, a swarming concentration study with selective maltose derivatives
from each group mentioned in Figure 3.8 and 3.9 was also done for the rhlA mutant and PAO1.

From group I, two maltose derivatives, BPDeβM and BDeβM showed a gradual increase
in the swarm area with neither any distinct tendril formation nor any swarming area “activity
reversal” (Figure 3.14). But another group I maltose derivative, BDβM, showed distinct tendril
formation at concentrations higher than 85 µM with an overall “activity reversal” for swarming
area (Figure 3.14). Among group II participants, 4-MBDβM and 3,5-DMBDβM showed

“activity reversal” with tendril formation at higher concentrations similar to the activity exhibited
by DβM which also belongs to the same group (Figure 3.14).

From group III, four maltose derivatives, DeβM, 4-tBuBDeβM, 4-tBuBDβM, and
HODeβM were tested. Maltose derivative HODeβM did not show any effect on the swarming
of rhlA mutant at any of the tested concentrations (i.e, between 5 to170 µM, result not shown).
The rest of the group III maltose derivatives, DeβM, 4-tBuBDeβM, 4-tBuBDβM exhibited
swarming activation of rhlA mutant at different concentration ranges. While DeβM at 85 µM did
not show much promotion of swarming area, it completely activated the swarming of the rhlA
mutant at 170 µM with fine tendril formation (Figure 3.14). The other two group III maltose
derivatives, 4-tBuBDeβM and 4-tBuBDβM activated the swarming motility of rhlA mutant at
low concentrations (5-10 μM), but at higher concentration (40-170 uM) they were not active
(Figure 9). In the low concentration (5-10 μM) range of 4-tBuBDeβM and 4-tBuBDβM, the
activated swarming area of the rhlA mutant varied significantly. A graph of swarming area
versus the concentration of the two group III maltose derivatives, 4-tBuBDeβM and 4tBuBDβM was plotted (Figure 3.15). Both the plots exhibited “activity reversal” around 5-10
μM. But maltose derivative 4-tBuBDeβM gave a maximum swarming area of ~39.6 cm2 at ~ 10
μM while 4-tBuBDβM had a maximum swarming area of ~ 5.5 cm2 at ~ 5 μM (Figure 3.15).
The control, rhlA mutant, without agents had a swarming area of 1.4 cm2.

Figure 3.14 Effect of different concentrations of various maltose derivatives on swarming of the
rhlA mutant. Concentrations (µM) are indicated above the pictures and identities of the maltose

derivatives are indicated to the left. Pictures were taken 24 h after inoculation of the bacteria on
semi-soft gel (0.5 % agar).
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Figure 3.15 Plot of swarming areas of the rhlA mutant versus the concentrations of 4tBuBDeβM (6) or 4-tBuBDβM (7). The rhlA mutant was inoculated on semi-solid (0.5 % agar)
for 24 h in presence of various concentrations of 4-tBuBDeβM (6) or 4-tBuBDβM (7).

At 85 µM, four group I maltose derivatives, 4-tBuBDeβM, 4-tBuBDβM, 4-MBDβM,
3,5-DMBDβM had induced tendril formation in PAO1 swarms (Figure 3.9). Concentration
dependent study with these four group I maltose derivatives revealed that induction of tendril
formation in PAO1 swarms becomes apparent at 20 µM concentrations of these agents in the
semi-solid gel (0.5 % agar). Tendril formation in presence of 4-tBuBDeβM was unique as the
swarm patterns formed petal shaped protrusions unlike the usual thin tendrils induced by the
other three group I maltose derivatives (Figure 3.16).

Of the three group II agents, two maltose derivatives BDeβM and DeβM did not induce tendril
formation in PAO1 at any of the tested concentrations (5 to 170 µM). However, for the third
group II maltose derivative, BDβM, when the concentration of was increased from low to high,
PAO1 showed wide petal-like tendril formation at 5 µM which transitioned into no tendrils
between 10-20 µM followed by thin tendril formation around 40-60 µM and then transitioning
again into wide tendrils followed by a final transition to form thin tendrils at 170 µM. This
oscillation in swarming pattern activity due to difference in chemical concentration is symbolic
of an oscillatory response by the bacteria to the chemical stimuli.201

Figure 3.16 Effect of different concentrations of various maltose derivatives on swarming of the
PAO1. Concentrations (µM) are indicated above the pictures and identities of the maltose
derivatives are indicated to the left. Pictures were taken 24 h after inoculation of the bacteria on
semisolid gel (0.5 % agar).

3.2.6 Swarming competition assay shows that 4-tBuBDeβM and 4-tBuBDβM inhibits DβM
promoted rhlA swarming
The wild type PAO1 is known to produce rhamnolipids and hence a swarming study
using such a strain would imply that these maltose derivatives have to compete with naturally
secreted rhamnolipids for the putative rhamnolipids receptor. Such a swarming assay serves as a
competitive antagonistic swarming assay. On the contrary, the rhlA mutant lacks the production
of rhamnolipids and serves as a platform for an agonist swarming assay. The rhlA mutant was
used in order to examine the effect of group III maltose derivatives on swarming.
Maltose derivatives in group III, 4-tBuBDeβM, 4-tBuBDβM and HODeβM at 85 µM,
showed no apparent swarming activation of the rhlA mutant. This swarming activation inability
of the group III maltose derivatives could imply the following: either these group III maltose
derivatives are not recognized or are non-binding to the putative receptor site and hence the
subsequent signaling cascade is not triggered leading to no swarming activation, or these maltose
derivatives are capable of binding to the putative receptor but unlike the group I and group II
derivatives which can agonize, group III agents antagonize the receptor site and hence no
swarming activation is observed.
The concentration dependent study using the two group III maltose derivatives, 4tBuBDeβM and 4-tBuBDβM, indicated that these agents were swarming agonists at a relatively
low concentration range of 5-10 µM and the third group III maltose derivative, HODeβM
showed no apparent effect on the rhlA mutant swarming at all tested concentrations (5-170 µM).
To investigate further if 4-tBuBDeβM, 4-tBuBDβM and HODeβM interact with the putative
receptor, a competition swarming assay was designed. Maltose derivative DβM fully activated
the swarming of the rhlA mutant (in comparison to swarming of wild type PAO1) with no

distinct tendril formation at 20 µM (figure 3.10). For the competition assays, semisolid gels (0.5
% agar) supplemented with 20 µM of DβM and incremental concentrations of either 4tBuBDeβM, 4-tBuBDβM or HODeβM were created and the rhlA mutant was inoculated. The
competition assays reveal that 40 µM of 4-tBuBDeβM completely inhibited the swarming
promoted by DβM (20 µM) of the rhlA mutant (Figure 3.17), while only 20 µM of 4-tBuBDβM
was required to completely inhibit the swarming. Also, both 4-tBuBDeβM and 4-tBuBDβM at
concentrations as low as 10 µM, started to induce tendril formation of 20 µM DβM-activated
rhlA mutant’s swarming (Figure 3.17). Maltose derivative HODeβM is incapable of inhibiting
the DβM-activated swarming of rhlA mutant. Also, the plot of resultant rhlA swarming area
versus increasing concentration of three maltose derivatives, 4-tBuBDeβM, 4-tBuBDβM and
HODeβM shows that effective concentrations of 4-tBuBDeβM and 4-tBuBDβM for inhibiting
DβM activated swarming were 40 and 20 µM respectively, whereas HODeβM did not inhibit
swarming at any tested concentration (Figure 3.18). These results indicate that two of the group
III maltose derivatives, 4-tBuBDeβM, 4-tBuBDβM may be stronger binding ligands than DβM
and that HODeβM may be a weaker binding ligand than DβM or may have no binding with the
putative receptor.

Figure 3.17 Nonswarming P. aeruginosa mutant, rhlA, inoculated on the M8 swarm semisolid
agar (0.5 %) plates containing mixture of 20 μM DβM with different concentrations of 4tBuBDeβM (6), or 4-tBuBDβM (7), or HODeβM (12)

140

rhlA swarm area
after 24 h (cm2)

120
100
80
60

HODeβM (12)

40

4-tBuBDeβM

20

4-tBuBDβM

(6)

(7)

0
0

10

20

30

40

50

60

70

80

90

Concentration (µM) of 12 or 6 or 7 (with 20 µM DβM)

Figure 3.18 Swarm area of rhlA mutant inoculated for 24 h on semisolid agar (0.5%) gel
containing a mixture of 20 µM DβM and increasing concentrations of or HODeβM (12), 4tBuBDeβM (6), or 4-tBuBDβM (7).

3.2.7 Swarming competition assay shows that C12EG4OH inhibits DβM promoted swarming of
rhlA mutant and SDS has no apparent effect
At 170 µM, two generic surfactants C12EG4OH and SDS showed no apparent effect on the
swarming of the rhlA mutant (Figure 3.6). A swarming competition assay with rhlA mutant
inoculated on semisolid gels (0.5% agar) containing DβM (at 20 µM) and increasing
concentrations of either C12EG4OH or SDS were set up to investigate whether these generic
surfactants are inhibiting or have no effect on swarming (Figure 3.19). While DβM at 20 µM
activates the swarming of the rhlA mutant, adding 20 µM of C12EG4OH in the semisolid gel
completely inhibited the DβM promoted swarming. On the contrary, SDS as high as 40 µM was
incapable of completely inhibiting the swarming of the rhlA mutant promoted by DβM. These
results indicate that while one generic surfactant, C12EG4OH could be having an interaction with
the putative swarming receptor another generic surfactant SDS exhibits no such interaction.

Figure 3.19 Nonswarming P. aeruginosa mutant, rhlA inoculated on the M8 semisolid (0.5 %
agar) swarm gels containing a mixture of 20 μM of DβM with different concentrations of
C12EG4OH, or SDS.

3.2.8 Maltose derivatives mimic rhamnolipids : DβM (85 µM) activated tendrils in nonswarming mutant rhlA repel each other
Tendril formation by P. aeruginosa swarms is an intriguing and a challenging
phenomenon. The primary understanding of why P. aeruginosa forms tendril is that it is an
adaptive mode of living in order to adjust to the environmental conditions. The tendril formation
phenomenon has been explained by many physico-chemical theories which include marangoni
effect, chemotaxis, and attractant-repellent theory.190, 193-195 While several models have been
proposed to explain tendril formation in P. aeruginosa, the mechanism of pattern formation still
remains unclear.
While it is clear that under the tested swarming conditions the PAO1 strain used in this
study does not form tendrils, the introduction of 85µM of DβM in the semisolid gel (0.5 % agar)
induced tendril formation (Figure 3.12). Also, inoculating the nonswarming mutant rhlA on
semisolid gel (0.5 % agar) with 20µM of DβM caused swarming activation with the swarm
covering the entire gel surface with no clear tendril formation (Figure 3.10). However, when the
concentration of DβM was increased to 85 µM, rhlA mutant swarms with fine tendril formation
(Figure 3.10). Additionally, at 85 µM, six maltose derivatives; 4-tBuBDeβM, DβM, 4-MBDβM,
3,5-DMBDβM, ADβM and 4-tBuBDβM induced tendril formation in PAO1 (Figure 3.9) and
four maltose derivatives; DβM, 3,5-DMBDβM, 4-MBDβM and ADβM reactivated rhlA mutant
with tendril formation (Figure 3.8). Deziel and co-workers had demonstrated that externally
added rhamnolipids can reactivate rhlA swarming with tendril formation similar to that of wild
type P. aeruginosa.195 The ability some maltose derivatives to activate the swarming of rhlA
mutant and induce tendril formation in both rhlA mutant and PAO1 indicates that these agents
could be mimicking rhamnolipids.

O’Toole and co-workers have also reported that when two colonies of wild type of P.
aeruginosa strain PA14 are inoculated on the same semisolid surface (0.5 % agar), the tendrils of
the two colonies seem to repel each other.202 The possible explanation given by O’Toole and coworkers is that the wild type strain secretes extracellular factors (possibly rhamnolipids) that
prevent colonization between two tendrils and also the merger of two swarm colonies.
Encouraged by the rhamnolipid mimicking ability of the maltose derivatives, semisolid gel (0.5
% agar) containing either zero or 85µM of DβM was inoculated with two colonies PAO1
separated on the surface. The two colonies of PAO1 on the semisolid agar that lacked DβM did
not merge. However, the distance between the tendrils of the two PAO1 colonies inoculated on
the semisolid agar containing 85µM of DβM was larger than between the two colonies on the gel
that lacked DβM (Figure 3.20). On increasing the concentration of DβM in the semisolid gel (0.5
% agar) inoculated with two colonies of rhlA mutant brought forward two kinds of colony
behaviours. At 20 µM of DβM the two rhlA colonies seem to merge to form one
indistinguishable swarm colony (Figure 3.20). However, when the concentration of DβM was
increased to 40 µM the two rhlA swarm colonies did not merge and the tendrils formed seemed
to repel each other (Figure 3.20). The separation and repulsion of tendrils seem to increase when
the concentration of DβM was increased to 85 µM (Figure 3.20). Such behaviour suggests the
generation of different rhlA phenotypes at different concentrations of DβM. Therefore we
hypothesize that at 20 µM DβM induces rhlA mutant to go from nonswarming to hyperswarming
phenotype whereas, at 85 µM DβM causes coexistence of hyperswarming and hyposwarming or
hyperswarming and nonswarming phenotype of rhlA (Figure 3.21).

Figure 3.20 PAO1 or rhlA mutant inoculated on two different locations on the same semisolid
agar (0.5 %) plate containing DβM (0 or 20 or 40 or 85 μM). Pictures are taken 24 h after
inoculation of bacteria on the agar plate.

Figure 3.21 Different phenotypes of rhlA on semisolid gel (0.5 % agar) depending on the
concentration of DβM

3.2.9 The swarming phenotype of rhlA mutant generated depends on the concentration of DβM
In order to test our hypothesis, whether DβM can induce formation of two different
phenotypes at different concentrations, the following swarming assay with rhlA mutant was
designed. A semisolid gel (0.5 % agar) was created such that two different concentrations of
DβM were present in the same swarm agar gel and rhlA mutant was inoculated.

Swarm gels containing one concentration of DβM were initially poured and solidified to
occupy half the volume of a petri dish and the other half was then filled with gel containing a
different or same concentration of DβM. In this way swarm plates were created having a
boundary at the center with two different concentration of DβM on either side (Figure 3.22). The
rhlA mutant was then inoculated on the swarm gel having a particular concentration of DβM and
the spread of the swarm colony across the concentration boundary was observed. We note that,
across the boundary the change the concentration may not be sharp and may actually be a
gradient from one concentration to another.
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Figure 3.22 Schematic representations for creating semisolid swarm agar plate containing two
concentrations of DβM

When the rhlA mutant was inoculated on the side of the semisolid gel that contained
85µM of DβM the reactivated swarm pattern had tendril formation but this swarm colony could
not spread across the boundary into a region that contained either lower or same concentrations
of DβM (20µM, 25µM, 35µM, 45µM, 85µM). On the contrary, when the rhlA mutant was
inoculated on the side that contained lower concentrations of DβM (20µM) the swarm colonies

spread with no distinct tendril formation and also crossed the concentration boundary into the
region of higher DβM concentrations (45µM, 65µM, 85µM). Interestingly, the swarming pattern
on entering the region of higher DβM concentration changed from no tendrils in the lower
concentrations to formation of distinct tendrils in the region of higher concentrations (Figure
3.23). This result suggests that, the phenotype formed on gels with 85 µM and 20 µM
concentrations of DβM are different. Also, the phenotype formed on 85 µM did not readily
change to form the phenotype associated with 20 µM concentration, but the phenotype formed
on 20 µM can change to form phenotype associated with 85 µM of DβM.

Figure 3.23 Images of swarm colonies of the rhlA mutant on semisolid gel (0.5 % agar)
containing two different concentrations of DβM. The rhlA mutant was inoculated on (A) 85 μM
DβM side of the agar plate. (B) 20 μM side of the agar plate. (C) both sides of the agar plate.

3.3 Conclusion

It has been reported that a P. aeruginosa mutant, rhlA that lacks the gene to produce
rhamnolipids is nonswarming but when rhamnolipids are externally added, the mutant swarms
with patterns similar to the wild type strain.202 This study brought forward a class of maltose
derivatives that are structurally related to rhamnolipids and that can activate the swarming of the
rhlA mutant. Other generic surfactants with poor structural resemblance to the natural
biosurfactant were incapable of exhibiting such swarming activation. Therefore, while swarming
is linked to the secretion of surface-active agents, not all surface active agents could accomplish
this bioactivity. The activation of swarming in rhlA mutant with patterns similar to that of wild
type strain by many maltose-derivatives suggested that these agents mimic the natural
biosurfactant, rhamnolipids. In the swarming agonist assays with the rhlA mutant, maltose
derivatives had variable ability to activate swarming and to induce tendril formation, suggesting
different levels of agonism to the putative receptor. The ability of maltose derivatives to
modulate swarming of wt. P. aeruginosa in the swarming antagonist assay also showed
variations.
Both the agonist and the antagonist assays showed that many maltose derivatives exhibited
an “activity reversal” phenomenon of transitioning from swarm-activating to swarm-inhibiting as
the concentration of the agents was increased. A similar “activity reversal” phenomenon had
been observed for the discovery of the prominent cell signaling molecule N-(β-ketocaproyl)
homoserine lactone.10 In addition, certain maltose derivatives appeared to cause a second
activation of swarming at relatively higher concentrations after first “activity reversal” cycle.

The physico-chemical theory of chemical attractant and repellant by Deziel and coworker
could not be applied to explain the activation of rhlA mutant’s swarming by maltose derivatives.
A representative maltose derivative, dodecyl-β-maltoside, caused phenotypic bifurcations of the
rhlA mutant and generated hyperswarming and hyposwarming cells. While, in the presence of
maltose derivative, the hyposwarming phenotype could transform into the hyperswarming
phenotype, the reverse transformation was not observed.
Multiple evidences presented here suggest an overall biological response by the bacteria to the
presence of maltose derivatives with many biological traits suggesting that these agents are
mimicking the natural ligand rhamnolipids. While the involvement of rhamnolipids in P.
aeruginosa bioactivities has been reported in a number of reports, the identification of its protein
receptor still remains elusive. Surface attachment deficient (SadB) protein being the target
receptor for rhamnolipids has been suggested by one such report. On the other hand, many
biological recognition events are mediated by carbohydrate-protein interaction and adhesins
proteins such as pilin and flagellin present on the bacterial surface mediate such interactions.
Therefore, whether maltose derivatives target the same receptor as that of rhamnolipids or
whether there exists a separate receptor for such ligands is an intriguing question for the future
work. Also, it is to be noted that there exists no correlation between the biofilm inhibition
abilities and the swarming activating abilities of the maltose derivatives, suggesting that either
the receptor for these two bioactivities is different or the receptor is the same, but the subsequent
cascading signaling effects are different.
This chapter highlighted the versatility of maltose derivatives to control swarming of P.
aeruginosa, in addition to their role in controlling biofilm development reported in earlier
chapters. The secretion of rhamnolipids and other biosurfactants have been reported in many

other bacteria. The effect of maltose derivatives on such species will be a good test of the
versatility of these agents to control multicellular behaviors of other species.

3.4 Materials and methods
Bacterial strains Wild type P. aeruginosa PAO1 and PAO1-EGFP strains were obtained from
Dr. Guirong Wang (Upstate Medical University, Syracuse). Non-swarming mutant of P.
aeruginosa, rhlA (PW6886, rhlA-E08::ISphoA/hah) was obtained from PA two-allele library
(PAO1transposon mutant library).203
Stock solutions of generic surfactants and maltose derivatives

Stock solution of all the agents

(11.5 mM) were prepared in autoclaved water, sterilized by filtering through 0.2 µm syringe
filter, and stored at -20 °C in sealed vials. Appropriate amount (same amount as of the stock
solution of maltose derivatives) of sterile water was added to controls in all assays to eliminate
solvent effect.
Swarming assay Swarm agar plates were made using M8 medium (50mM Na2HPO4, 25 mM
KH2PO4, 4 mM NaCl), supplemented with 0.2% glucose, 0.5% casamino acid (Difco), 1 mM
MgSO4 and solidified with 0.5 % Bacto-agar (Difco).202 Appropriate amount of maltose
derivative’s stock solution was added in the agar gel and thoroughly mixed before pouring in to
the petri dishes. For each set of experiment all the swarm plates were poured from same batch of
agar and allowed to dry for 1 h before inoculation of bacteria. Bacterial culture with OD600
between 0.4 to 0.6 was inoculated as 3 µl aliquots. Swarm agar plates were incubated at 37 °C
for 12 h and then incubated for additional 12 h at room temperature. Each swarming experiment
was repeated at least three times.

Swarm area measurement To measure swarming area, images of “swarm plates” were adjusted
to keep the diameters of all the petri dishes containing the semisolid gel to a constant 4.4 inches.
The adjusted images were printed and the swarming patterns were cut and weighed. With 1 cm2
square of the copy paper weighing 8.0 mg, the swarming areas were calculated.

Chapter 4
Maltose Derivatives Inhibit the Biofilm Formation of
Escherichia coli and Staphylococcus aureus
Overview
The active maltose derivatives exhibited versatile abilities to control three multicellular
activities of P. aeruginosa including biofilm formation, dispersion of preformed biofilm and
modulation of swarming motility (Chapter 2 and 3). All of the three multicellular activities of P.
aeruginosa that are affected by maltose derivatives are known to be either directly or indirectly
controlled by rhamnolipids, a class of naturally secreted glycolipid biosurfactants.
Apart from P. aeruginosa, only a few other bacterial species are known to produce
biosurfactants that are similar to rhamnolipids. Therefore it was necessary to identify the effect
of these maltose derivatives on other bacterial species, primarily to evaluate the universality of
such agents and to distinguish whether the action on P. aeruginosa is by mimicking
rhamnolipids or by a physical washing effect.
Two bacterial species that do not produce rhamnolipids, Escherichia coli, a gram negative
bacterium, and Staphylococcus aureus, a gram positive bacterium, were chosen for this study.
Tested maltose derivatives effectively inhibited the biofilms of both E. coli and S. aureus.
However, these maltose derivatives were sluggish dispersers of E. coli biofilm, and exhibited no
ability to disperse the biofilm of S. aureus. Additionally, contrary to the effect on P. aeruginosa,
the tested maltose derivatives lacked the ability to prevent the initial adhesion of E. coli on
polystyrene surface. The stark contrast between the activities of maltose derivative on P.

aeruginosa and two other bacteria, E. coli and S. aureus, suggests a biological response by P.
aeruginosa to these agents. Poor activities of such maltose derivatives against other bacterial
species also suggest that the antibiofilm action of such agents is not through physical washing
effects.

4.1 Background and significance
4.1.1 Difference between Gram positive and Gram negative bacteria
Since maltose derivatives effectively modulated the multiple multicellular activities of P.
aeruginosa, including initial adhesion on polystyrene surfaces, biofilm formation, dispersion and
swarming motility, it was important to understand the effect of these maltose agents on the
activities of other bacterial species. For comparative study of the effects of maltose derivatives
on the two other bacterial species we selected a Gram negative and a Gram positive strain of
bacteria, Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus), respectively.
Hans Christian Gram in 1884 discovered and first characterized bacteria into two
different classes, Gram positive and Gram negative based on their cell wall structure.204 Gram
negative bacteria have single layer of peptidoglycans in their cell wall and hence do not retain
the crystal violet (CV) dye, whereas Gram positive bacteria have a thick multilayer of
peptidoglycans and hence retain the CV dye.204 Apart from their role in being stained by organic
dyes, the bacterial cell wall and its thickness protects the bacteria from the action of antibiotics
and host immune system. Gram negative bacteria are usually more resistant to the action of
antibiotics than the gram positive bacteria.205 Apart from cell wall architecture, bacteria are
further classified based on their virulence and pathogenicity.

4.1.2 Staphylococcus aureus related infections
S. aureus is the most commonly encountered bacterium in nosocomial infections.206
Gram positive bacterium S. aureus is responsible for skin infections,207 abscesses,208 bloodstream
infections,209 pneumonia210 and toxic shock syndrome (TSS).211 Presently, some strains of S.
aureus are resistant to many existing antibiotics due to their intrinsic ability to quickly develop
resistance against antibiotics.212 During World War II, cell wall targeting antibiotic Penicillin
was primarily used for treating S. aureus related infections.213 But by the 1960s, Penicillin was
ineffective on almost eighty percent of the S. aureus related infections. Therefore Penicillin
structure was further modified to give second generation antibiotic, methicillin. But by the year
2002, methicillin resistant S. aureus (MRSA) strain emerged which showed resistance against
the commonly used antibiotic Methicillin.214, 215 S. aureus is therefore classified as multi drug
resistant (MDR) bacteria and is often referred as “super bug.” Further defense against antibiotics
can be achieved by the ability of S. aureus to form surface attached communities called biofilms.

4.2.3 E. coli and S. aureus do not produce biosurfactants
Although E. coli is known to swarm on semi-solid agar surfaces, the wetting agent
required to reduce the surface tension between swarming E. coli cells and the agar surface is still
unknown.216 It has been reported that, the lipopolysaccharides found on the outer membrane of
E. coli, are an important class of wetting agents which helps E. coli during swarming.78 Harshey
and coworker reported that an E. coli mutant strain that does not produce such
lipopolysaccharides was unable to swarm. On the other hand, the Gram positive bacterium, S.
aureus is a non-swarming species because it lacks two important factors that are critical for

swarming, the existence of flagella and the production of wetting agents or biosurfactants. But S.
aureus do retain the ability to colonize surfaces in search of nutrients by performing slow sliding
motilities with a rate of ~100 µm/min.217
4.2.4 Small molecules for inhibition of S. aureus biofilm formation
Gram positive bacteria carry out quorum sensing by secretion of peptide based signaling
molecules.218, 219 Therefore the acyl homoserine lactone (AHL) based synthetic mimics that can
interfere with the quorum sensing of many Gram negative bacteria are understandably ineffective
against Gram positive bacteria like S. aureus. Alternatively, the quorum sensing of Gram
positive bacteria can be inhibited by synthetic mimics of the signaling peptides. One of the
significant antagonists used against the biofilm and virulence of S. aureus is RNA-III inhibiting
peptide (RIP).220, 221 RIP peptide mimics RNA-III activating protein (RAP), and therefore can
compete with RAP for the phosphorylation of its target protein that ultimately controls S. aureus
virulence and adhesion. The competitive interference of RIP is through a nonmicrobicidal
mechanism.222 Other examples of Gram positive QS antagonist include peptides which inhibit
AgrC, a transmembrane sensor kinase. Protein AgrC is a part of a two-component signal
transduction system which detects the autoinducer peptides.223

4.2.5 Aim of the chapter
Results in chapter 2 suggested that the maltose derivatives do not interfere with the
quorum sensing of the P. aeruginosa. Results were also indicative of the role of maltose
derivatives as mimics of the natural biosurfactants that are secreted by P. aeruginosa,
rhamnolipids. The aim of this chapter was to study the effect of maltose derivatives on other

bacterial species such as E. coli and S. aureus that may or may not secrete similar biosurfactants
as P. aeruginosa.

4.2 Results and Discussion
4.2.1 Maltose derivatives did not inhibit the growth of E. coli and S. aureus
Selective maltose derivatives which inhibited more than 50 % of P. aeruginosa biofilm
were selected to further test their effect on the growth of E. coli and S. aureus at 170 µM (Figure
4.1). Out of five, four maltose derivatives BPDeβM, BDβM, 4-tBuBDeβM and DβM did not
inhibit the growth of E. coli; in fact, they promoted the growth. The fifth maltose derivative, 4tBuBDβM did not inhibit the growth for 12 h but after 12 h this agent retarded the growth of
planktonic E. coli (Figure 4.2). Four maltose derivatives, BPDeβM, BDβM, 4-tBuBDeβM and
4-tBuBDβM did not inhibit the growth of S. aureus, but DβM inhibited the growth slightly,
though it was not completely toxic (Figure 4.2).
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Figure 4.1 Structures of the five maltose derivatives tested
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Figure 4.2 E. coli and S. aureus growth response curve in absence and in presence of various
maltose derivatives at 170 µM. Error bar is the standard error of the mean from 6 replicates.

4.2.2 Inhibition of E. coli and S. aureus biofilms by maltose derivatives
After testing the effect of five maltose derivatives on the growth of the E. coli and S.
aureus these agents were further tested for their effect on biofilm formation.
For E. coli, the five maltose derivatives exhibited different biofilm inhibition efficacies.
The maximum E. coli biofilm inhibition was obtained by BPDeβM (58 %) followed by BDβM
(53 %), and DβM, 4-tBuBDβM and 4-tBuBDeβM showed 42, 28 and 24 % inhibition,
respectively at 110 µM concentration. Maltose derivative BPDeβM had previously exhibited
maximum biofilm potency against P. aeruginosa. Interestingly, even though 4-tBuBDβM was
slightly toxic to the growth of E. coli, its biofilm activity was not comparable to that of BPDeβM
(Figure 4.3).
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Figure 4.3 Inhibition of E. coli biofilm formation by maltose derivatives at 110 µM measured
using CV dye-based assay. Error bar is standard error of the mean from 6 replicates.

Apart from the action on Gram negative bacteria E. coli, the maltose derivatives were
also very effective at inhibiting the biofilm formation by S. aureus. The biofilm inhibition
percentages of maltose derivatives against S. aureus were higher than those against E. coli. The
most effective maltose derivative against S. aureus biofilm formation was BDβM (~ 89%
inhibition) followed by BPDeβM (~ 86 % inhibition) and DβM, 4-tBuBDeβM and 4-tBuBDβM
showed 85, 76 and 59 % inhibition, respectively at 110 µM concentration. The slight toxicity of
DβM to the growth of S. aureus did not enhance its activity beyond the biofilm inhibition
activity exhibited by BDβM (Figure 4.4).
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Figure 4.4 Inhibition of E. coli biofilm formation by maltose derivatives at 110 µM measured
using CV dye-based assay. Error bar is standard error of the mean from 6 replicates.

4.2.3 Effectiveness of maltose derivatives to prevent initial bacterial surface adhesion and
disperse preformed biofilm
Using an E. coli strain that constitutively expresses red fluorescent protein (E.
coli_pRSH103) the initial adhesion (after 2 hours) of bacteria on polystyrene surfaces in
presence and in absence of the five maltose derivatives was investigated. The content of adhered
bacteria on the surface was quantified by the measuring the amount of fluorescence expressed by
the bacteria. Results indicated that, maltose derivatives did not exhibit good ability to inhibit the
initial adhesion of E. coli_pRSH103 (Figure 4.5).

Fluorescence remaining after
treatment with agents

2500

Series1
E. coli_pRSH103 adhesion
2000
1500
1000
500
0
No agent

DβM

BPDeβM

BDβM

4-tBuBDeβM 4-tBuBDβM

Figure 4.5 Inhibition of adhesion by maltose derivatives at 110 µM (anti-adhesion) measured by
fluorescence assay. Error bar is standard error of the mean from 6 replicates.

The five maltose derivatives (BPDeβM, BDβM, 4-tBuBDeβM, DβM and 4-tBuBDβM)
were also tested for their abilities to disperse preformed biofilms of both E. coli and S. aureus.
Although maltose derivatives exhibited the ability to inhibit biofilm formation by E. coli, they
showed sluggish activity towards the dispersion of preformed E. coli biofilms (Figure 4.6).
Similarly, the maltose derivatives were also ineffective at dispersing the 24 h old biofilms
formed by S. aureus (results not shown).
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Figure 4.6 Dispersion of E. coli biofilm by adding 110 µM of maltose derivatives to the 24-h old
biofilms followed by quantification of remaining biofilm by staining with CV-dye. Error bar is
standard error of the mean from 6 replicates.

4. 3 Conclusion
While the tested maltose derivatives exhibited good ability to inhibit the biofilm
formation of both E. coli and S. aureus, they were not capable of dispersing the preformed
biofilms of both the bacteria. Additionally, the tested agents were also incapable of reducing
initial adhesion of E. coli onto polystyrene surfaces. Contrary to these observations, the maltose
derivatives had previously demonstrated strong abilities to interfere with multiple multicellular
behaviors of P. aeruginosa. These observations suggest that the maltose derivatives had poor
efficacies against bacterial strains that were incapable of producing biosurfactant, rhamnolipids.
Importantly, since maltose derivatives that were potent against P. aeruginosa had low efficacies
against E. coli and S. aureus supports the argument that the antibiofilm activities associated with

these agents is not a consequence of a physical washing effect but involves an intricate biological
process.

4.4 Materials and Methods

Bacterial strains and growth media
Wild type S. aureus strain was obtained from Dr. Guirong Wang (Upstate Medical University).
Wild type E. coli and E. coli_pRSH103 strains were obtained from Dr. Dacheng Ren (Syracuse
University). All the bacterial strains were grown in Luria-Bertani (LB) medium containing 10
g/L tryptone, 5 g/L yeast extract, and 10 g/L NaCl at 37 °C.

Stock solutions of synthetic maltose derivatives
Stock solutions of all the agents (11.5 mM) were prepared in autoclaved water, sterilized by
filtering through 0.2 µm syringe filter, and stored at -20 °C in sealed vials. Appropriate amount
of sterile water was added to controls in all assays to eliminate the solvent effect.
Crystal violet dye-based biofilm inhibition assay
Inhibitory effect of all the maltose hydrocarbons on E. coli or S. aureus biofilm formation was
determined by crystal violet dye based biofilm inhibition assays. Overnight culture of E. coli or
S. aureus was sub cultured to an OD600 of 0.01 into the LB medium. 200 µL of the sub culture
was aliquoted into the wells of 96-well polystyrene microtiter plate when it reached the OD600 of
0.1. Predetermined concentrations of the test compounds were then added to the respective wells
containing sub culture. Sample plates were wrapped in GLAD Press n’ Seal® followed by
incubation under stationary conditions for 24 h at 37 °C. After incubation the media was

discarded and the plates were washed with water and dried for 1 h at 37 °C. The sample plates
were stained with 200 μL of 0.1% aqueous solution of crystal violet (CV) and followed by
incubation at ambient temperature for 20 min. The CV stain was then discarded and the plates
were washed with water. The remaining biofilm adhered stain was re-solubilized with 200 μL of
30 % acetic acid. After the stain was dissolved (15 minutes), 100 μL of the solubilized CV was
transferred from each well into the corresponding wells of a new polystyrene microtiter dish.
Biofilm inhibition was quantified by measuring the OD600 of each well in which a negative
control lane wherein no biofilm was formed served as a background and was subtracted out. The
percent inhibition was calculated by the comparison of the OD600 for biofilm grown in the
absence of compound (control) versus biofilm grown in the presence of compound under
identical conditions. Biofilm inhibition assay with all the maltose derivatives was repeated four
times and each data point in the graph is the average of values from 6 wells.

Anti-adhesion assay

Overnight culture of E. coli_pRSH103 was subcultured to an

OD600 of 0.01 into the LB medium. Subculture was allowed to reach the OD600 of 0.1 in a rotary
shaker at 250 rpm and 37 °C. 200 µL of the subculture was then transferred to the wells of black
microtiter plate with and without (control) maltose derivatives. This black 96-well plate was then
incubated in a shaker at 37 °C for 2 h. After 2 h, bacterial culture from the plate was discarded
and each well was washed once with saline water (0.85 w/v% aqueous NaCl solution). Fresh LB
medium was added to the black 96 well plate and fluorescence of the surface adhered bacteria
was measured by Synergy 2 multi-mode microplate reader with Gen5 data analysis software at
an excitation wavelength of 500 nm and an emission wavelength of 540 nm. Background signal
from LB medium was eliminated from all the samples.

Dispersion assay for preformed biofilm

The plate for biofilm dispersion assay was set up

similar to crystal-violet based- biofilm inhibition assay but without adding any maltose
derivatives at the time of inoculation of bacteria in the 96 well plate. E. coli or S. aureus was
allowed to grow for 24 h at 37 °C. After 24 h, bacterial culture was pipetted out and replaced
with 200 µL of 110 µM maltose derivatives in fresh LB medium. After 24 h treatment with
maltose derivatives, biofilm was fixed and quantified using crystal violet dye as described above.
The amount of dispersed biofilm was determined by comparing (normalizing) the amounts of
biofilm at 48 h with and without maltose derivatives.

Chapter 5
Biofilm Inhibition Activities and Mechanism of Action of Brominated Furanones against
Escherichia coli and Pseudomonas aeruginosa
Overview
Among the different classes of biofilm inhibitors, halogenated furanones form a
prominent class which disrupts the formation of biofilm by interfering with the quorum sensing
of the bacterial species. This study is a mechanistic investigation of the action of brominated
furanones (BFs) on the formation of biofilms by Escherichia coli and Pseudomonas aeruginosa.
Here, four structurally related brominated furanones were synthesized and followed by study of
their inhibitory effects on biofilm formed by E. coli and P. aeruginosa. Structure activity studies
suggested that methyl substituent on the furanone ring and on the exocyclic vinyl double bond
were important for nonmicrobicidal inhibition of both E. coli and P. aeruginosa biofilms. Also, a
structure with a methyl substituent on the furanone ring was a more effective anti-biofilm agent
than the structure with methyl substituent on the exocyclic vinyl double bond. The biofilm
inhibition activity of brominated furanones on sdiA gene deleted E. coli strain was lower than on
wild type E. coli. Reduction in biofilm inhibition activity of brominated furanone suggested
importance of SdiA protein for activity of brominated furanones. Also, results with P.
aeruginosa shows that these brominated furanones were antagonist to las quorum sensing system
but agonist to rhl quorum sensing system. The SdiA protein of E. coli and the LasR protein of P.
aeruginosa are homologous to the acylated homoserine lactone (AHL) binding LuxR protein in
V. fischeri. Hence, BFs could be recognizing the pocket of the receptor protein that binds AHLs.

5.1 Background and significance
5.1.1 Controlling quorum sensing is a very well explored strategy for biofilm inhibition
Biofilms are highly hydrated and organized surface attached bacterial communities,
composed of bacterial cells embedded in a secreted polymeric matrix. It is estimated that the
formation of biofilm renders the bacteria thousand fold more resistant to the effect of antibiotics.
Another problem exacerbated by bacteria occupying a biofilm state is hypermutation. This
occurs when bacteria, in response to environmental pressures (such as antibiotics), mutate at
higher rates to evolve the genetic makeup to become resistant against toxic substances. What is
direr is the spreading of these resistant genes amongst diverse pathogens leading to the
generation of multi-drug resistant strains. Antibiotic resistance is one of the most acute public
health problems. From a medical perspective, most of the microbial infections in humans are
associated with biofilm mode of bacterial living. Billions of dollars are lost every year in
agriculture, engineering, medical and industrial sectors due to biofilm related problems.
The biological process that controls the biofilm formation is quorum sensing. Quorum
sensing is the cell density-dependent regulation of gene expression in bacteria, based on the
secretion of small molecules also called autoinducers. Among different strategies explored,
inhibition of quorum sensing is a highly explored antibiofilm strategy. Due to their importance in
controlling many bacterial multicellular behaviors, autoinducers have served as scaffolds for
designing small molecules to inhibit biofilm formation. These synthesized mimics possess the
ability to interfere with the quorum sensing by having either agonistic or antagonistic effects on
the receptor proteins of autoinducers.

Since, the structure of autoinducers and their respective receptor protein sites vary with
different bacteria, structural tuning is required to attain maximum inhibition. Hence it is
important to understand the signaling events during QS and the structural details of various
autoinducers.
5.1.2 E. coli is a model organism for studying biological processes
Escherichia coli (E. coli) is a gram-negative rod shaped bacterium, and is often the
“model organism” chosen by researchers for studying many biological processes. E. coli is a
common gastrointestinal bacterium found within the human gut and is essential for breaking
down food and releasing nutrients.224 The production of Vitamin K2 and B12 by E. coli is
beneficial to the host.225 Also, E. coli residing in the intestine have been shown to prevent
colonization of pathogenic microbes in the gastrointestinal tract.226 Usually, the E. coli strains
found in human guts are not harmful, but colonization of some E. coli strains can cause serious
infections to its host like diarrhea and food poisoning.227 The causative symptoms of diarrhea
arise when E. coli strains within the intestine reduce the ability of epithelial cells to absorb water.
Other E. coli related infections include gastroenteritis and septicemia. Importantly, many
diseases arising due to the formation of biofilms on medical devices such as prostatitis and
catheter infections have been associated with E. coli infestation.228 Since E. coli is one of the
most well studied bacteria, there exists a vast knowledge of its various biological systems that
can be used to interpret studies done on elucidating its biofilm formation pathways.

5.1.3 Quorum sensing in E. coli
E. coli deploys many chemical signals to carry out both intra-species and inter-species
cell-to-cell communication (Table 5.1). The quorum sensing circuit of E. coli has not yet been
completely plotted; many of the receptor proteins for putative signals are yet to be identified.18
Following are the three quorum sensing circuits of E. coli.

SdiA mediated QS system in E. coli
Signaling molecules, N-acyl-L-homoserine lactones (AHLs) are commonly deployed by
many gram negative bacteria to carry out quorum sensing, but E. coli lack the syntheses (LuxI
homolog protein) required for synthesizing AHLs.18, 229 Therefore, E. coli does not perform
intraspecies QS with the help of AHLs, however E. coli are fully capable of responding to such
chemical signals produced by other bacterial species.18, 229 This is because E. coli possess AHL
receptor protein, suppressor of cell division inhibitor, SdiA (homologous to V. fischeri LuxR and
P. aeruginosa LasR).230 It is known that essential amino acids which are necessary for binding
with AHLs, are conserved in SdiA and other such homologous proteins found on other bacteria
such as LuxR of V. fischeri and LasR of P. aeruginosa.231 Studies reveal that SdiA can bind
AHLs produced by other bacterial species and thereby allow E. coli to regulate gene
transcription and interspecies communication.232 Amino acids, 1 to 171 out of total 240 amino
acid of SdiA protein are involved in binding with AHL.233, 234 It has also been illustrated that
SdiA protein can detect chemical signals other than AHLs, like indoles secreted by E. coli
itself.235 SdiA protein has been reported to be involved in different bacterial activities including
biofilm formation, motility, virulence, acid resistance and transportation of autoinducer-II.236 Lee

and coworkers have demonstrated that indole, which is another quorum sensing regulator in E.
coli, controls the acid resistance through SdiA protein.237

AI-II regulated quorum sensing system in E. coli
AI-I produced by bacteria are used to perform intra-species communication during
quorum sensing. In addition, bacteria respond to the chemical signals secreted by other bacteria
through a universal inter-species communication mechanism, and for this, bacteria secrete
autoinducer-II (AI-II). Although, E. coli do not secrete AI-I, they do secrete AI-II known as
furanosyl borate diester which is synthesized by the LsrK syntheses and detected by LsrR
protein.238 It has been reported that when E. coli and S. typhimurium enter the stationary growth
phase, their AI-II signal gets degraded.239 The domestic laboratory strain of E. coli, DH5α lacks
the production of AI-II.239

Indole regulated quorum sensing system in E. coli
Another signaling molecule secreted by E. coli is Indoles. The early discovery of indole
production by E. coli was in 1897 by Theobald Smith and since then the production of such
agents has been reported in about 85 Gram-positive and Gram-negative species.240 The synthesis
of indoles in bacteria is catalyzed by enzyme tryptophanase which synthesizes the three
components, indole, pyruvate and ammonia on hydrolyzing tryptophan (Table 5.1).240 The
tryptophan catalyst found in E. coli is the TnaA protein.241, 242 Lee and coworkers also reported
that the regulation of indole signaling is mediated through the SdiA protein.237, 243 Many bacterial
bioactivities including biofilm formation,244 swarming motility,244 inducing resistance,245

forming persister cells246 and secretion of virulence factors247 is regulated through the indole
signaling process.
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5.11. Different quorum sensing regulating proteins in E.coli
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5.1.4 Quorum sensing and QS gene reporter assay for P. aeruginosa
As discussed in Chapter 2 and 3 (Sections 2.1.4 and 3.1.7) the two important quorum
sensing systems of P. aeruginosa are las and rhl circuits (Figure 5.1).248, 249 The synthetic
analogs of autoinducers are designed such that they can interfere with the QS by binding with the
receptor “R” proteins of both las and rhl quorum sensing circuits. Two types of assays have been
developed to investigate the agonistic or antagonistic activities of synthetic agents against the
two quorum sensing circuits of P. aeruginosa.
For reporting the agonistic activity of the agents towards either las or rhl quorum sensing
systems of P. aeruginosa, researchers have used two double knockout strains of PAO1, PAO-JP2
(plasI-LVAgfp) and PAO-JP2 (prhlI-LVAgfP). These double knockout strains lack the
autoinducer synthesis proteins, LasI and RhlI of the las and rhl systems, respectively and
therefore these strains are devoid of the production of natural autoinducers AI-1 and AI-2,
respectively. When externally added unnatural agents agonize either the LasR or the RhlR

proteins, this agonization induces the expression of green fluorescent protein by the two reporter
plasmids plasI-LVAgfp and prhlI-LVAgfp, respectively. Increase in fluorescence would imply
agonistic activities of the agents (Figure 5.2).
For reporting antagonistic effect of a synthetic agent on the las and rhl quorum sensing
circuits of Pseudomonas aeruginosa, a gene reporter assay has been created by using two
reporter strains, PAO1/ plasI-LVAgfp and PAO1/ prhlI-LVAgfp. 61, 114 The two reporter strains
secrete natural autoinducers that bind receptor proteins, lasR and rhlR activating either lasI or
rhlI genes respectively. The activation of either lasI or rhlI genes in turn expresses green
fluorescent protein that is encoded by the plasmid.250 If externally added agents are able to
significantly reduce the fluorescence of the two reporter strains, PAO1/ plasI-LVAgfp and
PAO1/ prhlI-LVAgfp then it would imply an antagonistic activity wherein the agent competes
with and dominates the natural autoinducers for the receptor sites (Figure 5.1, 5.2). 61, 114

Figure 5.1 The las and rhl QS circuits of P. aeruginosa. Competition between the unnatural
small molecule and natural autoinducers to bind to the receptor protein LasR is shown.251 Also,
shown in a box is a plasmid used to quantify the activation of LasR protein upon binding with
natural autoinducer or unnatural small molecule by expression of green fluorescent protein
(GFP). [Modified and reprinted with permission from Citation: B H Iglewski, (1997) Roles of
Pseudomonas aeruginosa las and rhl quorum-sensing systems in control of elastase and
rhamnolipid biosynthesis genes. J. Bacteriol. (179), 5756-5767; Copyright : 1997, American
Society for Microbiology]

Figure 5.2 Cartoon that depicts how expression of green fluorescent protein varies depending on
the agonistic or antagonistic activity of the small molecules.

5.1.5 Inhibition of quorum sensing by small molecules
Different classes of compounds such as pyrroloindoline triazole amides, 2aminobenzimidazole, non-native AHL, ketone analogues of AHL’s and brominated furanones,
have been used as antagonist against quorum sensing circuits of both E. coli and P. aeruginosa
(Figure 5.3). Melander and coworkers showed that pyrroloindoline triazole amides are effective
against the E. coli biofilm. Additionally, Melander and coworkers have demonstrated the use of
synthetic 2-aminoimidazole oroidin analogues for inhibition and dispersion of P. aeruginosa
biofilm.60 Further, Blackwell and coworkers synthesized more optimum 2-aminobenzimidazole
derivatives with high potencies for inhibiting and dispersing the biofilm of P. aeruginosa by
interfering with both las and rhl quorum sensing circuits.59 Blackwell and Suga groups in two
different works have reported the use of synthetic non-native AHL molecules for interfering with
the las and rhl quorum sensing circuits of P. aeruginosa.62, 63 Spring and coworkers made further
improvements to the design of non native AHLs by creating structures in which the lactone
functionality was replaced by a ketone group to decrease the hydrolysis of the molecule.252
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Figure 5.3 Examples of small molecules that interfere with bacterial quorum sensing and hence
attenuate the multicellular behaviors of the bacteria

5.1.6 Brominated furanones are an important class of quorum sensing inhibitors
Dichloromethane extract of red algae, Delisea pulchra (Bonnemaisoniaceae) was found
to have significant antifungal and antibacterial activity.253, 254 Further investigation of the
dichloromethane extracts obtained from red algae lead to the discovery of brominated furanones
as the active components for exhibiting anti-bacterial and anti-fungal activities.255 Brominated
furanones have been extensively studied since then for their role in different biological functions,
but the exact mechanism of the action of such agents still remains elusive.254 Brominated
furanones strongly inhibit multicellular behaviors like biofilm formation and swarming of gramnegative bacteria without inhibiting the growth of the bacteria (Table 5.2).56, 256-258 Structural
details of brominated furanones can be altered to either inhibit the biofilm without inhibiting the
growth or to inhibit the growth of certain gram positive bacteria.259-261 Brominated furanones
have also been used to inhibit the growth of certain fungi like Candida albicans.262
Persisters are the set of cells in the biofilm which are in a dormant phase with low
metabolic activities and hence such cells are immune to the action of antibiotics. As a
consequence persister cells prevent the antibiotics from exhibiting total control over the bacteria.
Ren and co-workers recently demonstrated that brominated furanones increased the susceptibility
of P. aeruginosa persister cells towards the action of antibiotic, Ciprofloxacin.263
Luk and co-workers had synthesized a small library of ten brominated furanones and
identified the important structural elements necessary for nonmicrobicidal inhibition of E. coli
biofilm formation.55 Out of the ten synthesized brominated furanones, three structures were
potent nonmicrobicidal biofilm inhibitors, two structures inhibited the growth of E. coli and the
rest had no effect on either the growth or biofilm of E. coli.55 The important structural element

identified by Luk and coworkers was that the conjugated exocyclic vinyl bromide on the
furanone ring was important for nonmicrobicidal action.55
Manefield and co-workers reported that brominated furanones can displace the natural
AHL ligands of Delisea pulchra from their LuxR homologous receptor protein.264 Further,
Givskov and co-workers showed that the action of BFs on D. pulchra is through both the
destabilization and the reduction in cellular concentration of LuxR homologous receptor
protein.265 Results by Zhou and co-workers have shown that naturally occurring brominated
furanones target AI-2 producing enzyme, LuxS (S-ribosylhomocysteine lyase) protein. For this
Zhou and coworkers first synthesized recombinant LuxS enzyme and then measured its activity
with increasing BFs concentration.57 They reported that the activity of the LuxS enzyme
decreased with increasing concentration of BFs. Therefore, even though BFs are structurally
dissimilar to naturally occurring AHLs, they can still interfere with AHL mediated functions and
the mechanism of how this interference occurs remains unclear (Figure 5.4).
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Figure 5.4 (A) General structure of natural acyl homoserine lactone (AHL). (B) Structure of
natural brominated furanone extracted from Delisea pulchra.

Table 5.2 Structures of brominated furanones and their activity against different bacterial species
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5.1.7 Aim of the chapter
The aim of the chapter is to identify the important structural elements of brominated
furanones for nonmicrobicidal inhibition of E. coli and P. aeruginosa biofilm formation and also
to investigate the mode of action of such agents on the two bacteria. Brominated furanones have
been shown to displace AHLs from their LuxR type protein.264 E. coli lacks the production of
AHLs but its biofilm is still inhibited by BFs and therefore it is not clear as to how BFs inhibit E.
coli biofilms. SdiA protein found in E. coli is homologous to LuxR type proteins and studies
aimed at exploring the effects of BFs on sdiA mediated quorum sensing of E. coli have never
been done before. This study examined the effect of BFs on the biofilm formation of both E. coli
and its sdiA mutant, AY1297. Also, the effect of BFs on both las and rhl quorum sensing
systems of P. aeruginosa was investigated.

5.2 Results and discussion
5.2.1 Synthesis of structurally closely related brominated furanones
Synthesis of three brominated furanones, BF8,55 BF4271 and BF10272, 273 (Figure 5.5) has
been previously reported. New structure reported, BF15 was synthesized using a literature
reported procedure with slight modification (Scheme 5.1), where in 4-oxohexanoic acid was first
brominated followed by dehydration with P4O10 and the double bond was introduced using NEt3
to eliminate HBr.274 The structures of the four brominated furanones BF8, BF4, BF10 and BF15
vary in three different ways (Figure 5.5). First, brominated furanones BF8 and BF4 differ only in
the methyl substitution at position C2 on the furanone ring. Second, BF4 and BF10 differ in a
bromide substitution at position C3. Third, BF10 and BF15 differ by a methyl substitution on the
exocyclic vinyl carbon, C5.
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Figure 5.5 Brominated furanones with systematic changes in structures. Variation of methyl
substituent on the furanone ring, carbon C2 (BF8 and BF4) and variation of bromide substituent
on the furanone ring, carbon C3 (BF4 and BF10), and variation of methyl substituent on the
exocyclic vinyl carbon C5 (BF10 and BF15).

[Figures in the result section of this chapter are adapted with permission from Citation: Shetye G. S.,
(2013), “Structures and biofilm inhibition activities of brominated furanones for Escherichia coli and
Pseudomonas aeruginosa” MedChemComm 4, 1079-1084; Copyright: 2013, Royal Society of
Chemistry.]
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Scheme 5.1 Synthetic scheme for brominated furanone, BF15

5.2.2 Methyl substitution either at C2 or C5 position is important for nonmicrobicidal activity of
brominated furanones
Toxicity assay with four brominated furanones was carried out to investigate their effect
on the growth of parent E. coli strain, RP437, its isogenic sdiA knockout mutant, AY1297 and P.
aeruginosa, strain PAO1. For getting the growth curve, optical density at 600 nm (OD600) of
bacterial culture with and without brominated furanones was plotted against time. Three
brominated furanones, BF8, BF4 and BF10 and one brominated furanone, BF15 were tested for
bacterial growth inhibition at the highest concentrations used for biofilm inhibition assays, i.e
200 µM and 300 µM, respectively (Figure 5.6). At these concentrations, two brominated
furanones, BF8 and BF15 did not show any observable inhibition of bacterial growth for any of
the three bacterial strains. However, BF4 and BF10 inhibited the growth of all three bacterial
strains. These results indicate that the presence of methyl substitution either at C2 (BF8) or C5
(BF15) position is very important for reducing the toxicity of brominated furanones towards the
bacterial growth. Brominated furanone BF4, was more toxic to the growth of both the wild type
E. coli and its sdiA mutant than BF10. This result is consistent with the fact that BF4 has two
reactive sites with two bromine substitution whereas BF10 has only one. Growth inhibition activity

of BF10 reduced in sdiA mutant than in wild type E. coli. Both BF4 and BF10 completely
inhibited the growth of PAO1.
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Figure 5.6 Effect of brominated furanones on the growth of (A) wt. E. coli (RP437), (B) ∆sdiA
E. coli (AY1297), and (C) wt. P. aeruginosa (PAO1) in LB-media monitored over 24-h at either
200 µM (BF8, BF4 and BF10) or 300 µM (BF15). Error bar is the standard error of the mean
from 6 replicates.

Since BF4 and BF10 inhibited the growth of E. coli and P. aeruginosa at 200 µM, lower
concentrations of these agents were tested to determine the concentration at which they do not
inhibit the growth. Both BF4 and BF10 did not inhibit the growth of both wild type E. coli and
P. aeruginosa at and below 100 µM (Figure 5.7 and Figure 5.8).
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Figure 5.7 Dose-response growth curve in LB-media of wt E. coli (RP437) and wt P. aeruginosa
(PAO1) in presence and absence of BF4. Error bar is standard error of the mean from 6
replicates.
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Figure 5.8 Dose-response growth curve in LB-media of wt E. coli (RP437) and wt P. aeruginosa
(PAO1) in presence and absence of BF10. Error bar is standard error of the mean from 6
replicates.
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5.2.3 Biofilm inhibition by brominated furanones was higher for wild type E. coli than its ∆sdiA
mutant
After determining the effect of all the brominated furanones on bacterial growth, the
effects of these agents on the biofilm formation ability of E. coli and its ∆sdiA mutant were
tested. At 200 µM, BF8 inhibited ~ 50 % of the wild type E. coli biofilm (Figure 5.9), but at this
concentration BF15 did not show any anti-biofilm activity (result not shown). Hence BF15 was
tested at 300 µM, but even at this higher concentration, BF15 was not as effective as BF8 at 200
µM (Figure 5.9 A). This result indicated that the presence of methyl substitution at C2 (BF8)
position is important for biofilm inhibition activity and the structure with methyl substitution on
the exocyclic double bond at C5 (BF15) position was not as effective. Both BF8 and BF15 were
more effective at inhibiting the biofilm of wt. E. coli (~ 50 % and 34 % inhibition respectively)
than inhibiting the biofilm of ∆sdiA mutant of E. coli (~26 % and 18 % inhibition respectively).
As discussed previously, SdiA protein is the receptor for AHLs and brominated furanones are
known mimics of AHLs. The mutant, ∆sdiA lacks the receptor for AHLs, and tested brominated
furanone had lower anti-biofilm efficacies against the mutant than wt E.coli, suggesting that
SidA could be a receptor for brominated furanones.
Brominated furanones, BF4 and BF10 inhibited the growth of wt. E. coli at 200 µM and
therefore, a lower concentration of 100 µM was used for biofilm inhibition studies. But at this
nonmicrobicidal concentration, both BF4 and BF10 were ineffective at inhibiting the biofilm of
E. coli (Figure 5.9 B).
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Figure 5.9 (A) Biofilm inhibition of wt. E. coli strain (RP437) and ∆sdiA E. coli (AY1297) by
BF8 (200 µM) and BF15 (300 µM) (B) Biofilm inhibition of wt. E. coli strain (RP437) by BF4
(100 µM) and BF10 (100 µM). As quantified by crystal violet dye-based assay. Media used for
biofilm assay was LB-media. Error bar is the standard error of the mean from 6 replicates

5.2.4 Confocal laser scanning microscopy-based assay for quantifying biofilm inhibition
Biofilms formed by wild type E.coli and ∆sdiA mutant with and without BF8, were also
quantified by confocal laser scanning microscopy (CLSM) based assay. For CLSM assay both
the E.coli strains RP437 and AY1297 were introduced with plasmid pRSH103 which
constitutively expresses red fluorescence protein. Biofilms of the parent E. coli strain and its
mutant ∆sdiA were then grown on sterile stainless steel (316L) coupons for 24-h in presence and
in absence of brominated furanone, BF8. After 24 h the surface-adhered biofilms on the steel
coupons were quantified by measuring the fluorescence. Biofilm inhibition results from CLSM
assay were consistent with those obtained from crystal violet dye-based assay. The representative
confocal images are presented in Figure 5.10. For both wild type E. coli and its mutant ∆sdiA,
BF8 treated steel coupons (Figure 5.10 B and 5.10 D) showed less fluorescent signal than steel

coupon with no agent (Figure 5.10 A and 5.10 C), indicating biofilm inhibition in the presence of
agents. However, the reduction in biofilm between steel coupons with and without BF8 for wild
type E. coli was quantitatively more than its sdiA mutant. To quantify the amount of biomass,
surface coverage and mean thickness of the biofilm on the steel coupon, software COMSTAT
was used. Four to five different locations on the steel coupons were randomly selected for this
quantification and Z-stacked images were taken. The biofilms quantified by measuring the
fluorescence for each strain without any added agents were normalized as 100% and the percent
biofilm reductions caused by the addition of BF8 were accordingly calculated.
The plot of average biomass, surface coverage and mean thickness of the biofilm formed
with or without 200 μM BF8 as calculated by COMSTAT are shown in Figure 5.11. The
COMSTAT-based quantification of biomass, average thickness and surface coverage of E. coli
(RP437) biofilm in presence of BF8 was significantly reduced as compared to its control (no
added agent). On the contrary, BF8 was less effective at reducing the biomass, average thickness
and surface coverage of the biofilm formed by the SdiA knockout mutant.

Figure 5.10 Representative confocal images of biofilms formed on steel coupon for 24 hr by
parent strain E. coli RP437 (A) without BF and (B) with 200 µM BF8; and by sdiA knockout
mutant E. coli AY1297 (C) without BF and (D) with 200 µM BF8. Scale bar = 76 µm.
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Figure 5.11 Statistical quantification of the average biomass, average thickness, and surface
coverage on steel coupons by biofilms formed by wild type E. coli (RP437) and its sdiA mutant
E. coli (AY1297) in presence and in absence of 200 µM of BF8. Error bar is the standard error of
the mean from 4 replicates.

5.2.5 Characterizing the biofilm inhibition by scanning electron microscopy
Scanning electron microscopy provides a direct characterization of the morphology of
dried biofilm and embedded microorganisms on a surface. Using microcontact printing, circular
patches of pentadecanethiol self-assembled monolayers (SAM) surrounded by bioinert tri
(ethylene glycol)-terminated alkanethiols, HS(CH2)11(OCH2CH2)3OH were created (schematic
representation is shown in Figure 5.12 E). The patterned gold surfaces were then placed in a 24well plate and inoculums of either E.coli RP437 or its ∆sdiA mutant, AY1297 (OD600 =0.05)
with or without (Controls) 200 μM BF8 were added and the biofilms were allowed to form for
24 h. Because tri(ethylene glycol)-terminated alkanethiols are bioinert, after 24 h no bacterial
attachment or biofilms were observed on this region. The formation of biofilms with embedded
bacteria on the circular regions of pentadecanethiol SAMs created a microarray pattern (Inset in
Figure 5.12 A). Figure 5.12 A and 5.12 C represents the circular patterned biofilm formed by
cultures of E.coli RP437 or E.coli AY1297 where as Figure 5.12 B and 5.12 D represents the
circular patterned biofilm formed by cultures of E.coli RP437 or E.coli AY1297 with added 200
µM of BF8. In the SEM micrographs, better contrast between circular regions of
pentadecanethiol and bioinert SAMs represented more amount of biofilm. The amount of E.coli
biofilm on patterned gold surfaces grown with no added BF8 (control; Figure 5.12 A) appeared
to be more than that formed with inoculums containing 200 µM of BF8 (Figure 5.12 B). On the
contrary, the difference in the amount of biofilm on gold surface with AY1297 mutant biofilms
grown in absence (control; Figure 5.12 C) and in presence of BF8 (Figure 5.12 D) was not very
conspicuous, suggesting lesser effect of BF8 on AY1297 biofilms.

Figure 5.12 Scanning electron micrographs of biofilm formed on patterned gold surfaces after
24-h inoculation with E. coli RP437 (A) in absence of BF8 and (B) with 200 µM BF8; and
biofilm formed by sdiA knockout E. coli AY1297 (C) in absence of BF8 and (D) with 200 µM
BF8. Scale bar = 200 µm. The insert in (A) shows the details of the E. coli in the pattern. (E) The
schematic representation of patterned SAMs of pentadecanethiol, HS(CH2)14CH3, surrounded by
tri(ethylene glycol)-terminated alkanethiols, HS(CH2)11(OCH2CH2)3OH, is shown to the right.

5.2.6 Inhibition of Pseudomonas aeruginosa biofilm was higher by BF8 than BF15
Unlike E.coli, P. aeruginosa produces quorum sensing signaling molecules, AHLs.
Previous reports have suggested that brominated furanones displace AHLs from their receptor
protein LuxR.264, 265 Also, results with E. coli strains in this study indicated that the efficacy of
brominated furanones to inhibit biofilm decreased for a strain which lacked LuxR type protein
SdiA (AHL receptor protein). Hence after the E. coli testing, brominated furanones were tested
for their action on P. aeruginosa biofilms. For P. aeruginosa biofilms, BF15 did not show
significant biofilm inhibition at 300 µM whereas 200 µM of BF8 showed ~ 43 % inhibition of

biofilm (Figure 5.13 A). The structure activity studies for P. aeruginosa biofilms inhibition with
brominated furanones correlated with inhibition results from E. coli study where the presence of
methyl unit at C2 position rather than C5 position was important for the activity of brominated
furanones. Brominated furanones, BF4 and BF10, inhibited the growth of P. aeruginosa at 200
µM. But BF4 was non-toxic below 100 µM, whereas BF10 was non-toxic at below 50 µM to the
growth of P. aeruginosa. Hence, BF4 was tested at 100 µM and BF10 was tested at 50 µM for
inhibition of P. aeruginosa biofilm. At the tested concentrations, both BF4 and BF10 did not
inhibit the biofilm formation of P. aeruginosa (Figure 5.13 B).
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Figure 5.13 Inhibition of P. aeruginosa PAO1 biofilm by; (A) BF8 (200 µM) and BF15 (300
µM) (B) BF4 (100 µM) and BF10 (50 µM). As quantified by crystal violet assay. Error bar is the
standard error of the mean from 6 replicates.

Crystal violet dye-based inhibition assay results were further confirmed by confocal laser
scanning microscopy assay (CLSM). Biofilm of fluorescently labeled P. aeruginosa (PAO1EGFP) was allowed to form on sterile steel coupons (316L) with or without BF8 for 24 h at 37
°C. After 24 h steel coupons were washed and viewed under confocal microscope to determine
the amount of biofilm formed based on the intensity of fluorescent signals from the steel

coupons. Steel coupon treated with 200 µM BF8 was less fluorescent and also the average
thickness of the biofilm was lower than the control which had no BF8 (Figure 5.14 A and B).
Further the biomass, average thickness and surface area were quantified using COMSTAT
software. Biomass on steel coupon treated with BF8 was 41 % lesser than its control (No agent)
(Figure 5.14 C). This percent reduction in biomass (Figure 5.14 C) caused by BF8 is consistent
with the biofilm inhibition value obtained from crystal violet dye-based assay (Figure 5.13). The
CLSM micrographs showed that there was no biofilm inhibition on steel coupons treated with
300 µM of BF15 (results not shown).
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Figure 5.14 Representative confocal images of P. aeruginosa biofilms on stainless steel
coupons; (A) without and (B) with 200 µM BF8. Scale bar = 76 µm; (C) The biomass, average
thickness and surface area of biofilm was quantified using COMSTAT software. The parameters
of P. aeruginosa biofilms formed without BF8 (no agent) were normalized as 100%. Error bar is
the standard error of the mean from 4 replicates.

5.2.7 Brominated furanones antagonize the las system but agonize the rhl system of P.
aeruginosa
Earlier results (section 5.2.3) from this study indicated that biofilm inhibition by
brominated furanones for E. coli was through sdiA dependent quorum sensing pathway. The
SdiA protein is homologous to the LuxR type protein which is also found in P. aeruginosa. P.
aeruginosa has two LuxR type proteins, LasR in las system and RhlR in rhl system. In order to
find out the effect of brominated furanones on these two LuxR type proteins we carried out
quorum sensing gene reporter assays. Two quorum sensing reporter strains were used for the las
and rhl quorum sensing systems, PAO1/plasI-LVAgfp and PAO1/prhlI-LVAgfp, respectively.
Both these strains constitutively express green fluorescent protein (GFP) upon activation of lasI
or rhlI gene, which gets activated upon binding of lasR with autoinducers. If brominated
furanones are antagonist to las or rhl system then they will displace natural autoinducers from
the receptor proteins and hence there will be a decrease in fluorescence due to lower levels of
expression of plasmids plasI-LVAgfp or prhlI-LVAgfp. But if the brominated furanones are
agonist then upon binding with lasR or rhlR proteins they will activate lasI or rhlI genes,
respectively and there will be an increase in fluorescence.
Decrease in fluorescent signal for PAO1/plasI-LVAgfp strain in presence of BF8 and
BF15 indicated that these agents are antagonists for las system (Figure 5.15). But increase in
fluorescent signal for strain PAO1/prhlI-LVAgfp indicated that brominated furanones are
agonists for rhl system at all the tested concentrations (Figure 10). Being antagonist to one
quorum sensing system (las) and agonist to another (rhl) could be the reason why brominated
furanones are not that effective at inhibiting the biofilms of P. aeruginosa. Even though BF15
was a better antagonist than BF8 to las system, at the same time, BF15 was a better agonist than

BF8 for rhl system. Hence, overall, BF15 was not as effective as BF8 at inhibiting biofilm
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Figure 5.15 Fluorescence signal of GFP expressed by P. aeruginosa having plasmid (A) plasILVAgfp), and (B) prhlI-LVAgfp in presence and in absence of BF15 and BF8 at either 100 or
200 µM. The fluorescent signals were corrected for cell density by dividing with OD600 of cell
culture. Error bar is standard error of the mean from 4 replicates.

5.2.8 Production of virulence factor, elastase B by P. aeruginosa is inhibited by brominated
furanones
P. aeruginosa deploys many virulence factors either openly or covertly for attacking host
systems and causing infections. Some of these prominent P. aeruginosa virulence factors are
secretion of alginate, lipopolysaccharides, rhamnolipids, proteases, phospholipases and
exoproteases.275 Elastase B (LasB), which is a 33 kDa protein, is one such exoprotease secreted
by P. aeruginosa and its expression is controlled by the lasB gene.276 The mode of action of
LasB is through the hydrolysis of cellular extracellular matrix and attack on intercellular tight
junctions.277, 278 One important function of LasB reported under laboratory setting is the
degradation of components of the innate immune system like surfactant proteins -A and D.279

Therefore, brominated furanones were further tested for their ability to inhibit production
of LasB by P. aeruginosa. Colorimetric assays were used to determine the amount of LasB in the
cultures grown with or without BFs. Both BF15 and BF8 at 200 µM inhibited the production of
LasB by almost 50 % (Figure 5.16). Inhibition of LasB along with quorum sensing gene reporter
assays suggested that brominated furanones antagonistically interfere with las system of P.
aeruginosa.
0.5
0.45

Elastase B activity

Br

H3C

0.4

O

0.35

O

BF15

0.3

Br

O

O

BF8

0.25

Br

0.2
0.15
0.1
0.05
0
Control
Control

200 µM
uM BF15
200
BF15

200 uM
200
µMBF8BF8

Figure 5.16 LasB produced by P. aeruginosa PAO1 in the absence (control) and presence of 200
µM of BF15 or BF8. Error bar is standard error of the mean from 4 replicates.

5.3 Conclusion
Four structurally related synthetic BFs showed similar trends in inhibiting the bacterial
growth and biofilm formed by both E. coli and P. aeruginosa. Methyl substitution at C2 and C5
positions were important for observing nonmicrobicidal biofilm inhibition. Among all the
synthetic brominated furanones tested, BF8 was the most effective at inhibiting the biofilm,
suggesting that methyl substitution at C2 position is optimum for maximum activity. Three
bioassays, crystal violet dye-based, confocal microscopy-based and scanning electron
microscopy-based assays gave consistent results that brominated furanones showed higher
activity for wild type E. coli than its sdiA mutant strain, AY1297. Results suggest that inhibition

of quorum sensing by brominated furanones in E.coli is dependent on its sdiA gene and
therefore, the SdiA protein could be a potential receptor for BFs.
The quorum sensing gene reporter assay for P. aeruginosa suggested that BFs were
antagonistic to the LasR in las system but agonistic to the RhlR in rhl system. This could be one
of the reasons of low inhibition activities of brominated furanones against the biofilm formed by
P. aeruginosa. Another reason could be the low binding affinity between the receptor protein
LasR and BFs. Hence there is a further scope to modulate the structure of brominated furanones
such that they will be antagonistic to both the QS systems which will increase their biofilm
inhibition activity. Interestingly both SdiA and LasR (autoinducer receptor in las system) are
homologous to the luxR type receptors that bind AHLs.

5.4 Materials and Methods
Chemistry
The synthesis of BF15 was executed under an atmosphere of argon in flame dried
glassware. 4-Oxohexanoic acid and anhydrous CH2Cl2 ( > 99 % with sure seal) was purchased
from Sigma Aldrich. HRMS was obtained through positive ESI on Bruker 12 Tesla APEX-QE
FTICR-MS with an Apollo II ion source at Cosmic instrumentation center, Virginia. TLC
visualization was done under UV light (254 nm). Solvents were removed in vacuo using Bűchi
rotary evaporator below 40oC. EMD silica gel 60 F254 pre-coated plates (0.25-mm thickness)
were used for TLC. Column chromatography was performed using Silicycle, silia-P flash silica
gel with 40-63μ mesh size. 1H and 13CNMR spectra were recorded on 300 MHz and 75 MHz
Bruker instruments respectively. 1H chemical shifts are reported in ppm relative to CDCl3 δ

7.27. 13C chemical shifts are reported in ppm relative to CDCL3 δ 77.0. FTIR was recorded on
Nicolet IR 200 FTIR instrument (Thermo Scientific)
Synthesis of brominated furanones (BF15)
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Step 1: 4-oxohexanoic acid (1A) (100 mg, 0.768 mmol) dissolved in dichloromethane
(CH2Cl2) (2 mL) with 1 drop of HBr (40% v/v in water) was added to a flame dried round
bottom flask under argon. Bromine (79 µL, 2 eq) was then added drop-wise. After complete
addition of bromine the mixture was allowed to stir at room temperature for 1 h. After complete
consumption of reactants (monitored by TLC, hexane : ethyl acetate, 2:1), the mixture was
diluted with CH2Cl2 (4 mL), then successively washed with 1 N Na2S2O3 (5 mL), brine (5 mL)
and dried over anhydrous Na2SO4. The solvent was evaporated in vacuo to obtain a viscous
yellow oily crude product 1B (dibromo-oxohexanoic acid, 0.150 g). This crude product was used
in step 2 without any further purification.
Step 2: Step 1 crude product (1B) (0.150 g, 0.52 mmol) was dissolved in CH2Cl2 (1.5
mL) in an oven dried round bottom flask under argon. The reaction mixture was cooled to 0 ̊C
and P4O10 (0.177 g, 0.62 mmol) was added. After stirring at 0 ̊C for 30 min the solution was
allowed to warm to room temperature and then further heated at reflux for 1.5 h. The reaction
mixture was then cooled to room temperature and transferred into a test tube and centrifuged (5
min, Metpath analytical centrifuge). The supernatant was decanted to yield a solid intermediate.
The solid intermediate was dissolved in CH2Cl2 (2.0 mL) and transferred into an oven dried

round bottom flask and cooled to 0 ̊C. Et3N (0.79 µL, 1.5 mmol) was then added and the reaction
mixture was allowed to stir at 0 ̊C for 1 h. The reaction mixture was then warmed to room
temperature and later heated at reflux for 1 h. Further, the reaction mixture was allowed to cool
to room temperature and aqueous NH4Cl (1.5 mL) was added. The aqueous phase was extracted
with EtOAc (6 × 2 mL). The organic layers were combined and dried over anhydrous Na2SO4,
and the solvent removed in vacuo. The impure compound was purified by column
chromatography using a gradient of 20:1 to 10:1 of hexane : EtOAc to give title compound as a
pale white solid (BF15) (yield – 0.065 g, 45 % (2 steps), Rf – 0.51( 2:1, Hexane : EtOAc, mp
116-118 ̊C). 1H NMR (300 MHz, CDCl3): δ 7.61 (d, J = 4.8 Hz, 1H), 6.28 (d, J = 5.1 Hz, 1H),
2.53 (s, 3H). 13C NMR (75 MHz, CDCl3): δ 168.9, 147.7, 138.1, 119.5, 108.7, 22.4. HRMS calcd
for (C6H5BrO2)Na+ = 210.9365, found = 210.9365, difference < - 1.0 ppm (Positive ESI on
Bruker 12 Tesla APEX-QE FTICR-MS with an Apollo II ion source). IR (KBr pellet): ῡ = 3130,
3105, 1777, 1753, 1658, 1546, 1261, 1132, 902, 820, 712 cm-1. The Z configuration of exocyclic double bond was determined by the noe observed at H-3 (δ 7.61) while irradiating at H-6
(δ 2.53).

Bacteria strains and growth media
E. coli RP437 and E. coli RP437 (pRSH103) (constitutively expresses red fluorescence proteins)
were provided by Dr. Dacheng Ren (Syracuse University). 10 µg/mL of tetracycline was added
to maintain the plasmid pRSH103 in all the bacterial cultures. Plasmids plasI-LVAgfp and prhlILVAgfp were provided by Dr. Hiroaki Suga (The University of Tokyo). 300 µg/mL of
carbenicillin was added to maintain the plasmids of PAO1-GFP, PAO1 (plasI-LVAgfp), PAO1
(prhlI-LVAgfp). All the bacterial strains were grown in Luria-Bertani (LB) medium containing

10 g/L tryptone, 5 g/L yeast extract, and 10 g/L NaCl at 37 oC. Single trial values reported for
each experiment (Figures 1, 2, 4, 5, 6, S2) were similar to values obtained from replicate (3 or
more) experiments.

Construction of AY1297 (E. coli RP437 but ∆sdiA)
Deletion of the sdiA gene in E. coli RP437 chromosome was achieved by P1
transduction. To prepare the donor P1 lysate, overnight culture of the donor strain (JW1901) was
diluted 1:100 into 5 ml fresh LB medium. The culture was grown at 37°C aerobically with
shaking at 220 rpm till the OD600 reached 0.1~0.2. 50 μl of 1 M CaCl2 and 100 μl P1vir stock
were added and the bacterial culture was continued to shaken continuously for ~3 hrs until cells
lysed. After lysis, 1 drop of chloroform was added and the cell culture was subject to continuous
shaking for 10 min. 1 ml of this suspension was removed and subject to centrifugation for 2 min
at maximum speed (16000 rcf). The supernatant was collected and a few drops of chloroform
were added. This P1 vir lysate was stored at 4°C.
To perform P1 transduction, overnight culture of the recipient strain (E. coli RP437) was
diluted 1:100 into 5 ml fresh LB medium. The culture was grown at 37°C with shaking at 220
rpm till the OD600 reaches 0.7. 50 μl of 1M CaCl2 was added to the culture followed by
continuous shaking for 15 min. Then 200 μl of the recipient cells were transferred to a sterile 1.5
ml eppendorf tube. P1 lysate from the donor strain prepared as above was added into the
recipient cells with varying volumes. Following P1 vir infection of the recipient cells, the tubes
carrying recipient cells were shaken at 37°C for 20 min. 100 μl 30% citrate was added to stop the
infection and 500 μl fresh LB medium was added for cell recovery. The culture was incubated
for 1 hr at 37°C with aeration. The cells were then spun down, resuspended in 30 μL 30% citrate
and 70 μL LB and spread on LB plates containing antibiotic (kanamycin) and 4 mM citrate.

Transductants were streaked twice on LB plates containing antibiotic and 4 mM citrate to
completely remove the P1vir. Single colonies were selected and positive transductants were
screened by colony PCR and subsequently verified by DNA sequencing.

Electroporation method for transferring plasmid
Plasmid in E.coli RP437 (pRSH103) was extracted using Qiagen plasmid extraction kit
and was then transferred to E.coli AY1297 (∆sdiA mutant) by electroporation. Briefly, overnight
culture of AY1297 was sub-cultured in 25 mL LB broth and was grown to reach an OD600 of 0.5
to 0.8 by shaking the culture at 37 °C. Flask containing subculture was cooled on ice for 30 min.
Cell pellet was obtained by centrifugation at 4500 rpm for 5 min. Supernatant was removed and
cell pellet was resuspended in 20 mL ice-cold 10 % glycerol. Cells were centrifuged at 4500 rpm
for 5 min. Supernatant was discarded and the cell pellet was resuspended in 1 mL ice-cold 10 %
glycerol. Cell suspension was transferred to a new 1.5 mL ice-cold microcentrifuge tube and
spun down at 13,000 rpm for 30 sec. Supernatant was discarded and the cell pellet was
resuspended in 500 µL ice-cold 10 % glycerol. The last time, cells were spun down at 13,000
rpm for 30 sec. After removal of the supernatant, cell pellet was resuspended in 100 µL ice-cold
10 % glycerol. 50 µL of the competent cell suspension along with 1 µL of plasmid DNA in TE
buffer was transferred to the cold 0.1 cm electroporation cuvette. Electroporator was set to Ec1
and pulse was passed through the cells. LB medium (1 mL) was immediately added to the
electroporator cuvette and cell suspension was transferred to a sterile microcentrifuge tube and
incubated for 1 h at 37 °C with shaking at 180 rpm. Cells were then spread on the LB plates
supplemented with respective antibiotics and incubated over night at 37 °C. Plasmids plasILVAgfp and prhlI-LVAgfp were transferred to the PAO1 using the same electroporation method
except that glycerol was replaced by sucrose in the preparation of competent cells.

Stock solution of brominated furanones
Stock solutions of all brominated furanones (10 mM) were prepared in DMSO, sterilized
by filtering through 0.2 µm syringe filter, and stored at -20 °C in sealed vials. Appropriate
amount of DMSO was added to controls in all assays to eliminate solvent effect.

Antimicrobial activities of BF against planktonic growth
Optical density was measured using Biotek ELx800 TM absorbance microplate reader
(BioTek Instruments, Inc., Winooski, VT) using Gen5TM data analysis software. The OD values
were taken in sterile conditions at 0, 2, 4, 6, 8, 10, 12, and 24 h.

Crystal violet-based biofilm inhibition assay
Inhibitory effect of four brominated furanones on biofilm formation by E.coli and its sdiA
knockout mutant was determined by biofilm inhibition assays. Overnight culture of both the
E.coli strains was sub cultured to an OD600 of 0.01 into the Luria-Bertani (LB) media.280 200 µL
of the sub culture was aliquoted into the wells of 96 well PVC microtiter plate when it reached
the OD600 of 0.05. Stock solutions of all the test compounds were made in DMSO (biology
grade, autoclaved). Predetermined concentrations of the test compounds were then added to the
respective wells of 96 well plate containing sub culture. Sample plates were wrapped in GLAD
Press n’ Seal® followed by incubation under stationary conditions for 24 h at 37 °C. After
incubation the media was discarded and the plates were washed with water. The sample plates
were then stained with 200 μL of 0.1% aqueous solution of crystal violet (CV) and then
incubated at ambient temperature for 30 min.281 The CV stain was then discarded and the plates
were washed with water. The remaining stain was solubilized with 200 μL of 95% ethanol. After

the stain was dissolved (15 minutes) 100 μL of the solubilized CV was transferred from each
well into the corresponding wells of a polystyrene microtiter dish. Biofilm inhibition was
quantified by measuring the OD540 of each well in which a negative control lane, wherein no
biofilm was formed, served as a background and was subtracted out. The percent inhibition was
calculated by the comparison of the OD540 for biofilm grown in the absence of compound
(control) versus biofilm grown in the presence of compound under identical conditions.

Confocal laser scanning microscopy (CLSM)
Biofilms were grown by inoculating the bacteria on 316 L stainless steel coupons (ca. 3/8
in. × 3/8 in., from McMaster-Carr) with or without BFs in a 24-well microtiterplate. Saran
wrapped plate was then incubated at 37 oC for 24 h without shaking. Each steel coupon was then
washed gently by dipping into 0.85 w/v% aqueous NaCl solutions 3 times (fresh NaCl solution
was used for each dipping) and then placed upside down on a microscope cover glass (50 x
24mm, No. 2, Fisher Scientific, Pittsburgh, PA). The biofilms were visualized using a Zeiss LSM
710 Confocal Laser Scanning Microscope (Carl Zeiss, Jena, Germany). A 488 nm laser line was
used to visualize biofilms formed by PAO1-GFP. Z-stacks from four randomly picked spots
were taken for each steel coupon. Quantification of analysis of biomass, mean thickness, and
surface area of the biofilms formed in the absence and presence of brominated furanones were
obtained from fluorescence image using COMSTAT software. Values are normalized to that of
the brominated furanone-free control.

Visual semi-quantification of biofilm on SAM patterned gold slides using scanning electron
microscopy
Semitransparent gold film of thickness ~ 280 Å was deposited onto the piranha-cleaned
glass substrates with an electron beam evaporation system from Thermionics (Port Townsend,
WA). About 80 Å of titanium was deposited before depositing gold to enhance the adhesion of
gold on glass substrate (angle of deposition - 45°, rate of deposition - 0.2 Å/s). Gold slides were
soaked in 2mM solution of (1-Mercapto-n-yl)-(triethylene glycols) for 15 h after microcontact
printing 1-pentadecanethiol using (PDMS) stamp. Gold slides were taken out of solution, washed
with ethanol and dried with nitrogen gas before placing them in bacterial cell culture.
Gold slides with circular patterns of 1-pentadecanethiol surrounded with (1-Mercapto-nyl)-(triethylene glycols) SAM were placed in a 24 well plate containing cultures of either E.coli
RP437 or E.coli AY1297 (OD600 =0.05) with 200 µM BF8 for 24 h at 37 °C. Control
experiments for both the bacterial strains were carried out under the same conditions but without
BF8. 24 well plates were covered and wrapped in GLAD Press n’ Seal® followed by incubation
under stationary conditions for 24 h at 37 °C. Biofilm on gold slides was fixed with 4%
paraformaldehyde solution, dehydrated with sequential soaking in solutions containing 10%,
30%, 50%, 70%, 90% ethanol, and pure ethanol, and sputter coated with gold-palladium alloy.
Topographic features of the patterned biofilm on gold surface and effect of BF8 were examined
under a JEOL JSM-5800LV Scanning Electron Microscope (SEM).

Gene reporter assays for las and rhl quorum sensing systems of P. aeruginosa 282
GFP used in this study is LVAgfp. LVAgfp is a modified form of GFP which is unstable
(estimated half-life of 40–60 min) as compared to native GFP (estimated half life of one day).250
The short half life of LVAgfp makes the real time detection of gene expression possible. Since
modified GFP (LVAgfp) has an excitation wavelength of 501 nm (excitation wavelength for
wild type GFP is 395 nm) and emission wavelength of 511 nm (similar to wild type GFP).59
An overnight culture of P. aeruginosa PAO1/plasI-LVAgfp in LB broth (supplemented
with 300 µg/mL of carbenicillin) was grown from a single colony from an LB agar plate
supplemented with 300 µg/mL carbenicillin. The overnight culture was diluted and grown to
OD600 of 0.1 in LB broth containing 300 µg/mL of carbenicillin. Bacteria culture (200 µL) was
added to each well of a polystyrene 96-well microplate (Costar 3370) containing appropriate
amount of brominated furanones or DMSO as a control. The plate was incubated at 37 °C for 24
h in a rotary shaking incubator (250 rpm). The culture from each well was then transferred to a
flat-bottom, 96-well plate with black wall (µClear, Greiner-One 655096). The fluorescence and
OD absorbance in each well was measured by Synergy 2 multi-mode microplate reader with
Gen5 data analysis software. Background signals from LB broth were deducted from all samples.
Fluorescence was measured at an excitation wavelength of 500 nm and an emission wavelength
of 540 nm.

Elastase B assay
Elastase B activity in P. aeruginosa was measured as previously reported,251 with some
modifications: Bacteria were grown overnight in LB media (10 g/liter tryptone, 5 g/liter yeast
extract, and 10 g/liter NaCl) at 37 oC, diluted and grown to midlog phase, and subcultured to LB
at OD600 of 0.05. The culture was then aliquoted to test tubes containing brominated furanones to
give the desired final concentrations. The tubes were incubated for 24 h at 37 °C with shaking
(250 rpm). Culture supernatants were recovered by centrifugation at 3000 rpm (Galaxy 5D
centrifuge, VWR) for 10 min at room temperature and then passed through a 0.45 µm PVDF
syringe filter (Santa Cruz Biotechnology). A 100 µL aliquot of the supernatant was added to 900
µL of Elastin-Congo red (ECR) buffer (100 mM Tris-HCl, 1 mM CaCl2, pH 7.2) containing 4.5
mg of Elastin-Congo red (Sigma-Aldrich) and incubated for 24 h at 37 oC with shaking (250
rpm). After incubation, 0.2 mL of 0.12 M EDTA was added to stop the reaction. Insoluble ECR
was removed by centrifugation and the absorbance of the supernatant (OD490) was measured.
Elastase B activity was measured by OD490 of the samples treated with brominated furanones
after subtracting the OD490 of the samples incubated in the absence of cell culture filtrate.
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